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1- Summary  
1-1- Summary  
Unlike the chromatin structure of somatic cells, sperm chromatin is very tightly compacted by 
virtue of the unique associations among the DNA, the nuclear matrix, and sperm nuclear proteins. 
Protamines (P1 and P2 family) are the most abundant proteins in human sperm nucleus and are 
important for condensation of the paternal genome of the spermatozoa that produce a more compact 
and hydrodynamic nucleus. This compact structure protects the genetic materials during transport 
of the paternal genome through the male and female reproductive tracts, also, allow proper fusion 
of male and female gametes and correct expression of the genetic information by the developing 
embryo. Human sperm protamine deficiency has been correlated significantly with reduced semen 
quality parameters (counts, motility and morphology), sperm penetration ability, sperm DNA 
integrity, and male infertility. 
Sperm DNA damage may occur at testicular, epididymal or post-ejaculatory levels. DNA damage 
in the male germ line has been associated with poor semen quality, low fertilization rates, impaired 
embryonal preimplantation development, increased abortion and an elevated incidence of disease in 
the offspring, including childhood cancer. 
Oxidative stress resulting from an imbalance in the productions of reactive oxygen species (ROS) 
and the antioxidant capacity appears to be the major cause of DNA damage in the male germ line. 
Spermatozoa are particularly susceptible to damage induced by excessive ROS; their plasma 
membrane contains large quantities of polyunsaturated fatty acids and their cytoplasm contains low 
concentrations of scavenging enzymes. Smoking was associated with an increase in ROS levels and 
a decrease in ROS-Total antioxidant capacity (TAC) scores. Many studies revealed that semen 
samples from smokers have a significantly higher ratio of single-strand-to double-strand breaks of 
DNA spermatozoa. 
The current study evaluates the relationship between the oxidative stress, smoking and human 
sperm DNA integrity. Other evaluations include the effect of smoking and sperm parameters, 
cotinine and oxidative stress biomarkers (ROS, MDA, and 8-OHdG) levels in seminal plasma, the 
effect of smoking on protamines, and the ratios of protamine 1 to protamine 2 in human 
spermatozoa and their effect on intracytoplasmic sperm injection (ICSI) and standard semen 
parameters.   
Semen samples of patients who underwent ICSI therapy (n=116) and healthy volunteers (n=50) 
were included in this study. The patients group and volunteers group were divided into two groups: 
smokers (where n=53 patients and n=19 volunteers) and non-smokers (n=63 patients and n= 31 
volunteers). Each semen sample was evaluated according to the WHO guideline (1999) except the 
morphology, which was evaluated undergo strict criteria. Chromatin condensation, DNA integrity, 
and protamines concentrations were investigated. In addition, the concentrations of ROS, MDA, 8-
OHdG and cotinine in seminal plasma were measured. Smears were prepared for evaluation of: 
sperm vitality (Eosin test) and morphology by normal staining; chromatin condensation (CMA3 
assay) and DNA integrity (TUNEL assay) by fluorescence technique. Aliquots of each sperms 
sample were used for protamine extraction and evaluation using acid-urea polyacrylamide gel 
electrophoresis. ROS, cotinine and 8-OHdG were evaluated by ELISA, while MDA were evaluated 
by chemical reactions.   
The results from this study showed significant differences (p<0.010) between volunteers and 
patients in sperm’s concentrations (80.2 ±27.5 vs.61.4 ± 31.1), motility (37.1 ± 14.7 vs. 27.4 ± 
12.0), vitality (45.2 ± 16.9 vs. 34.7 ± 17.3), sperm membrane integrity (53.4 ± 15.8 vs. 45.1 ± 
20.8), morphologically normal spermatozoa (45.9 ± 13.9 vs. 29.4 ± 12.7), chromatin condensation 
(positive CMA3) (23.3 ± 7.0 vs.32.9 ± 8.2), and DNA fragmentation (Tunel) (9.6 ± 5.4 vs. 14.2 ± 
5.6). In addition, an analysis of all samples showed that chromatin condensation evaluated by 
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CMA3 assay (bad sperms) showed significant negative (p<0.010) correlation with sperm 
concentration (r=-0.289), motility (r=-0.384), morphologically normal sperm (r=-0.514), viability 
(r=-0.458), and membrane activity (r=-0.343). Similarly, DNA integrity evaluated by TUNEL 
assay showed significant negative correlation (p<0.010) with motility, morphologically normal 
sperm, viability, and membrane activity (r=-0.330, r=-0.509, r=-0.406, r=-0.263 respectively). A 
significant positive (p<0.010) correlation between non-condensed chromatin and DNA integrity 
was also shown (r=0.479).  
All smokers samples (volunteers and patients) (n=72) showed significantly higher (p<0.010) levels 
than all non-smokers samples (volunteers and patients) (n=94) in sperm’s motility (35.8 ± 14.6 vs. 
23.4 ± 8.0), vitality (41.2 ± 17.3 vs. 33.5 ± 17.6), membrane integrity (54.1 ± 18.4 vs. 39.2 ± 18.4), 
morphologically normal spermatozoa (41.4 ± 13.7 vs. 26.6 ± 12.0), non-condensed chromatin (34.6 
± 8.1 vs. 26.4 ± 8.0), and DNA fragmentation (16.8 ± 5.1 vs. 9.6 ± 4.3).         
The oxidative stress biomarkers ROS, MDA, and 8-OHdG were significantly higher (p<0.010) in 
patients than in volunteers; ROS (103.85 ± 5.68 vs. 67.6 ± 42.2, p<0.010), MDA (7.82 ± 1.79 vs. 
6.45 ± 1.43, p<0.010), and 8-OHdG (1.95 ± 1.76 vs. 1.15 ± 0.82, p<0.050). In addition, these 
oxidative stress biomarkers (ROS, MDA, and 8-OHdG) of all samples showed significantly 
negative (p<0.010) correlations with sperm’s motility (r=-0.537, r=-0.513, r=-0.532), vitality (r=-
0.298, r=-0.309, r=-0.373), membrane integrity (r=-0.343, r=-0.362, r=-0.335) and morphologically 
normal sperm (r=-0.547, r=-0.514, r=-0.513). In contrast, significant positive (p<0.010) correlations 
between these biomarkers and non-condensed chromatin (r=0.629, r=0.555, r=0.545) and DNA 
fragmentation (r=0.630, r=0.624, r=0.600) were demonstrated. Fertilization and pregnancy rates 
were negatively affected by these biomarkers. 
Evaluation of smoking effects of both volunteers and patients smokers (n=72) compared to non-
smokers (n=94) on seminal plasma oxidative stress biomarkers showed significantly higher 
(p<0.010) concentrations in smokers compared to non-smokers; MDA (8.51 ± 1.43 vs. 6.10 ± 
1.18), ROS (128.75 ± 39.46 vs. 52.89 ± 28.48), and 8-OHdG (2.63 ± 1.54 vs. 0.71 ± 0.53).  
Seminal plasma smoking marker cotinine levels were found to be significantly higher in smokers 
than non-smokers (88.22 ± 58.05 vs. 2.34 ± 2.20, p<0.010). In general, negative significant 
(p<0.010) correlations were found between smoking marker cotinine levels in seminal plasma with 
sperm’s motility, vitality, membrane integrity and morphologically normal sperm (r=-0.489, r=-
0.322, r=-0.356, r=-0.555 respectively). Whereas, positive correlations (p<0.010) with sperm non-
condensed chromatin (r=0.549) and DNA damage (r=0.627) were demonstrated.  
Moreover, concentrations of P1 (416.30 ± 101.70) and P2 (363.60 ± 114.9) in patients were higher 
than that of volunteers (378.20 ± 100.00, 347.30 ± 77.30) and the P1/P2 ratio of patients was 
significantly higher than that of volunteers (1.22 ± 0.36 vs. 1.10 ± 0.20, p<0.050). The percentage 
of P2 in patients (46.7%) was lower compared to that of volunteers (47.9%). In addition, these 
findings showed that the concentrations of P1 were higher in samples of smokers than non-smokers 
(407.60 ± 128.80 vs. 402.63 ± 93.96, p>0.050) while the concentrations of P2 were significantly 
lower in smokers compared to non-smokers (335.60 ± 110.60 vs. 376.81 ± 97.36, p<0.050). The 
P1/P2 ratios were significantly higher (p<0.010) in smokers group compared to non-smokers (1.30 
± 0.42 vs. 1.09 ± 0.18).  
In the present study, direct quantitative measurements of sperm protamine concentrations revealed 
that P1 and P2 inversely correlated with DNA fragmentation. However, the concentrations of P1 
showed negative (p>0.050) correlations with non-condensed chromatin (r=-0.011, r=-0.091, r=-
0.167) and DNA fragmentation (r=-0.004, r=-0.053, r=-0.136) in all participant samples ––
volunteers and patients. Similar results were detected with P2 concentration (r=-0.126, r=-0.097, 
r=-0.208); (r=-0.060, r=-0.161, r=-0.036). Also, abnormalities in P1/P2 ratios inversely affected the 
sperm quality and function. The results indicated that in all participant samples P1/P2 ratios have 
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significant positive correlations (p<0.010) with the concentrations of the oxidative biomarkers; 
MDA (r=0.384), ROS (r=0.410), 8-OhdG (r=0.393) and cotinine (r=0.411).  
Smoking effect on protamines 1 showed that total amounts of protamines (1+2) in all non-smokers 
were higher than smokers (779.44 vs. 743.20). P1 concentrations in non-smokers and smokers were 
almost equal (402.63 ± 93.96; 407.60 ± 128.80, p>0.050), whereas, P2 concentrations in non-
smokers were significantly higher (376.81 ± 97.36 vs. 335.60 ± 110.60, p<0.050) than those of 
smokers. The P1/P2 ratios of all smokers, volunteers and patients, were significantly higher in 
comparison to those of non-smokers ––(1.30 ± 0.42, 1.19 ± 0.27, 1.34 ± 0.46) vs. (1.09 ± 0.18, 1.04 
± 0.11, 1.11 ± 0.20), respectively. These findings indicated that the causative agent for higher 
P1/P2 ratios in smokers was the under-expression of P2.  
In conclusion, the results of this study indicated that high levels of oxidative stress biomarkers 
(ROS, MDA, and 8-OHdG) induce lipid peroxidation of the sperm membrane and induce DNA 
damage which markedly influences sperm quality. It is quite probable that such a deleterious effect 
may account for some cases of male infertility, and the evaluation of oxidative stress biomarkers 
may be a part of infertile male workup in the near future. Also, oxidative stress inversely affects 
fertilization and pregnancy rates. Reactive oxygen species status may be used as an important 
indicator for clinical evaluation and treatment of malefactor infertility. 
In addition, in this study smokers showed high levels of oxidative stress biomarkers and decreased 
sperm quality as compared to non-smokers. This study also demonstrated that cigarette smoking 
impairs sperm function by reducing the quality and fertilizing capacity. This is probably because of 
high levels to toxic components of smoking such as cotinine that cause an increase of seminal 
plasma free radicals and oxidative stress.  
Quantification of the protamines revealed that most of the cases had high P1/P2 ratios and the 
majority was due to under-expression of P2. Results also showed that aberrant P1/P2 ratios are 
associated with reduced sperm quality and percentages of fertilization and pregnancy rates. 
Protamine concentrations (P1 and P2) were inversely correlated with the DNA fragmentation and 
non-condensed chromatin. Evaluation of the effects of smoking on protamines demonstrated a 
reduction in protamines concentrations and elevation of P1/P2 ratio in smokers as compared to non-
smokers. 
This is the first study conducted to evaluate the effect of smoking on the protamination process. 
Given the potential adverse effects of smoking on fertility, physicians should advise infertile 
patients who smoke cigarettes to quit smoking. Additional studies with large number of subjects are 
needed to confirm the effect of smoking on protamines and to clarify the potential mechanism 
behind this effect. 
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1-2- Zusammenfassung 
Im Gegensatz zu Körperzellen, hat das Chromatin der Spermien eine eigene Kondensation 
zwischen den DNA Strängen, der nukleären Matrix und den nukleären Proteinen. Die Protamine 
(P1 und P2 Familie) sind die am häufigsten vorkommenden Proteine des Spermnukleus und von 
entscheidender Bedeutung bei der Chromatinkondensation des paternalen Genoms. Diese 
Kondensation ist notwendig um das genetische Material während des Transportes des männlichen 
Genomes im weiblichen als auch männlichen Reproduktionstraktes, sowie des 
Gametenfusionierung und der Geschlechtsdifferenzierung, zu schützen. Ein Mangel an Protaminen 
im menschlichen Sperma korreliert signifikant mit einer Verminderung der Spermienqualität ( 
Motilität und Morphologie), ebenso wie schlechte Penetrationsfähigkeit der Eizelle, DNA Integrität 
und männliche Infertilität. 
Ein DNA Schaden in den Spermien kann im Hoden, Nebenhoden oder auch erst nach der 
Ejakulation stattfinden. Solch ein Schaden führt nicht nur zu einer eingeschränkten 
Spermienqualität sondern auch zu einer verminderten Fertilisationsrate, verminderte Implantation 
der Embryonen, höhere Abortrate und zunehmende Erkrankungen beim Neugeborenen, wie z.B. 
Krebserkrankungen. 
Oxidativer Streß, der durch ein Ungleichgewicht zwischen höheren Produktionen an ROS (reactive 
oxygen species) und eine verminderte antioxidantien Kapazität, scheint der Hauptverursacher von 
DNA Schäden in männlichen Gameten zu sein. Das Sperma ist besonders empfindlich für ROS, da 
die membran aus vielen ungesättigten Fettsäuren besteht und keine Reparaturenzyme, aufgrund 
mangelndem Zytoplasma, besitzt. Andererseits erhöht das Rauchen den Anteil der ROS und 
vermindert die antioxidative Kapazität. Viele Studien konnten zeigen, das die Spermien von 
Rauchern einen höheren Anteil an Einzel- und Dopplestrangbrüchen aufzeigen.  
Das Ziel dieser vorliegenden Arbeit war es den Einfluß des Rauchens auf die Entstehung des 
oxidativen Streß und daraus resultierende DNA- Schäden in Spermatozoen zu untersuchen. 
Darüberhinaus sollte der Einfluß des Rauchens auf andere Spermienparameter, die 
Cotininekonzentration im Seminalplasma und anderen Biomarkern des oxidativen Streß (ROS, 
MDA, 8-OHdG) analysiert werden. Weiterhin sollte der Einfluß des Rauchens auf das Protamin 1- 
Protamin 2 Verhältnisses in der Spermien-DNA sowie deren Zusammenhang mit anderen 
Spermienparametern und deren Einfluß auf die ICSI Ergebnisse untersucht werden. 
Ejakulate von ICSI Patienten (n=116) und gesunde Probanden (n=50) wurden im Rahmen der 
vorliegneden Doktorarbeit untersucht. Die Patienten-, als auch die Probandengruppe wurden in eine 
Raucher (Patienten n=53; Probanden n=19) und eine Nichtrauchergruppe (Patienten n=63; 
Probanden n= 31) unterteilt. Jede Spermaprobe wurde anhand der WHO Kriterien (1999) 
untersucht, die Morphologie nach Kruger- Kriterien. Darüberhinaus wurden die 
Chromatinkondenation, DNA Integrität und Protaminkonzentration beurteilt. Die Konzentrationen 
an ROS, MDA, 8-OHdG und Cotinine wurden im Seminalplasma gemessen. Es wurden Abstriche 
angefertigt zur Bestimmung der Spermienvitalität (Eosintest) und Morphologie, 
Chromatinkondensation (CMA3 Test) und DNA Integrität (TUNNEL Test) mittels 
Fluoreszenstechniken. Ein Teil jeder Spermienprbe wurde zur Bestimmung der Protamine genutzt 
durch Urea-Acid Polyacrylamid Gel Elektrophorese. ROS, Cotinine und 8-OhdG wurden durch 
Anwendung des ELISA bestimmt, während MDA durch chemische Reaktionen nachgewiesen 
wurde. 
Die Ergebnisse dieser Arbeit zeigten einen signifikanten Unterschied (p<0.010) zwischen den 
Probanden und den Spermienkonzentrationen der Patienten (80.2 ±27.5 mill./ml vs.61.4 ± 31.1 
mill./ml), Motilität (37.1 ± 14.7% vs. 27.4 ± 12.0 %), Vitalität (45.2 ± 16.9% vs. 34.7 ± 17.3%), 
Spermienmembranintegrität (53.4 ± 15.8% vs. 45.1 ± 20.8%), morphologisch normale Spermien 
(45.9 ± 13.9% vs. 29.4 ± 12.7%), Chromatinkondensation (positive CMA3) (23.3 ± 7.0% vs.32.9 ± 
8.2%), und DNA Bruchstücke (Tunel) (9.6 ± 5.4% vs. 14.2 ± 5.6%). Darüberhinaus zeigte eine 
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Analyse aller Spermienproben dass die Chromatinkondensation, dargestellt mittels CMA3 assay 
(schlechte Spermien) eine negative Korrelation (p<0.010) mit der Spermienkonzentration (r=-
0.289), Motilität (r=-0.384), morphologisch normale Spermien (r=-0.514), viability (r=-0.458), und 
Membran und DNA Integrität (r=-0.343).  
Gleichermaßen zeigte die DNA-Integrität, gemessen mittels TUNNEL Assay, eine signifikante 
negative Korrelation (p<0.010) mit der Motilität, morphologisch normale Spermien, Vitalität und 
Membranaktivität (r=-0.330, r=-0.509, r=-0.406, r=-0.263). Darüberhinaus konnte eine positive 
Korrelation (p<0.010) zwischen nicht-kondensiertem Chromatin und DNA-Integrität gezeigt 
warden (r=0.479).  
Weiterhin, alle Proben von Rauchern (Probanten und Patienten) (n=72) zeigten einen signifikant 
höheren Anteil motiler Spermien (p<0.010) als die Proben der Nicht-Raucher (Probanden und 
Patienten) (n=94), (35.8 ± 14.6% vs. 23.4 ± 8.0%), Vitalität (41.2 ± 17.3% vs. 33.5 ± 17.6%), 
Membranintegrität (54.1 ± 18.4% vs. 39.2 ± 18.4%), morphologisch normale Spermien (41.4 ± 
13.7% vs. 26.6 ± 12.0%), nicht kondensiertes Chromatin (34.6 ± 8.1% vs. 26.4 ± 8.0%), und DNA 
Fragmentierung (16.8 ± 5.1% vs. 9.6 ± 4.3%).  
Biomarker des oxidativen Stresses ROS, MDA, und 8-OHdG waren signifikant höher (p<0.010) 
bei der Gruppe der Patienten als der der Probanden; ROS (μmol/ml) (103.9 ± 5.7  vs. 67.6 ± 42.2, 
p<0.010), MDA (μM) (7.8 ± 1.8 vs. 6.5 ± 1.4, p<0.010), und 8-OHdG (ng/ml) (2.0 ± 1.8 vs. 1.2 ± 
0.8, p<0.050). Diese Marker des oxidativen Stresses (ROS, MDA, and 8-OHdG) aller Proben 
zeigten eine significant negative Korrelation (p<0.010) mit der Spermienmotilität (r=-0.537, r=-
0.513, r=-0.532), Vitalität (r=-0.298, r=-0.309, r=-0.373), Membranintegrität (r=-0.343, r=-0.362, 
r=-0.335) und morphologisch normale Spermien (r=-0.547, r=-0.514, r=-0.513). Im Gegensatz dazu 
wurde eine signifikant positive Korrelation (p<0.010) zwischen diesen Biomarkern und nicht-
kondensiertem Chromatin (r=0.629, r=0.555, r=0.545) und DNA Fragmentation (r=0.630, r=0.624, 
r=0.600) gezeigt. Die Fertilisation als auch die Schwangerschaftsrate wurden von diesen 
Biomarkern negativ beeinflusst. 
Effekte des Rauchens in beiden Gruppen Probanden als auch Patienten (n=72) verglichen mit 
Nicht-Rauchern (n=94) wurden die Marker des oxidativen Stresses im Seminalplasma untersucht 
und zeigten significant höhere Konzentrationen (p<0.010) bei Rauchern, verglichen mit Nicht-
Rauchern; MDA (μM) (8.5 ± 1.4 vs. 6.1 ± 1.2), ROS (μ mol/ml) (128.8 ± 39.5 vs. 52.99 ± 28.5), 
und 8-OHdG (ng/ml) (2.6 ± 1.5 vs. 0.7 ± 0.5).  
Darüberhinaus war der Cotininegehalt (ng/ml) im Seminalplasma von Rauchern signifikant höher 
als bei Nicht-Rauchern (88.22 ± 58.05 vs. 2.34 ± 2.20, p<0.010). Zusammenfassend konnte eine 
signifikant negative (p<0.010) Korrelation zwischen dem Rauchermarker Cotinine im 
Seminalplasma und den Spermienmarkern Motilität, Vitalität, Membranintegrität  und 
morphologisch normale Spermien  (r=-0.489, r=-0.322, r=-0.356, r=-0.555). Weiterhin konnte eine 
positive Korrelation (p<0.010) zwischen Spermien mit nicht-kondensiertem Chromatin   (r=0.549) 
und DNA Schäden  (r=0.627) gezeigt werden.  
Die Konzentrationen von P1(ng/106 sperm) (416.3 ± 101.7) und P2 (ng/106 sperm) (363.6 ± 114.9) 
waren bei den Patienten höher als bei den Probanden (378.2 ± 100.0, 347.3 ± 77.3), ebenso war das 
P1/P2 Verhältnis bei den Patientensignifikant höher als in der Probandengruppe (1.2 ± 0.4 vs. 1.1 ± 
0.2, p<0.050), jedoch der prozentuale Anteil an P2 war bei der Patientengruppe niedriger (46.7%) 
verglichen mit der Probandengruppe (47.9%). Diese Ergebnisse zeigen, dass die Konzentrationen 
an P1 (ng/106 sperm)  bei den Raucherproben höher waren als bei den Nicht-Rauchern (407.6 ± 
128.8 vs. 402.6 ± 94.0, p>0.050) die Konzentrationen an P2 (ng/106 sperm) waren signifikant 
niedriger bei der Rauchergruppe als bei den Nicht-Rauchern (335.6 ± 110.6 vs. 376.8 ± 97.4, 
p<0.050). Das P1/P2 Verhältnis war significant höher (p<0.010) in der Raucher-Gruppe verglichen 
mit der Nicht-Rauchergruppe (1.3 ± 0.4 vs. 1.1 ± 0.2).  
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In der vorliegenden Untersuchung wurde außerdem ein direkter quantitativer  inverse 
Korrelatione zwischen der Konzentration an Spermienprotaminen P1 und P2 (ng/106 sperm) und 
der DNA Fragmentation (%) gemessen. Darüberhinaus zeigte die Konzentration an P1 (ng/106 
sperm) eine negative Korrelation (p>0.050) mit nicht-kondensierten Chromatin % (r=-0.011, r=-
0.091, r=-0.167) und DNA Fragmentation % (r=-0.004, r=-0.053, r=-0.136) in allen 
Teilnehmenden, Patienten und Probanden. Ähnliche Ergebnisse zeigten sich für die P2 (ng/106 
sperm) Konzentrationen (r=-0.126, r=-0.097, r=-0.208); (r=-0.060, r=-0.161, r=-0.036). Ebenso 
konnten Abnormalitäten bei der P1/P2 Ratio gezeigt werden mit inversem Effekt auf die Spermien 
Qualität und Funktion. Diese Ergebnesse zeigen, dass in allen Proben (Probanden als auch 
Patienten) die P1/P2 Ratios eine signifikant positive Korrelations (p<0.010) mit den 
Konzentrationen an oxidativen Biomarkern zeigt MDA (μM) (r=0.384), ROS (μmol/ml) (r=0.410), 
8-OhdG (ng/ml) (r=0.393) und Cotinine (ng/ml) (r=0.411).  
Der Einfluß des Rauchens auf die Protamine 1 und den gesamt Anteil aller Protamine (1+2) (ng/106 
sperm) bei allen Nicht-Rauchern war höher als bei den Rauchern (779.4 vs. 743.2). Die P1 (ng/106 
sperm) Konzentrationen waren bei den Nicht-Rauchern und Rauchern fast identisch (402.6 ± 94.0; 
407.6 ± 128.8, p>0.050), wohingegen die P2 (ng/106 sperm) Konzentration bei Nicht-Rauchern 
signifikant höher war (376.8 ± 97.4 vs. 335.6 ± 110.6, p<0.050) als bei den Rauchern. Die P1/P2 
Ratio aller Raucher, Probanden und Patienten, war signifikant höher im Vergleich zu der Nicht-
Raucher (1.3 ± 0.4, 1.2 ± 0.3, 1.3 ± 0.5) vs. (1.1 ± 0.2, 1.0 ± 0.1, 1.1 ± 0.2). Diese Ergebnisse 
zeigen daß der ursächliche Indikator für eine erhöhte P1/P2 Ratio ein verminderter Anteil an P2 ist.  
Zusammenfassend belegen die Ergebnisse dieser Arbeit, dass ein hoher Anteil an oxidativen 
Stressmarkern (ROS, MDA und 8-OHdG) eine Lipidperoxidation in der Spermienmembran 
verursachen, als auch einen Schaden in der DNA und somit die Spermienfähigkeit beeinflußt. Es ist 
möglich, dass diese Schäden durch Peroxidation eine männlichen Subfertiliträt verursachen und 
daher kann die Evaluierung des oxidativen Stresses als entscheidender klinischer Parameter in der 
Beurteilung als auch Behandlung der männlichen Subfertilität dienen. 
Darüberhinaus zeigte diese Arbeit, dass Oxidativer Stress durch Rauchen ensteht und dadurch die 
Spermienqualität bei Rauchern herabgesetzt ist im Vergleich zu Nicht-Rauchern. 
Sowohl die Parameter als auch die Funktionsfähigkeit der Spermien wird beeinsträchtigt. Die 
Ursache hierin liegt in der toxischen Substanz des Rauchens einerseits und dem Cotininanstieg 
andererseits im Seminalplasma. 
Die qualitative Bestimmung der Protamine zeigt, dass in den meisten Fällen die P1/P2 Ratio höher 
waren durch eine P2 Minderexpression. Dieses Verhältnis führt zu einer Verminderung der 
Spermienqualität und damit Verminderung der Fertilisationsfähigkeit und Schwangerschaftsrate. 
Die Bestimmung des Protamines bei Rauchern zeigt , dass Raucher weniger Protamin besitzen und 
die P1/P2 Ratio erhöht ist im Vergleich zu Nicht-Rauchern. 
Nach unseren besten Kenntnissen und Literaturrecherche ist dies die erste Untersuchung über einen 
Zusammenhang zwischen Rauchen und Protaminkonzentrationen und P1/P2 Ratio in Spermien. 
Unter Berücksichtigung des negativen Effektes des Rauchens auf die Fertiltät sollte der Arzt bei 
einem subfertilen Patienten immer ein Rauchverbot empfehlen. Weitere Studien sind notwendig um 
durch eine größere Patientenzahl diese Ergebnisse zu untermauern.  
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2- Introduction 
Infertility affects approximately 15% of couples trying to conceive and a male cause is believed to 
be a sole or contributing factor in approximately half of these cases (Oehninger, 2001), up to 40% 
of men in the study had sperm abnormalities, without known  specific etiological factors (de 
Kretser, 1997). Disorders of the male reproductive system have become an important public health 
issue as they can cause infertility, miscarriages and abnormal outcomes in the offspring. Basic 
semen analysis consists of measuring seminal volume, pH, sperm concentration, motility, 
morphology and vitality (Centola and Ginsburg, 1996). These parameters may describe important 
aspects of the functions of the testes and sperm, but they do not address the integrity of the genetic 
material of the male gamete. 
Mammalian spermatogenesis is a complex process through which physiological, biochemical and 
morphological changes occurs, resulting in a transformation of round diploid spermatogonia into 
fully differentiated haploid spermatozoa with a condensed nucleus, acrosome and flagellum. These 
reactions include a variety of mechanisms including DNA methylation, phosphorylation, 
acetylation and ubiquitination of the histone, the main proteins of chromatin, component (Berger, 
2002; Govin et al., 2004; Li et al., 2008).  Spermatogenesis is characterized by two distinct stages, 
spermatocytogenesis and spermiogenesis (D’Occhio, 2007).  
Spermatocytogenesis involves mitotic divisions including proliferation and maintenance of 
spermatogonia (Senger, 1999), which will undergo meiosis to form primary spermatocytes. These 
spermatocytes will develop into secondary spermatocytes, which then differentiate into spermatids. 
Spermatids can be divided into three categories: early spermatids with round nuclei, intermediate 
spermatids with elongating nuclei, and mature spermatids with condensed nuclei (Dadoune, 2003). 
In the mid-spermiogenesis histone nucleoproteins of the meiotic germ cells are replaced by 
protamine nucleoproteins leading to changes in the shape and size of the nucleus and the 
compaction state of the chromatin (Dadoune, 2003).  
The final stage of spermatogenesis includes spermiogenesis in which a fully differentiated, mature 
sperm produced from an early round spermatid. The remodeling that occurs during spermiogenesis 
including replacement of somatic histones with protamines produces a cell in which the nucleus is 
transcriptionally inactive, and the majority of the cytoplasm is shed in the form of a residual body 
(Sakkas et al., 2002; Aoki and Carrell, 2003).  
Sperm DNA is organized in a specific manner that keeps the nuclear chromatin compact and stable 
(Agarwal & Said, 2003). Packaging of the sperm DNA with specific nucleoproteins; protamines 
into tight and crystalline status at least six times more condensed than in mitotic chromosomes, 
sperm chromatin structure protects the integrity of the genetic materials during transport of the 
paternal genome through the male and female reproductive tracts or injection into oocyte cytoplasm 
(Fuentes-Mascorro et al., 2000; Zini  et al., 2001; Evenson et al., 2002). Spermatozoa retain some 
of their original histone content that forms less-compact nucleosome structures, which is important 
in the sperm nucleus to respond to oocyte signals for pronucleus formation after sperm penetration 
(Bench et al., 1996; Gineitis et al., 2000).   
2-1- Human sperm chromatin structure 
Sperm chromatin differs from somatic cells in structure and composition. Sperm chromatin has a 
somatic cell-like structure during the last meiotic division of spermatocytes leading to round 
spermatids and consists of histone-DNA complex formed classical nucleosome core particles 
(Evenson, 1999). The nucleosome comprises DNA enveloped around an octamer of core histones 
(Kornberg, 1974; Noll, 1974). Each nucleosome is connected by linker DNA to give somatic 
chromatin the appearance of beads on a string (Wolffe, 2001). Concomitant with visible changes in 
sperm chromatin organization, histones are removed from the DNA of spermatocytes in early 
spermatids and replaced by transition proteins. Transition proteins are then replaced by protamines 
 14 
that are responsible for the final condensation and stabilization of sperm chromatin (Steger, 
1999; Kierszenbaum, 2001; Zhao et al., 2001). 
Therefore, sperm chromatin is a highly organized, compact structure consisting of DNA and 
nucleoproteins. Protamines are the most abundant nucleoproteins in mature sperm. They are 
positively charged and replace histones during spermiogenesis (Carrell et al., 2007). This 
condensed, insoluble and highly organized sperm chromatin structure protects the genetic materials 
during transport of the paternal genome through the male and female reproductive tracts, also, 
allow proper fusion of male and female gametes and correct expression of the genetic information 
by the developing embryo (De Jonge 2000; Solov’eva et al., 2004). Humans express two 
protamines, protamine 1 (P1) and protamine 2 (P2), both of which are expressed in roughly equal 
quantities with a mean P1/P2 ratio of approximately 1.0 (Balhorn et al., 1999; Carrell and Liu, 
2001; Oliva, 2006). 
Human sperm nuclei contain approximately 85% protamines in their nucleoprotein component, 
considerably fewer than those of a bull, stallion, hamster and mouse (Gatewood et al., 1987; Bench 
et al., 1996). Human sperm chromatin, therefore, is less regularly compacted and frequently 
contains DNA strand breaks (Sakkas et al., 1999b; Irvine et al., 2000).  
Sperm DNA interacts with protamines in a unique fashion that involves the coiling of sperm DNA 
into toroidal subunits, also known as doughnut loops. Toroid containing 50–60 kb of DNA is the 
packaging unit of the sperm chromatin. Each toroid represents a DNA loop-domains highly 
condensed by protamines and fixed at the nuclear matrix. They are cross linked by disulfide bridges 
of cysteine residues of the protamines (Fuentes-Mascorro et al., 2000). Thus, chromosome contains 
many toroids; at the completion of spermiogenesis there can be up to 50,000 toroidal structures 
packed within the sperm nucleus (Balhorn et al., 1999). Toroids and all 23 chromosomes are 
clustered by centromeres into a compact chromocenter positioned well inside the nucleus with 
telomere ends united into diamers exposed to the nuclear periphery (Zalensky et al., 1995; 
Solov’eva  et al., 2004) The retention of 15 % histones, which are less basic than protamines, leads 
to the formation of less compact chromatin structure. This structure facilitates the decondensation 
process after fertilization. Reduction of the protamine disulphide bonds that allows protamine 
removal is one of the first steps to occurr (Gatewood et al., 1987). Protamines replacement by 
histones may also be necessary for silencing of the paternal genome and reprogramming of the 
imprinting pattern of the gamete (Aoki and Carrell, 2003). Figure 1 represents the major chromatin 
changes occurring during the nucleohistone–nucleoprotamine transition.
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Figure 1. Schematic representation of the major chromatin changes occurring during the nucleohistone–
nucleoprotamine transition in spermiogenesis and the subsequent nucleoprotamine unpacking and nucleohistone 
structure reconstitution at fertilization. The round spermatid (top left) has a chromatin structure similar to that present 
in all somatic cells, with the DNA organized in nucleosomes and many genes being actively transcribed. During the 
initial stages of spermiogenesis, histones are hyperacetylated and undergo other modifications, nucleosomes are 
disassembled, topoisomerase II unwinds superhelicity of the DNA, transcription ceases and transition proteins (TNPs) 
bind the DNA. At the final stage of spermiogenesis, TNPs are removed and protamines progressively bind the DNA. 
During sperm maturation in the epididymis, the formation of disulphide bonds in protamines further stabilizes the  
nucleoprotamine complex. At fertilization, the highly compact nucleoprotamine structure must be unpacked and 
reorganized into a nucleosomal structure. Histones are represented in red and DNA is represented by blue lines. The 
presence of hyperacetylation in the N-terminal histone tails is indicated by ‘Ac’. Transition proteins are represented as 
orange elongated ovals. Protamines are represented as red elongated ovals (Adapted from Oliva, 2006). 
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2-2- Sperm Nuclear Proteins 
2-2-1- Histones  
Histones, the main proteins of chromatin, are essential for packaging of the DNA in chromosome 
(Redon et al., 2002). Conventional histones are mostly synthesized and assembled into 
nucleosomes during S phase progression; whereas, replacement histones can be produced and 
incorporated throughout the cell cycle (Govin et al., 2004). The highly basic nature of histones 
facilitates DNA-histone interactions, and contributes to the water solubility of histones. They are 
characterized by relatively high levels of lysine and arginine.  
The mutagen family encoding the five classes of replication-dependent histones has been identified 
from the human genome sequence. The human replication-dependent histone genes are found in 
clusters: the largest cluster is on chromosome 6 (6p21–p22) and contains 55 histone genes (Albig 
and Doenecke, 1997; Albig et al., 1997) and is termed HIST1. Two smaller clusters of histone 
genes are present in HIST2 the first on chromosome 1 (located at 1q21), which contains six genes, 
and the second, termed HIST3 on human chromosome 1(located at 1q42), which contains three 
histone genes (Marzluff et al., 2002). 
Histones are part of the building structural unit of chromatin,the nucleosome, which consists of 146 
base pairs of DNA wrapped around an octamer of core histones, including two molecules of H2A, 
H2B, H3 and H4 (Luger et al., 1997). There is also a fifth histone H1 that protects additional DNA 
fragments linking neighboring nucleosomes (Khochbin, 2001). More specifically, the histones H3 
and H4 form a dimer, two H3–H4 dimers associate into a (H3–H4) 2 tetramer. DNA wraps around 
this tetramer, forming a tetrameric particle. Histones H2A and H2B heterodimerize and 
heterodimers associate on each side of the tetrameric particle to form a nucleosome (Luger et al., 
1997). Variants of histones H2A, H2B, H3 and H1 also have been identified (Table 1). 
Table1. Variants of histones in mammalian spermatogenic cells (adapted from Govin et al., 2004; 
D’Occhio et al., 2007) 
Histone Somatic Variants Gametogenic variant Testis specific variant 
H1 H1b, H1c, H1d, H1e, H1° H1a H1t, HILS1 
H2A H2A.1, H2A.2, H2A.Z H2A.X TH2A 
H2B H2B.1 -- TH2B 
H3 H3.1, H3.2, H3.3 -- TH3/H3t 
H4 No variants No variants No variants 
 
In addition to the somatic-type histone variants, spermatogenic cells express testis-specific histones 
that replace somatic histones (Dadoune, 2003). A structural difference had been observed between 
testis-specific histones and somatic histones in the N-terminal region, the core region and the C-
terminal region. The testis specific histone variants did not undergo polyadenylation and was 
translated early during spermatogenesis (Zalensky et al., 2002).  H2B variant had been localized in 
telomeres and contain a phosphorylatable amino acids instead of four prolines found in the N-
terminal region of the somatic H2B (Churikov et al., 2004a). 
Moreover, histones are subject to post translational modification by enzymes primarily on their N-
terminal tails, but also in their globular domains. Such modifications include methylation, 
citrullination, acetylation, phosphorylation, ubiquitination, and ADP-ribosylation. This affects their 
function in gene regulation. 
Recently, Li et al., (2008) found that the core histones and chromosome 16 telomeric regions were 
localized at the base of the sperm nuclei. Also, previous studies reported that the nucleohistone 
components localized in the posterior region of the nuclei and extend to the region occupied by the 
sperm nuclear annulus, likely provide an anchor (Ward and Coffey, 1989; Barone et al., 1994). 
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Other reports showed that histones associated with specific regions that include the telomeres, 
promoter and repeating regions and certain small gene-rich regions (Wykes and Krawetz, 2003; 
Namekawa et al., 2006). 
The highly packaging of the sperm nucleus might be necessary for proper relaxing of the male 
genome during fertilization (Zalensky and Zalenskaya, 2007). van der Heijden et al., (2006) 
suggested that nucleohistone component remains in the nucleus could serve as a template for the 
replacement of protamines by histones after fertilization. While others have suggested that this 
histones could influence transcription of some genes after fertilization (Gardiner-Garden et al., 
1998). Perhaps this unique packaging is essential for appropriate decondensation and 
reorganization of the paternal genome following fertilization. In contrast, both protamines were 
distributed more evenly throughout the nucleus (Li et al., 2008). 
2-2-2- Transition nuclear proteins (TPs) 
Replacement of histones with protamines pass first through another type of nuclear proteins called 
transitional proteins (TPs). Despite the presence of at least four transition proteins, in man 
(Luerssen et al., 1988) transitional proteins 1 (TP1) and 2 (TP2) are the major ones. Transition 
proteins, TP1 and TP2 are unique to mammalian spermatogenesis and play an important role in the 
spermiogenesis process. The transition nuclear proteins (TPs) constitute 90% of the chromatin 
basic proteins during the steps of spermiogenesis between histone removal and the deposition of the 
protamines (Yu et al., 2000). 
They are arginine- and lysine-rich proteins. They are of intermediate basicity. TP1 is a 6.2 kDa 
protein of about 54 amino acid rich in arginine (20%), lysine (20%), histidine and serine.  They are 
distributed uniformly throughout the molecule, but contains no cysteine (Kistler et al., 1975; 
Dadoune, 1995; 2003). It is important for destabilization of the spermatozoa DNA probably due to 
the presence of two tyrosine residues flanked by basic amino acids (Schumacher et al., 1998). In 
vitro studies have shown that the possible functions of TP1 includes relaxation of the DNA in 
nucleosomal core particles (Singh and Rao 1988), decreasing the melting temperature of DNA 
(Akama et al., 1998), and stimulating the DNA- relaxing activity of topoisomerase I (Akama et al., 
1999). Also TP1 can stimulate single-strand break repair in vitro and in transfected somatic cells 
(Caron et al., 2001). 
TP2 is a 13 kDa protein (117–138 amino acids) containing proline (13%), serine (22%), arginine 
(14%), lysine (9%) and cysteine (5%) basic residues (Grimes et al., 1975; Dadoune, 2003). Also it 
has a highly basic C terminal domain and a zinc finger N-terminal domain (Meetei et al., 2000), 
which is essential for the recognition of CpG islands in the genome (Pradeepa and Rao, 2007). 
Contrary to TP1, TP2 can increase the compaction of the DNA in nucleosomal cores, increasing the 
melting temperature of DNA. It has been proposed to be a DNA-condensing protein (Baskaran and 
Rao 1990). Pradeepa and Rao, (2007) showed that TP1 is a DNA melting protein while TP2 is a 
DNA condensing protein and TP2 has zinc, which is essential to the recognition of CpG islands in 
the genome. 
The sequence of TP1 is highly conserved in various mammals, while the TP2 sequence is poorly 
conserved (Kremling et al., 1989; Alfonso and Kistler 1993). The mRNA of these proteins (TP1 
and TP2) first appears in the post-meiotic, round spermatid stage in mice and are degraded around 
stages, 13–14 of spermiogenesis, while the proteins are observed in stages 12 and 13 and are 
removed by stage 14 when replaced with protamines (Kistler et al., 1996). In addition, in transgenic 
mice, failure of complete chromatin compaction and increase in DNA denaturation was indicated 
due to the reduced amount of protamine 2 that resulted in animals without TP2 (Zhao et al., 2001; 
Cho et al., 2003; Meistrich et al., 2003). 
The work of Zhao et al., (2004) on mice showed that TP1 and TP2 had partially complemented 
each other and both are required for normal chromatin condensation, for reducing the number of 
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DNA breaks, and for preventing the formation of secondary defects in spermatozoa, eventual 
loss of genomic integrity, and sterility. 
TP1 and TP2 are encoded by single copy genes, Tnp1 and Tnp2. Tnp2 is found in the same 
chromosome with the two protamine genes (Engel et al., 1992), which suggests that they arose by 
gene duplication and might have retained common functions (Meistrich et al., 2003). On the other 
hand, Tnp1 was found on a separate chromosome (Heidaran et al., 1989).  
Transition protein 3 (76–103 amino acids) has been isolated and characterized in the rat, ram and 
boar (Dadoune, 2003). Transition protein 4 also has been characterized in rat and boar late 
spermatid nuclei; it is a basic protein of 138 amino acids comprising a highly basic amino-terminal 
region and a less basic carboxy-terminal region (Wouters-Tyrou et al., 1998). In the rat, transition 
protein 4 is a unique protein, is immunologically distinct from transition proteins 1–3, protamine 1 
and histones, and shares no sequence homology with other known proteins (Unni and Meistrich, 
1992). 
2-2-3- Replacement of histones by protamines 
Replacement of histones by protamines involved many steps, including the expression and 
incorporation of testis-specific histone variants, histone hyperacetylation, replacement of histones 
with transition proteins and protamine incorporation and phosphorylation (Aoki and Carrell, 2003; 
Churikov et al., 2004b). At the end of the spermatogenesis, the nucleosomal structure is 
disassembled and replaced by transition proteins, then finally by protamines. This transition is 
continuing with many changes in the chromatin activities (Kierszenbaum and Tres, 2004; Li et al., 
2008). Although, protamines replaced most of the histones ––approximately 85%. The human male 
gamete retains approximately 15% of its genome in a histone-bound state (Gatewood et al., 1987, 
Li et al., 2008) in camparison to other species such as the mouse where replacement reached more 
than 98% (de Yebra et al., 1993; Zalensky et al., 2002. This structure facilitates the decondensation 
process after fertilization. Reduction of the protamine disulphide bonds to allow protamine removal 
is one of the first steps occurring. Figure 2 highlights the key events in the transition of somatic 
histones to replacement by protamines. Most of these spermatozoal histones are variants of their 
somatic histone counterparts, whichpackage the DNA into nucleosomes that are more closely 
packed than in somatic chromatin. The DNA that is packaged by histones in mature sperm includes 
the genes for ε-globin and γ-globin (Gardiner-Garden et al., 1998) and telomeric DNA (Banerjee et 
al.,1995; Zalenskaya et al., 2000).   
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Figure 2. Diagram highlighting the key events in the transition of somatic histones to replacement by protamines. 
Somatic histones undergo site-specific methylation, phosphorylation and ubiquitination which facilitates their 
replacement by testis-specific histones (t) during meiosis. Hyperacetylation of H4-t is a key factor in relaxation of the 
DNA coil to facilitate replacement of the testis-specific histones by the transition proteins, whereas topoisomerase 1 
relieves torsional stress by causing double-strand breaks which are subsequently re-ligated. Protamines 1 and 2, 
processed from a pool of RNP particles, undergo maturation before and during binding to the DNA and replacemnt of 
the transition proteins. HR6B, ubiquitin-conjugating enzyme E2B (UBE2B) (RAD6 homolog); HAT, histone 
acetyltransferase; Suv39, H3 Lys 9 histone methyltransferase (adapted from Carrell et al., 2007). 
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Hyperacetylation of the histones regulation by histone acetyl transferases and histone 
deacetylases reduces the binding between nucleosomes and DNA, leading to chromatin relaxation 
and is also associated with the activation of topoisomerases that inducing strand breaks (Hazzouri 
et al., 2000; Marcon and Boissonneault, 2004). This histone hyperacetylation and rapid turnover of 
acetyl groups could rapidly and reversibly expose binding sites in chromatin for subsequent binding 
of chromosomal proteins (Oliva and Mezquita, 1982). It was proposed that hyperacetylation of core 
histones may facilitate the replacement of histones by protamines (Oliva and Mezquita, 1986; Oliva 
et al., 1987; Sonnack et al., 2002).  
However, DNA relaxation under the effect of histones hyperacetylation and topoisomerases activity 
allows the replacement of histones with transition proteins (Kierszenbaum, 2001; Meistrich et al., 
2003). The transition nuclear proteins (TPs) replaced about 90% of the chromatin basic proteins 
during the steps of spermiogenesis (Yu et al., 2000). Finally, protamines replace the transition 
proteins to form a highly compact nucleoprotamine complex. After binding to the DNA, the 
formation of disulphide bonds between protamines further stabilizes the nucleoprotamine complex 
(Balhorn et al., 1992). A significant overlap in the expression of histones, transition proteins and 
protamines was proposed (Meistrich et al., 2003). Therefore, expression of the proteins has been 
shown to have some overlap in human-elongating spermatids (Aoki et al., 2006b). 
Immediately after the translation of P1 and P2 intermediate, they were phosphorylated (Green et 
al., 1994; Papoutsopoulou et al., 1999). This phosphorylation is necessary for proper binding of the 
proteins to DNA. However, once protamines were bound to DNA, dephosphorylation occurred and 
this process appears to be essential for proper condensation of the chromatin (Gusse et al., 1986; 
Aoki and Carrell, 2003). 
A conformational change in the packaging of the chromatin was induced once the transition 
proteins were replaced by protamines. A loop of less than half the size of somatic cell histone loops 
formed followed by formation of toroidal structures, which have a 6–20-fold increase in packaging 
compaction (Ward and Coffey, 1991; Balhorn et al., 2000). P1 and P2 may bind to the major and 
minor groove of DNA or to the DNA surface by interacting electrostatically with phosphate 
residues (Balhorn et al., 1999; Fuentes-Mascorro et al., 2000).   
2-2-4- Protamines 
Protamines are a diverse family of small and highly basic proteins (5–8 kDa) which are about half 
the size of a typical histone. They are short of about 50-110 amino acids, and they are positively 
charged due to the high content of positive charged amino acid, the arginine residues (the major of 
the amino acid residues) that form about 55 to 79% of the amino acid residues, permitting a strong 
binding with DNA. But, the total number of amino acids and the positions of the arginine residues 
have changed considerably (Rooney et al., 2000). It was proposed that the driving forces for this 
arginine-rich selection could be (i) the DNA-binding function of the protamine P1 resulting in a 
more compact sperm nucleus and (ii) the interaction and strong activation of oocyte creatine kinase 
II by protamine (Ohtsuki et al., 1996; Rooney and Zhang, 1999). 
A significant amount of cystein residues that are very important in final sperm nuclear maturation 
by forming multiple inter- and intra protamine disulfides cross bonds (Loir and Lanneau, 1984). 
Formation of these inter and intra molecular disulphide bonds between cysteine residues will 
strongly stabilize the nucleoprotamine structure in the sperm nucleus and stabilize the folding of 
different protamine domains (Vilfan et al., 2004). 
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2-2-4-1 - Genes of protamines 
Humans have one copy of the protamine 1 gene (PRM1) and one copy of the protamine 2 gene 
(PRM2) per haploid genome, located on chromosome 16 at 16p13.3 (Figure 3; Oliva and Dixon, 
1991; Wykes and Krawetz, 2003). The mammalian P1 and P2 genes contain a single intron. The 
sequences of these genes (PRM1 and PRM2) are organized in the form of a loop domain together 
with the transition protein 2 gene (TNP2) and a sequence called gene4  or protamine 3 (Engel et al., 
1992; Martins et al., 2004). The P1-P2-TP2 locus spans a 28.5-kb region and is organized in a 
linear array, a structural feature affording concurrent expression of the P1, P2 and TP2 genes 
(Choudhary et al., 1995). The P1 gene is present in all mammalian species, whereas P2 is present in 
the mouse, hamster, rat, stallion and man (Calvin, 1976; McKay et al., 1986; Bower et al., 1987; de 
Yebra et al., 1993). However, in some species, the protamine 2 gene is present but the protein is 
absent (Maier et al., 1990). 
The protamine 3 (gene 4) contains a repeating glutamic and aspartic acid residues similar in 
number and distribution to the clusters of arginine and lysine residues found in the DNA-binding 
domains of protamines. The amino-acid sequence for this protein approximately has the same size 
as protamine P2. This composition with a high content of negatively charged amino acids suggests 
that it is not binding or condensing DNA and may have other functions (Balhorn, 2007).  
The structure of the protamine genes plays a major role in their transcriptional regulation (Aoki and 
Carrell, 2003): First, the highly conserved sequence of cAMP-response element (CRE) that is 
present in all protamine genes and is found residing from position -57 to -48 (Johnson et al., 1988),  
regulates transcription by binding various CRE proteins to this regulatory region (Tamai et al., 
1997). Second, upstream regulatory sequences in the individual P1 and P2 promoters bind other 
trans-acting proteins, thereby directing transcriptional activation or suppression (Peschon et al., 
1989; Zambrowicz et al., 1990). Third, in round spermatids, the P1 and P2 genes are located in a 
large methylated domain which facilitates nuclear matrix attachment and potentiation of the P1-P2-
TP2 gene locus (Choi et al., 1997). The repetitive alanine (Ala) elements that is found in the matrix 
attachment regions (MAR) serve as sites of methylation that flanked this P1-P2-TP2 multigenic 
locus (Schmid et al., 2001). Fourth, the presence of a TATA-box in all protamine genes facilitates 
binding of transcription factors to their promoters, thereby playing a major role in transcription 
initiation. 
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Figure 3: Transcription of the protamine genes and translation and processing of human protamines. (A) Schematic 
representation of the genomic structure of protamine genes (PRM1 and PRM2) and the transcription, translation and 
processing involved in the synthesis of mature protamine. TNP2, gene-encoding transition protein 2. (B) Amino acid 
sequences for human P1 and for the main components (P2, P3 and P4) of the protamine 2 family. It should be noted 
that P2 is the most abundant component, while P3 and P4 are minor components of the P2 family. The arginine, 
histidine and lysine residues are shown in bold. Cysteines are underlined (adapted from Oliva, 2006). 
 
2-2-4-2 - Synthesis of protamines 
Protamines are synthesized in the late-stage spermatids of many animals and plants and bind to 
DNA, condensing the spermatid genome into a genetically inactive state (Balhorn, 2007). They are 
synthesized in soluble polyribosomes in the cytoplasm of elongating spermatids (Kleene, 1996). 
Protamine P1 is synthesized directly as a mature protein, whereas the protamine P2 family 
generated by proteolysis from a precursor encoded by a single gene (Wouters-Tyrou et al., 1998). 
The P2 family members differ from each other only by the N-terminal extension of 1–4 residues, 
although the P2 component is the most abundant (Figure 4) (Yoshii et al., 2005). The ratio of the 
contents of protamine P1 and protamine P2 (P1/P2 ratio) in the human sperm nucleus is roughly 
similar, P1/P2 ratio is about 1 (Balhorn et al., 1988; Corzett et al., 2002; Mengual et al., 2003; 
Aoki et al., 2005a). Transcription and translation of protamine mRNAs has been shown to occur in 
specific spermatid stages (Millar et al., 2000), and protamine mRNA has not been detected in 
sertoli or interstitial cells or in other tissues (Wykes et al., 1995). 
Post-translational modifications of protamines included the phosphorylation-dephosphorylation 
process and formation of the disulfide bonds that form during the final stages of sperm maturation 
and epididymal transit in eutherian mammals. However, during chromatin remodeling, two distinct 
stages have been described involving protamines (Love and Kenney, 1999; Dadoune, 2003). Stage 
1 involves the phosphorylation and dephosphorylation of serine and threonine residues of 
 23 
protamines (Dadoune, 2003) and Stage 2 involves the stabilization of DNA by the formation of 
inter- and intra-molecular disulfide bonds between cysteine residues of protamine molecules (Love 
and Kenney, 1999). Direct phosphorylation of the protamines after synthesis occurred. This step 
may be required for the proper binding to DNA (reviewed in Oliva and Dixon, 1991); but, after 
binding to DNA, most of the phosphate groups are removed and cysteine residues are oxidized, 
forming disulfide bridges that link the protamines together (Balhorn, 2007). In humans, it has been 
shown that phosphorylated protamines are still present in mature spermatozoa and the 
corresponding phosphorylation sites of P1 and P2 have been determined (Papoutsopoulou et al., 
1999). Given the importance of phosphorylation in regulating protein function, the possibility that 
altered protamine phosphorylation could also be associated with infertility or assisted reproduction 
outcomes deserves to be evaluated (Oliva, 2006). 
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Figure 4. A schematic drawing of key regulators of expression of protamines 1 and 2 at the levels of genomic 
transcription, translation and post-translational modifications to yield the mature protamine products. The key 
regulating protein complexes are shown for each stage of protein maturation. CREM, cAMP response element 
modulator; ACT, activator of CREM in the testis; TFIIA, transcription factor II alpha; CRE, CREM response element; 
TBP, TATA box binding protein; PABP, poly-a binding protein; CPE, cytoplasmic polyadenylation element; CPEB, 
cytoplasmic polyadenylation element binding protein; PCM, polyadenlyation consensus motif; SRPK1, serine/arginine 
protein-specific kinase-1; CAMK4, calcium/calmodulin-dependent protein kinase IV (adapted from Carrell et al., 
2007). 
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2-2-4-3- Characteristic structural features 
Mammals including humans express two protamines (protamines P1 and P2). They are the most 
abundant nuclear proteins present in the human sperm nucleus (Aoki and Carrell, 2003; Carell et 
al., 2007). Most of the information about the structure of protamines and DNA-protamine 
complexes were obtained from studying the protamines P1 and P2 of placental mammals, and from 
the fish protamines salmine and clupine (Balhorn, 2007). The human P1 and P2 genes encode a 50 
amino-acid protein and a final processed protein of 57 amino-acids, respectively. Overall, there is 
approximately 50 % identity between human P1 and P2. 
2-2-4-3-1- Protamine P1 
The P1of the mammalian placenta is exactly 49 or 50 amino acids long and contains three domains. 
A central arginine-rich DNA-binding domain flanked on both sides by short peptide segments 
containing cysteine residues. In most species, the central DNA binding domain typically consists of 
a series of anchoring sequences containing 3-11 consecutive arginine residues, which bind the 
protein to DNA (Balhorn, 2007). P1 synthesized as a mature protein coded by a single gene. Also, 
P1 was found in all studied vertebrates (Yoshii et al., 2005; Torregrosa  et al., 2006).  
2-2-4-3-2- Protamine P2  
P2 has several features that distinguish it from P1: the gene PRM2 codes for a precursor protein 
that has been shown to bind to DNA first, then undergo proteolytic processing (de Yebra et al., 
1993; Queralt  et al., 1995). P2 is synthesized as a precursor protein of 103 amino acids and 
undergoes proteolytic cleavage of its amino-terminus (Balhorn et al., 1999). In humans, there are 
two differently processed forms of protamine P2 (P2 and P3) bounded to DNA. The two forms of 
the P2 protein differ only in their three amino-terminal amino acids; P3 is three amino acids shorter 
(at 54 amino-acid residues) than P2 (57 amino acids) and they seem to be products of the same 
PRM2 gene. A third protamine P2 (named P4) sequence variant has also been detected in humans 
(Balhorn et al., 1977; Gusse et al., 1986). In addition, protamine P2 differs from P1 in that P2 binds 
to zinc. Roughly equal amounts of P1and P2 are considered normal in human spermatozoa (Bianchi 
et al., 1992; de Yebra  et al., 1993; Oliva, 2006). 
However, many hypotheses discuss the differences between P1 and P2 protamines: 
(i) Unlike P1 protamine, P2 protamines are zinc-finger proteins with one Cys2–His2 motif (Bianchi 
et al., 1992). 
(ii) Although the arginine content of both proteins is similar, P2 is slightly more basic due to its 
higher histidine and lysine content. 
(iii) P2 proteins are expressed only in some mammals; whereas, P1 is invariably present in all 
mammals, indicating a more basic and conserved function for P1 and an accessory function for P2 
protamines in some species.  
(iv) Alterations of P1 or P2 protamines in infertile patients impact differently on the integrity of the 
DNA and in the assisted reproduction outcome (Aoki et al., 2005b). 
Both protamines will undergo post-transcriptional modifications before binding to the DNA and 
generating the highly compact nucleoprotamine complex (Oliva, 2006). 
Protamines phosphorylation is required to facilitate their binding with DNA. The physiological 
significance of protamine phosphorylation had been proposed: first, Oliva and Dixon, 1991 
suggested that P1/P2 phosphorylation is required for correct binding to DNA and their subsequent 
dephosphorylation induces chromatin condensation in the sperm nucleus (Oliva and Dixon, 1991). 
Second, phosphorylation (not dephos-phorylation) may also promote correct chromatin 
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condensation (Papoutsopoulou et al., 1999). In humans, it has been shown that phosphorylated 
protamines are still present in mature spermatozoa and the corresponding phosphorylation sites of 
P1 and P2 have been determined (Papoutsopoulou et al., 1999). 
2-2-4-4- Protamines Functions 
Several proposed functions of the protamines had been reviewed by Oliva and Dixon, (1991):  
(i) Condensation of the paternal genome of the spermatozoa that produce a more compact and 
hydrodynamic nucleus. Those allow the sperm to move faster and more efficient to fertilize the 
oocyte. 
(ii) Protecting the paternal genome from the effect of nucleases or mutagens potentially present in 
the internal or in the external media. 
(iii) Competition and removal of transcription factors and other proteins from the spermatid 
resulting in a blank paternal genetic message, devoid of epigenetic information, therefore allowing 
its reprogramming by the oocyte. 
(iv) Involvement in the imprinting of the paternal genome during spermatogenesis. 
(v) Protamines could be part of a checkpoint during spermiogenesis.  
(vi) They may play a role in the fertilized oocytes. 
Balhorn, (2007) demonstrated that of the above proposed functions for protamines, only one has 
been unequivocally demonstrated. The synthesis and deposition of protamine in spermatid 
chromatin has been shown to correlate temporally with the condensation of the genome of the 
elongating spermatid and the concomitant termination of transcription. Each protamine P1 
molecule binds to 10-11 bp of DNA; protamine P2 binds to a slightly larger segment of DNA 
(around 15 bp). This binding neutralizes the negative charge along the phosphodiester backbone of 
DNA and enables adjacent DNA molecules to pack close together. Protamine binding to DNA does 
result in the production of an uncharged chromatin complex that enables the DNA molecules to be 
condensed into a volume some 1/20th that of a somatic nucleus. This condensation enables the 
production of a smaller, more hydrodynamic head, and contributes, albeit indirectly, to head shape 
(Balhorn, 2007).   
Formation of intermolecular and intramolecular disulphide bonds between cysteine residues in the 
protamines will strongly stabilize the nucleoprotamine structure, which in turn stabilizes the folding 
of different protamine domains in the sperm nucleus (Vilfan et al., 2004). Glutathione peroxidase 
activity could be involved in disulphide cross-linking in protamines (Conrad et al., 2005). 
2-2-4-5- Structural – functional relationships 
Oliva, (2006) had reviewed many structural and functional roles of protamines in the cell: 
1- By providing positive charge residues, they bind the strong negatively charged paternal genomic 
DNA allowing the formation of highly condensed complex (Lewis et al., 2003). 
2- By containing cysteines, they allow the formation of the disulphide bridges between the adjacent 
protamine molecules, therefore stabilizing the nucleoprotamine complex (Balhorn et al., 1992).  
3- They are of the highest rates of evolutionary variation among proteins (Oliva, 1995; Lewis et al., 
2003). A positive Darwinian selection has been proposed as a cause of this rapid evolution rate 
(Rooney and Zhang, 1999; Wyckoff et al., 2000). 
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2-2-4-6- Sperm DNA integrity and Protamines  
Spermatozoa DNA fragmentation may occur due to the attack of different endo- or exogenous 
factors such as nucleases, free radicals, mutagens and other agents if protamination of the DNA is 
not completed (Szczygiel and Ward, 2002; Sotolongo et al., 2003). One of the hypotheses about the 
function of protamines is that they could be involved in the protection of the genetic message 
delivered by the spermatozoa (Mengual et al., 2003).  
It is important to note that many groups showed that DNA fragmentation is more frequent in 
protamine-deficient spermatozoa and a significant negative correlation with fertilization rate was 
found (Nasr-Esfahani et al., 2004b; 2005; Aoki et al., 2005b; Torregrosa et al., 2006). Greco et al., 
(2005) showed that the use of ICSI with testicular sperm had improved the pregnancy rates in 
patients with poor pregnancy rates and decreased DNA integrity of ejaculated spermatozoa. Thus, a 
reasonable explanation could be that incomplete or abnormal protamination, as observed in many 
studies (Table 2), could lead to incomplete disulphide bond formation and incomplete DNA 
protection during epididymal passage in these patients.  
Sperm DNA fragmentation is correlated significantly with low P1/P2 ratio compared with normal 
and high P1/P2 ratios (Aoki et al., 2005b). Moreover, patients who under-expressed P1, P2 or both 
P1 and P2 had significantly elevated levels of DNA fragmentation compared with patients normally 
expressing P1and P2. 
Heterogeneity in protamine expression and a clear correlation between under-expression of 
protamines, DNA damage and lack of viability was detected using many techniques (TUNEL 
assay, CMA3 and Aniline Blue staining assays) (Manicardi et al., 1995; Hammadeh et al., 2001; 
Aoki et al., 2006b). 
2-2-4-7-Protamines and infertility 
Human sperm protamine deficiency had been correlated significantly with diminished semen 
quality parameters (counts, motility and morphology), sperm functional ability, and sperm DNA 
integrity (de Yebra et al., 1993; 1998; Balhorn et al., 1999; Carrell and Liu, 2001; Mengual et al., 
2003; Aoki et al., 2005a). Many studies correlated the male infertility with aberrations in protamine 
expression (Chevaillier et al., 1987; Balhorn et al., 1988; Chevaillier et al., 1990; Belokopytova et 
al., 1993; de Yebra et al., 1993; Carrell and Liu, 2001; Aoki et al., 2005a).  
The abnormality in protamines (P1 or P2) may be explained by reduced protamine transcription, 
altered translation of the transcript or failed post-translational modifications, but none of these 
explanations would directly explain the associated decline in sperm counts and function unless the 
regulation of protamine exchange is linked to a broader control of spermatogenesis (Carrell et al., 
2007). In addition, a number of these studies have described infertile male populations with 
abnormally elevated ratios of P1 to P2 (P1/P2) (Balhorn et al., 1988; Chevaillier et al., 1990; de 
Yebra et al., 1993; 1998; Carrell and Liu, 2001; Aoki et al., 2005a). The main reason for high 
P1/P2 ratio is the under expression of P2, but subsequent studies have demonstrated that P1 
dysregulation also accounts for some abnormalities (Aoki et al., 2005a). However, P2 
dysregulation is more common and this may be explained by the fact that the P2 gene is derived 
more recently than the P1 gene, which may suggest that the regulatory mechanisms governing P2 
gene expression are not as stringent and are more susceptible to variation than the P1 gene (Lewis 
et al., 2003).  
Moreover, complete selective absence of P2 had been documented in a small population of infertile 
men (de Yebra et al., 1993; Carrell and Liu, 2001). In another report, a population of infertile males 
with deregulated P1 expression and abnormally reduced P1/P2 ratios was identified (Aoki et al., 
2005a). 
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Protamines are critical for proper sperm chromatin packaging (Balhorn et al., 2000). In another 
work by Aoki et al., (2005b) they indicated that protamine concentrations (P1, P2, and total 
protamine) inversely correlate with the DNA fragmentation index and patients with low P1/P2 
ratios have markedly increased DNA damage. Besides, for the first time the same group in 2006 
demonstrated existence of significant variations in the protamine levels of individual human sperm 
cells. These protamine variations related significantly to sperm cell viability and DNA damage and 
may be of clinical significance (Aoki et al., 2006a). 
Torregrosa et al., (2006) also, demonstrated that sperm cells of infertile patients and controls 
contain different levels of pre-P2. The presence of pre-P2 in infertile patients correlates negatively 
with sperm count, normal morphology and motility of the sperms and correlates positively with the 
P1/P2 ratio, with the presence of other proteins and, at low pre-P2 levels, with decreased DNA 
integrity. The correlation detected between pre-P2 and the P1/P2 ratio in the patient samples is 
consistent with the hypothesis that, incomplete processing of pre-P2 may result in lower levels of 
mature P2 and therefore an increased P1/P2 ratio (Bench et al., 1998; de Yebra et al., 1998). Also, 
the correlation between pre-P2 and the presence of other proteins could indicate that a general 
failure in the histone to protamine replacement occurs in the samples with higher pre-P2. This 
hypothesis would be consistent with the inverse correlation of pre-P2 levels and sperm count, 
normal morphology and motility. 
2-2-4-8- Determination of protamines 
2-2-4-8-1- Direct determination  
Direct protamine extraction and applying Acid Urea Polyacrylamide Gel Electrophoresis (AU-
PAGE) is the standard method to measure and quantify the protamines (Mengual et al., 2003; Aoki 
et al. 2005a). Moreover, due to the use of protamines as drugs, there are many sensitive 
pharmaceutical methods developed for detection of protamines (Shvarev and Bakker, 2005) and 
new proteomic approaches based on liquid fractionation mass spectrometry or new fluidic devices 
that have the potential to make protamine quantification even easier and faster in the near future.  
Table 2 summaries the studies in which protamines were detected directly after extraction from 
sperm samples and separated by polyacrylamide gel electrophoresis.  
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Table 2. Studies in infertile patients where protamines were detected directly after extraction from sperm 
samples and separated by polyacrylamide gel electrophoresis (modified from Oliva, 2006) 
Reference Main findings 
Silvestroni et al., 1976 Protamines not detected in the spermatozoon of infertile patients 
Chevaillier et al., 1987 Proteins additional to the normal ones were found in infertile patients 
Balhorn et al., 1988 -P1/P2 ratio = 0.98 ± 0.12 in normal samples (n = 17)                                                          
-P1/P2 ratio = 1.58 ± 0.24 in infertile patients (n = 7)                                                         
-Increased P1/P2 ratio in six of the seven patients studied 
Lescoat et al., 1988 Heterogeneous protamine fraction observed in patients with altered seminal parameters (n = 11) 
compared with samples with normal parameters (n = 11) 
Bach et al., 1990 Percentage of protamines is different in the patients with abnormal seminal parameters compared to 
patients with normal parameters 
Blanchard et al., 1990 -Round-headed spermatozoa from patients (n = 2) contain less protamines and more histones and 
intermediate proteins than the normal spermatozoa (n = 2)                            
-Expression of P2 proteins is lower in round-headed sperm 
Belokopytova et al., 1993 P1/P2 ratio = 0.99 ± 0.06 in normal samples (n = 20) 
de Yebra and Oliva, 1993 Description of an optimized method to extract and analysis protamines by gel electrophoresis to 
allow easier and faster clinical application 
de Yebra et al., 1993 -P1/P2 ratio = 1.10 ± 0.08 (normal) in 22.4% of infertile patients (n = 26)                         
-P1/P2 ratio = 3.00 ± 2.84 (abnormal) in 74.1% of infertile patients (n = 86)                     
-Absence of detectable P2 in 3.4% of the patients (n = 4) 
Colleu et al., 1996 The densest Percoll gradient fractions were enriched in less-intermediate proteins and more P2 in 
patient samples with normal count and motility (n = 12) 
Khara et al., 1997 -P1/P2 ratio = between 0.55 and 1.29 in patients with FI 50% (n = 18)                              
-P1/P2 ratio = outside the 0.55–1.29 range in patients with FI <50% (n = 3) 
de Yebra et al., 1998 Detection of increased protamine P2 precursors by western analysis in patients with an increased 
P1/P2 ratio 
Bench et al., 1998 P1/P2 ratio varied in patients’ samples obtained at different times 
Carrell et al., 1999 Differences in protamine content and sperm ultrastructure found in two siblings associated with 
different ICSI outcomes 
Evenson et al., 2000 Appearance of protamine P2 precursors detected by electrophoresis between 33 and 39 days post-
hyperthermia in one patient 
Carrell and Liu, 2001 -12 of 13 patients without detectable P2 had a reduction in the sperm penetration assay in  
comparison with the patients with P2                                                                                   
 -P2 precursor bands associated with reduction in the penetration capacity 
Mengual et al., 2003a -P1/P2 ratio = 1.01 ± 0.15 in control fertile men (n = 10)                                                     
-P1/P2 ratio = 1.51 ± 0.48 in oligozoospermic patients (n = 12)                                              
-P1/P2 ratio = 1.23 ± 0.65 in asthenozoospermic patients (n = 13)                                                 
-Little heterogeneity between Percoll fractions from individual samples and marked differences 
between patients and controls 
Nasr-Esfahani et al., 2004b Negative significant correlation of fertilization rate with protamine deficiency and P1/P2 ratio 
Chen et al., 2005 Altered levels of protamines present in infertile patients are shown to improve upon patient treatment 
Aoki et al., 2005a -P1/P2 ratio = 1.06 ± 0.01 in fertile donors (n = 87)                                                            
-P1/P2 ratio < 0.8 in 13.6% of the patients (n = 37)                                                             
-P1/P2 ratio = between 0.8 and 1.2 in 46.7% of the patients (n = 127)                                      
-P1/P2 ratio > 1.2 in 39.7% of the patients (n = 108)                                                            
-P1/P2 ratio correlates with sperm penetration score and fertilization rate 
Aoki et al., 2005b DNA fragmentation raised in low P1/P2 samples versus normal/high P1/P2 ratio 
Aoki et al., 2006a Correlations between P1 and P2 proteins and mRNA detected by real-time PCR 
Aoki et al., 2006b Protamine-deficient sperm appear to be more susceptible to DNA strand breaks, evidenced by the 
significantly increased DNA damage 
Zhang et al., 2006 Increased proportion of H2B to protamine in infertile men 
Torregrosa et al., 2006 P2 precursors related to protamine content and DNA integrity 
Zini et al., 2007 Semen samples from asthenospermic infertile men possess a significantly higher ratio of sperm 
nuclear histone (H2B) to protamine (PRM1+PRM2) than do fertile men. 
De Matio et al., 2009 P2 precursors related to poor pregnancy outcome 
Hammoud et al., 2009 Inverse correlation between P1/P2 ratio and the level of histone expression in the different layers of 
the density gradient. 
FI, fertilization index; P1, protamine 1; P2, protamine 2; H2B, histone 2B. 
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2-2-4-8-2- Indirect assessment of sperm chromatin structure by histochemical Procedures 
 Indirect detection methods based on different staining procedures or fluorochromes techniques. Of 
these methods: 
1- Chromomycin A3 (CMA3) assay 
In situ competition between protamine and CMA3 indicated that CMA3 staining inversely 
correlated with the protamination state of spermatozoa (Bizzaro et al., 1998). CMA3 staining has 
been shown to be increased in the sperm cells of infertile patients (Nasr-Esfahani et al., 2004a, 
2005). However, CMA3 staining cannot distinguish whether the potential protamine deficiency is 
due to a lack of P1, P2 or a combination of both. 
2- Sperm chromatin structure assay (SCSA) 
SCSA based on the Acridine Orange (AO) stain red–green shift to differentiate double- versus 
single-stranded DNA (Evenson and Wixon, 2005). 
3- Aniline Blue Staining 
Aniline blue staining procedures were used to detect the presence of histones and therefore 
indirectly infer the presence of lower amounts of protamines in the sperm nucleus (Chevaillier et 
al., 1987).  
4- Other new sperm chromatin structure tests based on sperm chromatin dispersion are also being 
proposed (Jager, 1990).  
Depending on the results of these indirect methods on studying the sperm chromatin composition, 
structure, accessibility and integrity of the DNA it is difficult to interpret these results (Erenpreiss 
et al., 2006). 
2-3- Reactive Oxygen Species (ROS) and Male Infertility 
Reactive oxygen species (ROS) are free radicals that carry unpaired electrons which tend to bind 
other molecules and alter them. The ROS of primary interest are the superoxide anion (.O2 ‾), 
hydroxyl radical (.OH), and hypochlorite radical (.OHCl). ROS are highly disruptive to cellular 
function, and play a role in male-factor infertility. They may affect and damage all types of cells 
and may play a role in as much as 40% of male-factor infertility (Sharma and Agarwal, 1996). 
Agarwal et al., (2006) reported that high ROS may serve as a marker of male-factor infertility. 
They also suggested that ROS measurement be included in clinical diagnosis of idiopathic 
infertility.  
The unique structure of sperm makes it highly susceptible to damage by these molecules. The head 
of the sperm is covered with unique lipid membrane rich in polyunsaturated fatty acids that make 
up approximately 40% of the lipids in the sperm head, which are important for membrane fluidity, 
sperm motility, capacitation, and sperm binding to the egg zona pellucida. These polyunsaturated 
fatty acids are extremely susceptible to oxidative damage. ‘Oxidative Stress’ is an imbalance 
between the ROS generating factors and ROS scavenging systems (Sikka, 2001). Furthermore, it 
has been shown that ROS can damage DNA by causing deletions, mutations, and other lethal 
genetic effects (Tominga et al., 2004). Damage of the sperm DNA by free radicals induces 
activation of the poly (ADP ribose) synthetase enzyme. This splits NAD+ to aid the repair of DNA. 
Depletion of the NAD
+
 concentration will disrupt the function of the cells and cause cells death. 
The relative proportion of ROS–producing immature sperm was directly correlated with nuclear 
DNA damage value in mature sperm and inversely correlated with recovery of motile mature sperm 
(Aitken et al., 1998b)       
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Agarwal, et al., (2003) proposed that oxidative damage of mature sperm by ROS-producing 
immature sperm during their co-migration from seminiferous tubules to the epididymis may be an 
important cause of male infertility. Also, sperm may be damaged by oxidative stress in epididymis 
where it is stored after its production (Vernet et al., 2004). Mustafa et al., (2004) demonstrated that 
infertile patients with high ROS levels in their seminal plasma had a higher percentage of apoptosis 
than normal healthy donors. 
Furthermore, sperm head contains the acrosomal enzymes as well as the chromosomes that will 
eventually fuse with the maternal chromosomes. The mid-piece of the sperm contains mitochondria 
that generate the energy to propel the tail of the sperm. These mitochondria is considered the 
internal source of reactive oxygen molecules. Mitochondria generate hydrogen peroxide (H2O2) and 
the sperm plasma membrane NADPH oxidase system (Agarwal et al., 2003). Another important 
external source of ROS is the leukocytes that is found in semen. They produce H2O2 and Oxygen 
(O2). The phagocytes and -lymphocytes produce –O2 which appear to use NADPH oxidase like 
enzymes. Furthermore, ROS may be increased with certain medications, radiation, pollutants and in 
patients with spinal cord injuries (Potts and Pasqualotto, 2003). The quality of the sperm may 
increase ROS generation as a consequence of the presence of excess residual cytoplasma that 
indicate immaturity of the sperm and functionally defective (Aziz et al., 2004) and are capable of 
producing increased amounts of ROS (Sikka, 2001). A strong positive correlation exists between 
immature spermatozoa and ROS production, which in turn negatively affects the sperm quality 
(Said et al., 2004). The excessive production of ROS that exceeds critical levels can overwhelm all 
the antioxidant defense systems of spermatozoa and seminal plasma causing oxidative stress (de 
Lamirande et al., 1997). 
2-3-1- Physiologic role of ROS 
Spermatozoa may require ROS for their functions depending on the nature and the concentration of 
the ROS as well as the location and length of exposure to ROS (Agarwal and Saleh, 2002). Under 
certain physiological conditions, spermatozoa produce small amounts of ROS, to facilitate their 
ability for fertilization the oocytes “capacitation” and acrosomal reaction. Also, ROS is required for 
the progressive movement during epididymial transit (Visconti and Kopf, 1998).    
2-3-2- Consequences of excessive generation of ROS 
Excessive generation of ROS in semen could be a cause of infertility (Sharma and Agarwal, 1996). 
The main ROS produced in spermatozoa is hydrogen peroxide. Moderately elevated concentrations 
of hydrogen peroxide did not affect sperm viability but did affect the motility of the sperm through 
depletion of intracellular ATP and the subsequent decrease in the phosphorylation of axonemal 
proteins (Kemal Duru et al., 2000; Misro et al., 2004). Also, high concentrations of hydrogen 
peroxide induce cell death as a result of lipid peroxidation and were negatively correlated with the 
quality of sperm in the original semen (Gomez et al., 1998). However, pathological levels of ROS 
detected in semen of infertile men are more likely a result of increased ROS production rather than 
reduced antioxidant capacity of the seminal plasma (Zini et al., 1993). 
A meta-study conducted by Agarwal and Prabakaran, (2005) showed that ROS levels correlated 
significantly with in vitro fertilization (IVF) rate. Recently Hammadeh et al., (2008a) showed that 
ROS and TAS concentration in seminal plasma did not differ significantly between the patients 
undergoing IVF or ICSI therapy, but negative correlation was shown between ROS concentration 
in seminal plasma and sperm vitality, membrane integrity, sperm density, chromatin condensation, 
and DNA single stand breaks in both IVF and ICSI groups.  
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2-3-3- (8-hydroxy-2'-deoxyguanosine (8-OHdG)) level 
8-hydroxy-2′-deoxyguanosine (8-OHdG) resulted from oxidative DNA damage following specific 
enzymatic cleavage after 8-hydroxylation of the guanine base. 8-OHdG induced the G:C to T:A 
conversion during DNA replication. Hydroxylation of guanosine occurs in response to both normal 
and metabolic processes and variety of environmental factors. 8-OHdG used as a biomarker of 
oxidative stress in many cases including renal carcinogenesis (Toyokuni et al., 1997), diabetes 
mellitus (Leinonen et al., 1997) and ageing (Kaneko et al., 1996). It was reported that sperm DNA 
damage is closely related to male infertility, and 8-OHdG is a sensitive biomarker of oxidative 
DNA damage caused by ROS in human sperm (Shen and Ong 2000).  
Furthermore, the significance effect of oxidative stress on sperm DNA integrity was supported by 
Loft et al.,(2003) who reported that pregnancy occurring in a single menstrual cycle was inversely 
associated with the level of 8-hydroxy-2′-deoxyguanosine, an indicator of oxidative DNA damage 
in spermatozoa (Loft et al., 2003). The oxidized deoxynucleoside, 8-OHdG if not repaired 8-OHdG 
modifications in DNA are mutagenic and may cause embryonic loss, malformations, or childhood 
cancers (Agarwal et al., 2006). 
A recent study conducted by Ishikawa and colleages demonstrated that increased 8-OHdG 
expression in the testis was associated with deficient spermatogenesis in infertile men with 
varicocele (Ishikawa et al., 2007). In addition, the work of Kao et al., (2008) showed significant 
negative correlations between sperm motility and 8-OHdG and between motility and lipid 
peroxides. They concluded that oxidative stress and oxidative damage were increased significantly 
in spermatozoa with declined motility, and the antioxidant capacities in the spermatozoa and 
seminal plasma were lower in males who had infertility or subfertility.  
2-3-4- Lipid peroxidation (Malondialdehyde, MDA) 
Lipid peroxidation is a well established-mechanism of cellular injure and is used as an indicator of 
oxidative stress (Yagi, 1998). Lipid peroxides, derived from polyunsaturated fatty acids, are 
unstable and decomposed to form a complex series of compounds that include reactive carbonyl 
compounds, such as Malondialdehyde (MDA). MDA is a naturally occurring product of lipid 
peroxidation. Malondialdehyde (MDA) is hydrophilic, and released from low density lipoproteins 
(LDL) into aqueous surroundings. 
The measurement of Thiobarbituric Acid Reactive Substances (TBARS) is a well-established 
method for screening and monitoring lipid peroxidation (Armstrong and Browne, 1994). The 
MDA-TBA compound formed by the reaction of MDA and TBA under high temperatures (90-100 
oC) and acidic conditions is measured colorimetrically at 530-540 nm or fluorometrically at an 
excitation wavelength of 530 nm and emission wavelength of 550 nm.  
Human sperm plasma membranes are enriched with polyunsaturated fatty acids (PUFA), par-
ticularly docosahexaenoic acid with six double bonds (Khosrowbeygi and Zarghami, 2007). 
Physiologically, the high concentrations of PUFA in sperm are important for maintaining 
membrane fluidity and flexibility during fertilization process. Lipid peroxidation is known to cause 
impairments such as membrane damage, damage to sperm chromatin (Oyawoye et al., 2003), 
reduced sperm-oocyte fusion (Pasqualotto et al., 2004), and decrease in a chromosomal function 
(Aziz et al., 2004). The mechanism by which oxidative stress induced motility loss in mammalian 
spermatozoa involved the induction of peroxidative damage to the sperm plasma membrane 
(Tavilani et al., 2005). Seminal plasma malondialdehyde, which is the stable lipid peroxidation 
product, is a simple method to evaluate the effect of lipid peroxidation on sperm (Geva et al., 
1998). 
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Tavilani et al., (2008) observed a higher content of lipid peroxidation product malondialdehyde 
(MDA) in spermatozoa of asthenozoospermic compared with normozoospermic samples (p<0.05). 
Although, the difference between MDA of seminal plasma was not significant between two groups.  
On the contrary, measurement of the seminal levels of malondialdehyde and antioxidants in men 
with both normal and abnormal seminogram by Nabil et al., (2008) showed that malondialdehyde 
level was significantly elevated in oligozoospermic and azoospermic men. They concluded that 
Lipid peroxidation plays a significant role in disrupting sperm functions and semen quality 
especially sperm motility and morphology and may account for some cases of male infertility.  
2-4- Smoking and sperm parameters 
2-4-1- Introduction  
Cigarette smoking is a serious health problem for most societies. Consumption of tobacco exerts 
widely adverse effects on different aspects of health (O'Dowd, 2006). Studies about the relation 
between smoking and semen quality reveal conflicting results. Also, cigarette smoking has 
mutagenic properties, and having been associated with an overall reduction in semen quality, and 
specifically a reduction in sperm count and motility and increase in number of abnormal cells (Potts 
et al., 1999). In addition, Taszarek et al., (2006) and Agarwal et al., (2005) demonstrated that 
cigarette smoking alters semen quality, which could worsen the fertilizing capability in infertile 
men, while others found that the average values of conventional sperm parameters (sperm density, 
motility, normal morphology, viability) were normal (Sepaniak et al., 2006). 
A strong body of evidence indicates that the negative effects of cigarette smoking on fertility 
comprises fairly every system involved in the reproductive process. Therefore, couples in their 
reproductive age should be strongly discouraged to smoke (Soares and Melo, 2008). In addition, 
cigarette smoking has hazardous effects on spermiogenesis either by direct action or by its 
associated compounds such as cotinine on sperm kinetic variables. Besides, smoking effects on 
sperm parameters could be mediated by decreases in seminal insulin-like growth factor-I (IGF-I) 
(Hassan et al., 2009). 
2-4-2-Smoking and semen quality 
Several published studies have conquered and supported the fact that tobacco smoking significantly 
affects semen quality (Chen et al., 2004, Marinelli et al., 2004, Martini et al., 2004, Stutz et al., 
2004, Pasqualotto et al., 2005). Mostafa et al., (2006) demonstrated that ascorbic acid in seminal 
plasma decreased significantly in smokers and infertile men in comparison to non-smokers and 
fertile men, and is significantly correlated with the main sperm parameters (count, motility and 
normal morphology). Gaur et al. conducted a study on semen samples of 100 cigarette smokers and 
100 strictly non-smoking (primary infertility patients) and showed a decrease in sperm motility in 
smokers in comparison to non-smokers. Therefore, they pointed out that asthenozoospermia 
(decreased in motility) may be an early indicator of reduced semen quality in light smokers. In 
addition, they reported significantly high teratozoospermia (poor morphology) in heavy smokers 
compared to non-smokers. It has been shown that maternal smoking affects reproductive 
parameters of their offspring (male) during adolescence (Gaur et al., 2007). 
In addition, studying semen samples provided from fertile smokers (n=25), fertile non-smokers 
(n=21), infertile smokers (n=23) and infertile men non-smokers (n=32), showed that sperm quality 
parameters in men smokers was approximately lower than those in men non-smokers (Colagar et 
al., 2007). Also they showed that cigarette smoking has dosedependent effect on sperm parameters 
and is associated with reduced sperm quality and the risk of idiopathic male infertility. 
Pasqualotto et al., (2008) evaluated the effect of cigarette smoking on antioxidant levels and the 
presence of leukocytospermia in infertile men. They found a lower level of superoxide dismutase 
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and catalase in infertile patients and men who smoke cigarettes compared to fertile donors. 
Therefore, cigarette smoking decreases sperm motility and antioxidant levels and may be a possible 
reason for infertility in men who smoke cigarettes. They recommended that infertile patients who 
smoke cigarettes should quit smoking.  
On the contrary, other previous studies are not in agreement with these results (Trummer et al,. 
2002; Belcheva et al., 2004; and Pasqualotto et al., 2006). 
2-4-3- Effects of Smoking on Semen Volume 
Pasqualotto et al., (2005) carried out a study to assess the effect of smoking on the semen 
parameters and concluded that male smoking does not significantly impair the usual sperm 
parameters, namely, concentration, motility and morphology. However, they found that sperm 
volume is affected by smoking in a dose-depended manner. More precisely, sperm volume declined 
significantly between non-, mild, moderate and heavy smokers, with a mean 2.8ml, 2,4ml, 2,3ml 
and 2.1ml, respectively. Ramlau-Hansen et al., (2007) presented an overall study two years later, 
which supported that there is an inverse dose-response relation between smoking and semen 
volume. This study incorporated seven separate occupational or environmental semen studies 
performed from 1987 to 2004, resulting in a total of 2562 men evaluated. 
On the contrary, Sobreiro et al., in (2005) evaluated the effect of smoking, among other parameters, 
on semen characteristics of 500 fertile men, who attended a clinic for vasectomy for sterilization 
purposes. These men were asked to provide samples before the vasectomy and the group’s results 
showed that smoking has no influence on semen parameters whatsoever. Others showed that 
testicular and ejaculate volume were similar in smokers and non-smokers (Richthoff et al., 2008). 
2-4-4- Effect of Smoking on Sperm Concentration 
An association between cigarette smoking and sperm density (10
6
/ml) was found to exist according 
to the investigation carried out by Kunzle et al., (2003). The men they included in their study had 
attended the infertility clinic with their spouses, seeking causative factors concerning their 
infertility issues and the overall result was a significant decrease in sperm density of smoking 
males, compared to non-smoking controls (Kunzle et al., 2003).  
Ramlau-Hansen et al., (2007) in a study carried out in 2007, found a 19% lower sperm 
concentration in smoking men, compared to non-smokers. Moreover, Bouvet et al., (2007) showed 
that tobacco consumption has an adverse effect on spermatogenesis process resulting in a decrease 
sperm concentration and increase in the mean percentage of morphologically abnormal 
spermatozoa. Also, in a recent study researchers found a significant reduction in total sperm counts 
in smokers when compared to non-smokers (Richthoff et al., 2008). 
On the other hand, Pasqualotto et al., (2005) evaluated a group of men who attended the clinic for 
vasectomy for sterilization purposes, by dividing them into groups: non-smokers, mild smokers, 
moderate smokers and heavy smokers. All conventional semen parameters were evaluated and they 
found no significant differences in sperm concentration among the four groups. Additionally, no 
significant negative correlation between tobacco smoking and sperm concentration was detected by 
Hassa et al., (2006).  
2-4-5- Effect of Smoking on Sperm Motility  
Heavy smokers seem to have an enhancing effect on progressively rapid motile sperm compared to 
light-smoking infertile men (Ozgur et al., 2003). The possible explanations for this enhancement of 
rapidly progressive motility due to heavy smoking in comparison to light smoking is definitely 
related to number of cigarettes per day, which may constitute a threshold for the enhancement of 
rapid progressive motility in smokers.  
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Many studies had found a negative significant correlation between smoking and sperm motility 
or morphology and lower sperm density (Vine et al., 1994; Zenzes, 2000). Zavos et al. (1998) 
confirmed this effect; by exposing isolated spermatozoa of non-smokers in vitro to separated 
seminal plasma from smokers, they observed a decreased in sperm motility. In a study conducted 
by Gaur et al. on semen samples from cigarette smokers and strictly non-smoking (primary 
infertility patients) showed a decrease in sperm motility in smokers in comparison to non-smokers 
(Gaur et al., 2007).  
In another study, Kumosani et al., (2008) showed that cadmium (Cd) concentration was found to be 
significantly higher in smokers than in non-smokers either in fertile or infertile groups. Together 
with this increase in seminal Cd a significant decrease in Ca(2+)-ATPase activity, decrease in 
seminal zinc and decrease in sperm motility were found. Also, recently Hassan and team found that 
the percentage of motile spermatozoa was significantly lower in smokers than in the controls. This 
sheds light on the harmful effect of cigarette smoking on sperm motility (Hassan et al., 2009).  
2-4-6- Effect of smoking on sperm Morphology  
Abnormal sperm morphology is related to sperm head abnormalities, and may involve the 
acrosome, nucleus and post acrosomal region (Zamboni, 1987). Guo et al., (2006) investigated the 
impact effect of cigarette, alcohol consumption and sauna on spermatozoa and demonstrated that 
normal morphologic sperm rates in cigarette, alcohol consumption and sauna groups were lower 
than those in the corresponding control groups. In addition, heavy smoking produces 
teratozoospermia, which further reduces semen quality (Gaur et al., 2007). 
Moreover, the relationship between cigarette smoking and the blood lead levels (BLL) (lead as a 
component of cigarette smoke) and their effect on sperm morphology, sperm chromatin and DNA 
integrity of factory workers revealed that BLL level was considerably higher among smokers as 
compared to non-smokers and workers with higher BLL were found to be at a higher risk of sperm 
morphological abnormality and chromatin DNA integrity (Hsu et al., 2008).  
2-4-7- Effect of smoking on sperm chromatin integrity (DNA)  
The etiology of sperm DNA fragmentation is still poorly understood, but relationship between 
cigarette smoking and increased DNA damage has been shown in infertile smokers compared of 
non-smokers (Zenzes, 2000; Saleh et al., 2003a).  
Sepaniak et al., (2006) showed that smokers’ spermatozoa have a significantly higher DNA 
fragmentation than that of non-smokers (32% versus 25.9%, p<0.01). Besides, there was no 
significant difference in conventional parameters between smokers and non-smokers. These 
findings suggested that cigarette smoking may have deleterious effects on sperm nuclear DNA. 
Recently, Elshal et al., (2008) found that cigarette smoking of idiopathic infertile men was 
significantly associated with DNA fragmentation index (DFI %), high DNA stainability (HDS %) 
as indicator of immature spermatozoa and lipid peroxidation (TBARS) of sperm plasma membrane 
and decreased superoxide dismutase (SOD) levels. There are currently various techniques for the 
evaluation of sperm DNA fragmentation. These techniques have been recently reviewed (Evenson 
and Wixon, 2006 a; b).  
In a meta-analysis study conducted by Collins et al., (2008) to evaluate the predictive value of 
sperm DNA integrity tests for pregnancy from in vitro fertilization treatment, a small but 
statistically significant association between sperm DNA integrity test results and pregnancy in IVF 
and ICSI cycles was found. But it was also concluded that this is not strong enough to provide a 
clinical indication for routine use of these tests in infertility evaluation of men. It is possible that yet 
to be determined subgroups of infertile couples may benefit from sperm DNA integrity testing. 
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2-4-8- Cotinine level in seminal plasma 
Exposure to tobacco smoke can be detected by nicotine and its metabolites. Nicotine [3 - (1- methyl 
– 2 - pyrrolidinyl) pyridine] is the principal alkaloid in tobacco and is present as a major component 
of tobacco smoke. It is absorbed in measurable quantities by both active and passive smokers, the 
latter having been shown to inhale an amount of nicotine proportional to the product of 
concentration, duration of exposure and respiration rate (Bently et al., 1999). It has been shown in 
human liver microsomes that nicotine and cotinine [1 – methyl – 5 - (3 - pyridinyl)- 2 - 
pyrrolidinone] are oxidized primarily via CYP 2A6 (Messina et al., 1997). Nicotine is primarily 
metabolized to cotinine, and cotinine is further metabolized to trans-3’-hydroxycotinine in the 
human liver, which is a major metabolite of nicotine in humans (Nakajima et al., 1996). 
Nicotine has a short half life and is not used as a marker for tobacco smoke exposure. Cotinine and 
hydroxycotinine are the major metabolites of nicotine, and cotinine is the major psychoactive 
substance found in cigarette smoke (Zenzes et al 1996). Cotinine, which is easily detectable in 
human body fluids, such as urine, saliva (Zenzes et al 1996), and seminal plasma (Pacifici et al., 
1993), had been used as a specific biomarker of cigarette smoking (Hulka, 1991). Also, cotinine 
with a half-life in sperm of 5–7 days is a better indicator of long-term exposure to cigarette smoke 
than urinary metabolites index (Jarvis et al., 1988). However, the concentration of cotinine and 
hydroxycotinine in the seminal plasma is significantly correlated with total sperm motility of 
spermatozoa (Pacifici et al., 1993). Zavos et al., (1998) found that smoking affected sperm viability 
and had a strong detrimental effect on motility of spermatozoa. There is a small but significant 
correlation between cotinine concentration in seminal plasma and abnormal sperm morphology, but 
not for other semen variables (Wong et al., 2000). Cotinine concentration of 400-800 ng/ml impairs 
sperm motility, membrane function and their ability to undergo capacitation (Sofikitis et al., 2000). 
In a study conducted on 35 smoking and 30 non-smoking students, it was shown that cotinine 
levels, sperm density and total number of motile spermatozoa would differ significantly between 
the groups (Chen and Kuo, 2007). In addition, some previous work from our group showed an 
inverse correlation between cotinine concentration and ejaculate volume, sperm concentration, 
motility, vitality, morphology membrane integrity, DNA fragmentation (TUNEL), TAS 
concentration and fertilization (Hammadeh et al., 2008b). 
2-5- Factors that influence sperm chromatin structure  
Sperm chromatin structures can be altered by many factors including temperature, chemicals and 
toxins, disease and molecular disturbances (Karabinus et al., 1997; Sailer et al., 1996; Ahmadi and 
Ng, 1999; Bochenek et al., 2001; Love et al., 2002). 
2-5-1- Temperature 
Sperm production requires a temperature, which is three to five degrees below body temperature. 
The scrotum has a built-in thermostat, which keeps the sperm at the correct temperature while they 
are being stored. This is why the testes hang away from the body, so sperm can develop at the 
temperature they need (35° - 36° C). A study conducted by Karabinus et al., (1997) demonstrated 
that bulls showed a reduction in sperm chromatin stability around 12 days after exposed to heat 
stress. The exposure of mice testes to 40oC for 60 minutes induced moderate changes in sperm 
chromatin, whereas, exposure to 42oC for 60 minutes induced marked chromatin abnormalities in 
virtually all stages of spermatogenesis (Sailer et al., 1995). In fact, it had been shown that testicular 
hyperthermia, either direct or indirect, can cause DNA damage via an increase in the 
histone/protamine ratio (Evenson & Libman, 2000; Zini and Libman, 2006).  
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2-5-2- Chemicals and toxins 
A causal relationship between cigarette smoking and impaired reproductive function is highly 
suspected due to the fact that smokers inhale a range of toxins such as nicotine, carbon monoxide, 
cadmium and other mutagenic compounds (Zavos et al., 1998). Smoking has been shown to 
increase sperm DNA damage (Sun et al., 1997; Potts et al., 1999) which may be a result of seminal 
oxidative stress (Saleh et al., 2002a). The latter was supported by reports that oxidative stress not 
only damages the sperm plasma membrane but also induces high frequencies of single- and double-
strand DNA breaks (ssDNA, dsDNA) (Twigg et al., 1998a; Aitken, 1999). 
2-5-3- Disease 
Genital tract infections may cause spermatozoal DNA damage and have been associated with 
increased levels of ROS (Aitken & De luliis, 2007). Ureaplasmal (Ureaplasma urealyticum) 
infection in men did not alter sperm motility but was associated with a high incidence of chromatin 
instability (SCSA, 60%) that was reversed by treatment with antibiotic (Reichart et al., 2000). 
Similar sperm chromatin instability was reported in men suffering from prostatitis, which also 
returned to normal after antibiotic treatment (Evenson et al., 1991). Varicocele constitutes a serious 
cause of male infertility although it is, also, present in 15% of patients who tried to have children 
(Marmar, 2001). Significant higher levels of spermatozoal DNA damage were noticed in infertile 
men with varicocele compared to normal controls, due to high levels of ROS and elevated 
intratesticular temperature (Saleh et al., 2003b).  
2-5-4- Molecular disturbances 
A proportion of infertile men have diminished levels of protamine 2 in ejaculated sperm, which has 
been attributed to the persistence of histones or incomplete processing of protamine 2 precursors 
(Foresta et al., 1992; de Yebra et al., 1998). 
2-5-5- Age and spermatozoa DNA damage 
According to Barroso et al., (2000) and Aitken et al., (2003b) the age-related effect in older men is 
due to a higher exposure to oxidative stress in their reproductive tracts that may damage the sperm 
DNA and mitochondrial and nuclear membranes. Singh et al., (2003) demonstrated an increase in 
sperm double stranded DNA breaks and a decrease in apoptosis with age. They found DNA that 
damages in men aged 36–57 years were highly significant compared to those aged 20–35 years. 
However, the percentage of apoptosis was significantly lower in the older group. Moreover, 
Kuhnert and Nieschlag, (2004) showed that paternal age is associated with a variety of anomalies, 
such as diminished semen quality, numerical and structural chromosomal abnormalities, that can 
decrease reproductive capacity and fertility and increase the frequency of spontaneous abortions. 
2-6- Origin of sperm DNA damage  
A successful fertilization, and normal embryo and fetal development resulting in a healthy 
offspring require normal sperm genetic material. For this reason any damage in sperm chromatin or 
DNA structure may cause an alteration in the health of the offspring. The source(s) of sperm DNA 
damage in the male germ line have not yet been elucidated. Damage may occur at testicular, 
epididymal or post-ejaculatory levels. DNA damage in the male germ line has been associated with 
poor semen quality, low fertilization rates, impaired pre-implantation development, increased 
abortion and an elevated incidence of disease in the offspring, including childhood cancer (Lewis & 
Aitken, 2005). Thoroughly, this damage is thought to arise due to environmental stresses, gene 
mutations or chromosomal abnormalities (Agarwal and Said, 2004). Sperm chromatin 
abnormalities may occur during, or as a result of, DNA packaging at spermiogenesis (Sailer et al., 
1995), free-radical (reactive oxygen species; ROS) (Aitken et al., 1998a) or apoptosis (Gorczyza et 
al., 1993). The precise source or mechanism of mammalian sperm damage has not been completely 
understood (Lewis & Aitken 2005). Therefore, abnormalities in proteolytic cleavage of the 
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processing protamine precursors may act as an additional source of human sperm chromatin 
heterogeneity and potential infertility (de Yebra et al., 1998; Evenson et al., 2000). 
Several studies have shown that sperm from infertile men are also more susceptible to DNA 
damage under the effect of several factors; both H2O2 and X–irradiation (McKelvey-Martin et al., 
1997; Hughes et al., 1998), cryopreservation (Donnelly et al., 2001) and the routine in vitro 
incubation of the testicular spermatozoa prior to ICSI injection from men with obstructive 
azoospermia (Dalzell et al., 2003). 
DNA fragmentation is characterized by both single and double DNA strand breaks, and is 
particularly frequent in the ejaculates of subfertile men (Irvine et al., 2000). Torregrosa et al., 
(2006) listed  several hypotheses proposed to explain the origin of decreased DNA integrity in the 
sperm cells of infertile patients, which include:  
(1) Incomplete repair during meiosis (Baarends et al., 2001) 
(2) Incomplete repair of DNA breaks arising from the action of topoisomerase II during 
spermiogenesis (Marcon and Boissonneault, 2004) 
(3) Incomplete removal of apoptotic cells (Sakkas et al., 2002; Weng et al., 2002) 
(4) Incomplete protamination resulting in increased susceptibility of DNA (Cho et al., 2003; Aoki 
et al., 2005a) 
(5) Defects in the expression of transition proteins (Adham et al., 2001; Meistrich et al., 2003; 
Shirley et al., 2004; Zhao et al., 2004; Suganuma et al., 2005) 
(6) Damage mediated by heavy metals or toxins interacting with protamines (Bal et al., 1997; 
Quintanilla-Vega et al., 2000) 
(7) Increased ageing and oxidation of the spermatozoa during passage and storage in the male tract 
(Ollero et al., 2001; Suganuma et al., 2005) 
(8) Increased action of exogenous factors such as infection and increased oxidant action of 
leukocytes (Alvarez  et al., 2002) 
 In two separate studies on mice sperm by (Shaman et al., 2007 and Yamauchi et al., 2007a) 
researchers proposed that sperm DNA degradation occurs due to sperm chromatin fragmentation 
(SCF)—induced pathway. They reported a mechanism by which the DNA is degraded to facilitate 
decondensation of the tight toroid. This process was initiated by topoisomerase IIB and ended by 
sperm nuclease action.  During the passing of the sperm through epididymis, this process may be 
executed (Yamauchi et al., 2007a). Physiologically, this mechanism is associated with DNA 
replication in oocytes and is thought to be part of the process by which paternal DNA is prevented 
from influencing initial cleavage of the embryo and may help in preventing the passing of the 
damaged DNA to the fertilized oocytes (Yamauchi et al., 2007b). Pathologically, infertile sperm 
may possess an aberrant SCF induced DNA degradation pathway explaining the increased load of 
DNA damage (reviewed by Aitken and De Luliis 2007).  
Even though, the causes of DNA damage are still uncertain, up-to-date abnormal sperm 
chromatin/DNA structure is thought to arise from four potential sources (listed below) (Sakkas et 
al., 1999b; Agarwal and Said, 2004; Erenpreiss et al., 2006). Because markers of sperm DNA 
damage or chromatin integrity are still relatively new, factors contributing to these sources of 
damage remain largely unclear. However, their discovery is vital for the development of 
preventative or treatment measures (Aitken and De Luliis, 2007). 
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2-6-1- Defects in recombination 
Deficiencies in recombination during spermatogenesis due to defect in checkpoint system during 
ligation of DNA double strand breaks may lead to persistent sperm DNA fragmentation in 
ejaculated spermatozoa, which usually lead to cell abortion (Bannister and Schimenti, 2004;  
Erenpreiss et al., 2006).  
2-6-2- Spermatid maturation abnormalities 
DNA strand breaks have been found in round and elongating spermatids. DNA breaks are 
necessary for transient relief of torsional stress, favoring removing of the nucleosome histone cores, 
and aiding their replacement with transitional proteins and protamines during maturation in 
elongating spermatids (Marcon and Boissonneault, 2004; Laberge and Boissonneault, 2005). 
Ligation of these breaks is important for restoring the DNA integrity and for reassembly of the 
important unit of genome expression, the DNA loop-domain. 
Chromatin re-packaging requires decondensation of the chromatin by hyperacylation of the histone 
and introduction of breaks by topoisomerase II (Laberge and Boissonneault, 2005) during 
epididymal transit replacement of histones by protamines completed and chromatin condensation 
restored. However, if these temporary breaks are not repaired, DNA fragmentation in ejaculated 
spermatozoa may occur.  
Animal models have proven the relationship between aberrant chromatin condensation and 
presence of DNA breaks (Cho et al., 2003; Zhao et al., 2004). 
Human sperm DNA contains a segment of partially denatured DNA that represent a potential DNA 
break if induced by any factors (Muriel et al., 2004) 
The relative spermatid DNA/chromatin conformational fragility may be responsible for the 
presence of higher levels of spontaneous DNA damage in sperm than in somatic cells (Fernandez et 
al., 1998). In addition, elongating chromatids have a lower repair capacity for strand breaks (van 
Loon et al., 1993). 
2-6-3- Oxidative stress  
The first indication that oxidative stress might be involved in the disruption of normal sperm 
function came from John MacLeod (1943), who observed that human spermatozoa rapidly lose 
their motility when incubated under high oxygen tensions. 
High levels of reactive oxygen species (ROS) are toxic to sperm quality and function (Saleh and 
Agarwal, 2002a; Hammadeh et al., 2006). About 25–40% of the infertile patients had elevated 
levels of ROS (Padron et al., 1997). Oxidative stress resulted by an imbalance between the 
productions of ROS and the antioxidant capacity (Sharma and Agarwal, 1996). Many studies 
showed that oxidative stress appears to be the major cause of DNA damage in the male germ line 
(Figure 5) (Saleh et al., 2003a; Aitken and Sawyer 2003; Aitken et al., 2003a, b). 
Hydrogen peroxide, superoxide and free radicals are part of the ROS that are highly reactive 
oxidizing agents (Warren et al., 1987). Low levels of ROS are necessary for modulating gene and 
protein activities that is vital for sperm proliferation, differentiation and function. The major 
sources of ROS are the defective spermatozoa (specifically those with retained cytoplasm), semen 
leukocytes and mitochondria (Vernet et al., 2001; Zini and Libman, 2006). Other ROS-generating 
systems are the enzymes nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX5) 
that is potentially capable of generating ROS in the presence of calcium and NADPH (Aitken et al., 
1997; Banfi et al., 2001), lipoxygenase (Oliw and Sprecher, 1989), tumor-associated cell surface 
NADH oxidase (tNOX) (Morré and Morré, 2003) and cytochrome P450 reductase (Baker et al., 
2004).  
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One of the mechanisms by which oxidative stress impacts upon sperm function, particularly 
motility and sperm–oocyte fusion, is through the stimulation of a lipid peroxidation in the plasma 
membrane (Aitken and Clarkson 1987; Aitken et al., 1998a; b). Spermatozoa plasma membrane has 
high unsaturated fatty acid content that makes it particularly susceptible to ROS–mediated damage, 
as well as, spermatozoa lack of appropriate repair mechanisms. Protection of the sperm DNA from 
oxidative stress can be achieved by tight DNA packaging and high levels of antioxidants present in 
seminal plasma (Twigg et al., 1998b).   
A defect in spermatid protamination and disulphide bridge formation due to inadequate oxidation 
of thiol-groups will negatively affect the sperm chromatin packaging, making sperm cells more 
vulnerable to ROS induced DNA fragmentation (Erenpreiss et al., 2006).  
Many studies have indicated a significant correlation between DNA damage and high levels of 
ROS in infertile patients (Fraga et al., 1996; Kodama et al., 1997; Sun et al., 1997; Twigg et al., 
1998a, b; Kemal Duru et al., 2000; Barroso et al., 2000; Aitken and Baker, 2004). Furthermore, the 
significant effect of oxidative stress on sperm DNA integrity was supported by Loft et al. (2003) 
who reported that pregnancy occurring in a single menstrual cycle was inversely associated with 
the level of 8-hydroxy-2′-deoxyguanosine, an indicator of oxidative DNA damage in spermatozoa. 
Tremellen, (2008) had summarized the routine laboratory tests signs that suggest the possible 
existing of oxidative stress in seminal plasma as follow: 
1. Poor sperm motility (Asthenozoospermia) 
2. Poor sperm morphology (Teratozoospermia) 
3. High number of round cells in semen ((Leukocytes?) 
4. Increased semen viscosity 
5. Poor sperm membrane integrity on hypo-osmolar swelling test (HOS-test) 
6. Poor fertilization on routine IVF 
7. Poor sperm motility after overnight incubation with the oocyte 
8. Poor blastocyst development in the absence of a clear female factor (advanced maternal age/poor 
ovarian reserve)  
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Figure 5. Oxidative stress as a major cause of defective sperm function and DNA damage. Summary of some of the 
factors that render human spermatozoa vulnerable to oxidative stress and the way in which such stress can generate 
pathology (adapted from Lewis & Aitken 2005). 
 
2-6-4- Abortive apoptosis  
Another cause for the DNA double-strand breaks (DSBs) in the spermatozoa of infertile patients 
can arise through an abortive apoptotic pathway (Cisternas and Moreno, 2006). Spermatozoa that 
are marked for apoptotic degradation may have normal mitochondrial activity, high or low motility 
(Barroso et al., 2000) as well as normal morphology (Host et al., 2000a; b). 
It has been suggested that an early apoptotic pathway, initiated in spermatogonia and 
spermatocytes, is mediated by Fas protein. Fas is a type I membrane protein that belongs to the 
tumor necrosis factor–nerve growth factor receptor family (Suda et al., 1993; Krammer et al., 
1994). It has been shown that sertoli cells express Fas ligand, which by binding to Fas leads to cell 
death through apoptosis (Suda et al., 1993), limiting the size of the germ cell population to numbers 
sertoli cells can support (Rodriguez et al., 1997). Some studies have not found correlations between 
DNA damage and Fas expression (Muratori et al., 2000), or, in contrast, have not revealed ultra-
structural evidence for the association of apoptosis with DNA damage in sperm (Barroso et al., 
2000). 
Furthermore, 20% of ejaculated spermatozoa that showed DNA strand breaks and the apoptotic 
marker annexin V, was reported (Oosterhuis et al., 2000). Whereas,  according to an investigation 
by Sakkas et al., (1999a), it was reported that DNA strand breaks and apoptotic markers did not co-
exist together in the same mature spermatozoa. The percentage of spermatozoa with DNA 
fragmentation in normal donors and different groups of patients is illustrated in figure 6. 
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Figure 6. Frequency of DNA fragmentation in human ejaculated spermatozoa. The percentage of DNA fragmentation 
in the above groups was determined using TUNEL assay. Five studies evaluated normal donors. Three of the studies 
also assessed a group of infertile patients, two evaluated varicocele patients, one evaluated cryptorchidism patients and 
two assessed testicular cancer patients (adapted from Angelopoulou et al., 2007).  
  
Alternatively, if the apoptotic cascade is initiated at the round spermatid phase, when transcription 
(and mitochondria) is still active, abortive apoptosis might be an origin of the DNA breaks. 
Although many apoptotic biomarkers have been found in the mature male gamete, particularly in 
infertile men, their definitive association with DNA fragmentation remains elusive (Lachaud et al., 
2004; Henke et al., 2004; Paasch et al., 2004). It was demonstrated in elongated spermatozoa stage 
that high levels of DNA breaks were associated with high level of topoisomerase II (Roca and 
Mezquita, 1989; McPherson and Longo, 1993a). Topoisomerase II possibly needed to relieve 
torsional stress caused by the negative supercoiling associated with histone to protamine transition 
(Balhorn, 1982). It was indicated that topoisomerase II may act by causing double-strand breaks, 
which are re-ligated again (termed sperm chromatin fragmentation) or acting by conjuncting with 
an extracellular nuclease to cause regulated double-strand breaks in protamine-bound DNA (termed 
sperm DNA degradation) (Sotolongo et al., 2005; Shaman et al., 2006). This topoisomerase/ 
nuclease-induced DNA degradation may be a specialized apoptotic pathway in sperm, different 
from the normal function of topoisomerase in relieving torsional stress, followed by re-ligation of 
the DNA break (Shaman et al., 2006). 
In ejaculated human sperm both apoptosis and necrosis are seen. However, it is uncertain whether 
ejaculated sperm retains the ability to activate the apoptotic cascade or whether the detected 
apoptotic markers in spermatozoa are, simply, the expression of an apoptotic process that has began 
before the event of ejaculation (Sakkas et al., 2002). Moreover, during in vitro processing, 
spermatozoa cannot enter in the apoptotic pathway and they are eliminated by necrosis (Greco et 
al., 2005). 
2-7- Clinical significance of sperm DNA damage 
2-7-1- DNA damage and semen parameters 
Different studies reported either weak or no correlation between conventional semen parameters 
and sperm DNA damage, most of them indicated that spermatozoa from patients with abnormal 
sperm count, morphology and motility had increased levels of DNA damage (reviewed in 
Erenpreiss et al., 2006). 
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If sperm DNA damage resulted as adverse effect of ROS, then a relationship to sperm motility 
could be expected. This is due to the effect of ROS on the lipid peroxidation of sperm membranes 
rich with unsaturated fatty acids (Erenpreiss et al., 2006). Besides, some studies report a correlation 
between sperm DNA damage and motility (Gandini et al., 2000; Giwercman et al., 2003). 
However, it should be remembered that these processes are inter-related. Unrepaired DNA DSB’s 
can lead to defective sperm packaging which, in turn, as a consequence of persistent DNA 
fragmentation or due to the other reasons, can cause increased access to ROS attack. 
2-7-2- The relationship between sperm DNA integrity and fertilization (Natural conception) 
In vivo fertilization probability almost close to zero in patients with sperm DNA damage exceeds 
30% as detected by SCSA (Evenson et al., 1999; Spano et al., 2000). The DNA in human 
spermatozoa is extensively damaged at high levels of oxidative stress, resulting in severely 
disrupted in fertilizing potential of the spermatozoa as a consequence of collateral peroxidative 
damage to the sperm plasma membrane (Aitken et al., 1998a). A recent meta-analysis by Evenson 
and Wixon, (2008) indicated a strong correlation between sperm DNA damage and failure to 
achieve a natural pregnancy.  
2-7-3- Sperm DNA damage and pre-implantation development  
Post-fertilization development of the embryo can be seriously disrupted by DNA damage. Such 
disruption is associated with the abortive transcription of damaged genes originating from the 
paternal genome (Tesarik et al., 2002; 2004). Embryonal pre-implantation development is 
negatively correlated with DNA damage as detected by nick translation (Sakkas et al., 1998), 
TUNEL (Ahmadi and Ng 1999), Comet (Morris et al., 2002), and SCSA (Virro et al., 2004) assays. 
Furthermore, chromatin structure abnormalities are associated with reduced rates of embryo 
cleavage, again emphasizing the link between chromatin integrity and developmental potential.  To 
avoid the inheritance of an abnormal paternal genome after ICSI, Spano et al., (2000) suggested the 
use of blastocyst for implantation.  
2-7-4- Intrauterine insemination (IUI) 
High levels of sperm DNA damage have generally been associated with lower IUI pregnancy rates 
(Duran et al., 2002; Muriel et al., 2006; Bungum et al., 2007). In patient samples with >12% sperm 
DNA damage detected by TUNEL used for insemination, no pregnancy was achieved (Duran et al., 
2002). Also, if the proportion of sperm cells with DNA damage exceeded 30% as detected by 
SCSA, then the probability of fertilization by IUI seemed to be close to zero (Saleh et al., 2003a; 
Bungum et al., 2004). Thus, the artificial insemination cycles in which DNA fragmentation is high 
had been found to correlate negatively with pregnancy (Duran et al., 2002). Therefore, sperm DNA 
damage assessment has a high predictive value for the outcome of both natural conception and IUI. 
2-7-5- In vitro fertilization (IVF) and Intracytoplasmic sperm injection (ICSI) 
Many of systemic review and meta-analysis of IVF and IVF/ICSI studies showed that sperm DNA 
damage is associated with a significant increase in the rate of pregnancy loss after IVF and ICSI 
(reviewed by Zini and Sigman, 2009). Tomlinson et al., (2001) reported a significant negative 
correlation between sperm DNA damage and embryo quality in IVF cycles. Many studies reported 
that a sperm DNA fragmentation index (DFI) less than 27%, detected by SCSA, is necessary to 
obtain a successful pregnancy by IVF and ICSI (Larson et al., 2000; Larson-Cook et al., 2003). 
However, other studies did not have similar results (Bungum et al., 2004; Gandini et al., 2004; 
Check et al., 2005); these results indicated that successful pregnancies in IVF/ICSI cycles can even 
be obtained using semen samples with a high proportion of DNA damage. These data are in 
accordance with and confirm previous investigations by Hammadeh et al. (1998), Host et al. 
(2000b), and Larson-Cook et al. (2003), who showed that sperm DNA damage is more predictive 
in IVF and much less in ICSI. Successful fertilization was achieved by ICSI technique, despite the 
high levels of DNA damage in the injected spermatozoa, regardless of whether ejaculated or 
testicular spermatozoa are used during therapy (Hammadeh et al., 1998; Esterhuizen et al., 2000; 
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Lewis et al., 2004; Aitken, 2004). A recent meta-study by Collins et al., (2008), suggested that 
sperm DNA damage has no measurable impact on pregnancy rates in ICSI. Whereas, other studies 
showed an inverse relationship between pregnancy rates with ICSI and the level of DNA 
fragmentation in testicular and ejaculated sperm (Lewis et al., 2004; Bungum et al., 2004; Virro et 
al., 2004).  
2-7-6- Embryonal loss 
DNA abnormalities have been associated with unexplained recurrent pregnancy loss including 
sperm DNA fragmentation (Carrell et al., 2003a; Saleh et al., 2003a). Depending on the severity of 
the genetic damage and the ability of the oocyte to repair it, the embryo may fail at any stages of 
pregnancy or might develop to term with abnormalities. Low pregnancy rates were obtained in 
patients with sperm DNA damage (DFI ≥30%) (Check et al., 2005). Also, it had been shown by 
Carrell et al., (2003b) that the proportion of sperm with DNA damage was significantly higher in 
men from couples with recurrent pregnancy loss, compared with the general population or fertile 
donors. 
2-7-7- Effect of sperm DNA quality on offspring 
Many studies indicated that sperm DNA damage can affect the health of the embryo, fetus, and 
offspring (Bonde et al., 2003; Perreault, 2003; Savitz, 2003). A possible consequence of sperm 
DNA damage is infertility in the offspring (Aitken and Krausz, 2001; Silber and Repping, 2002). 
Association between paternal occupations involving exposure to metals, solvents and pesticides and 
an increase in birth defects and childhood diseases had been indicated (Olshan and Mattison, 1994). 
Moreover, one concern raised from studies of smokers is the increased risk of childhood cancer of 
the offspring of men with a high proportion of sperm DNA fragmentation in their sperm. It was 
shown that the offspring of these men, whose ejaculate are under oxidative stress (Manicardi et al., 
1995) and whose semen is characterized by high chromatin fragmentation, are four to five times 
more likely to develop childhood cancer than the children of non–smoking fathers (Ji et al., 1997; 
Virro et al., 2004). Another study has demonstrated that 15% of all childhood cancers are directly 
attributed to paternal smoking (Sorahan et al., 1997). A powerful association exist between 
childhood disease and paternal occupation (Sawyer et al., 2003).  
However, the linkage between sperm DNA damage and abnormalities in offspring is not confirmed 
to smokers.  
Aitken and Krausz, in 2001 proposed that sperm DNA damage is promutagenic and can give rise to 
mutations after fertilization, as the oocyte attempts to repair DNA damage prior to the initiation of 
the first cleavage. Mutations occurring at this point will be fixed in the germ line and may be 
responsible for the induction of not only such pathologies as described above (infertility and 
childhood cancer in the offspring), but also for a higher risk of imprinting diseases (Cox et al., 
2002; DeBaun et al., 2003). 
2-8- Assessment of sperm DNA damage 
Spermatozoa DNA damage detection may be considered a good indicator to identify males with 
reduced fertilization capacity or to initiate a healthy pregnancy. A number of direct and indirect 
assay methods have been used for the assessment of sperm DNA damage; of the common methods 
used for direct detection the Terminal deoxynucleotidyl transferase-mediated deoxyuridine 
triphosphate-nick-end labeling assay (TUNEL) and Comet assay. The most common indirect 
method for assessing DNA damage include the sperm chromatin integrity assays like sperm 
chromatin structure assay (SCSA) (Andrabi, 2007).  
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2-8-1- Factors that influence the predictive value of DNA damage assays 
The predictive value of DNA fragmentation tests depends on several factors associated with the 
DNA damage itself (Lewis et al., 2008). These include:  
1. Single- vs. double-stranded DNA fragmentation. Single strand breaks are easier to repair than 
double strands breaks. 
2. Percentage of spermatozoa with DNA damage. The probability for fertilization decreases as the 
number of affected sperm increases. 
3. Degree of DNA fragmentation per spermatozoon. The higher the degree of DNA fragmentation, 
the lower the probability the oocyte or the embryo of repairing the damage. 
4. Whether there is primary and/or secondary DNA damage. Apoptosis during spermatogenesis and 
nicks produced during the process of spermiogenesis are considered primary, while damages due to 
hydroxyl radical or damage produced due to exposure to ionizing radiation are considered 
secondary damage. Primary damage in this case consists of, for the most part, double-stranded 
DNA fragmentation. 
5. Type of DNA fragmentation test used. Tests that measure DNA damage under physiological 
conditions like COMET at neutral pH or TUNEL have higher predictive values than tests that 
measure DNA damage or susceptibility to DNA denaturation under non-physiological conditions. 
6. Whether DNA damage affects coding sequences. The probability that DNA damage affects a 
protein coding sequence is relatively low because more than 90% of DNA consist of non-coding 
sequences.  
7. Ability of the oocyte to repair sperm DNA damage in ART. Repairing ability depends on the 
extent of sperm DNA damage and on the quality of oocytes 
8. Ability of the embryo to repair DNA damage. It depends on quality of the embryo and the extent 
of DNA damage introduced in the embryo’s genome by the fertilizing spermatozoon. 
9. Number of metaphase II oocytes. 
10. Sample processing. Processing of the sperm-like centrifugation and incubation, for example, 
may increase the percentage of DNA fragmentation. 
 2-8-2- Assessment Methods 
In general, all assays can be divided into three groups: the assays’ principles, as well as the 
advantages and disadvantages of assays from all three groups, are described:  
2-8-2-1- Chromatin structural probes using nuclear dyes 
Nuclear dyes are both sensitive and simple to use and therefore attractive for clinical use. Many 
factors affect the staining of the chromatin by planar ionic dyes: 
1. DNA secondary structure and conformation. Fragmented DNA is easily denatured 
(Darzynkiewicz, 1994). However, even a single DNA strand break causes conformational transition 
of the DNA loop-domain from a supercoiled state to a relaxed state. Supercoiled DNA takes up 
intercalating dyes like acridine orange (AO) because this reduces the free energy of torsion stress. 
2. Chromatin packaging density. If the chromatin is regularly arranged and sufficiently densely 
packed, dye co-planar polymerization providing metachromatic shift (change of color) is favored 
(Erenpreisa and Zaleskaya, 1983). However, if the chromatin is packaged even more densely (as in 
normal sperm), the polymerization of the dye is hindered (Erenpreisa et al., 1992) and may even 
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prevent dye binding, especially by large, bulky dyes at an unfavorable pH. The latter case is seen 
with aniline blue (AB) at low pH where it stains basic proteins loosely associated with DNA and is 
unable to bind to the chromatin of normal sperm, which is very densely packaged. 
3. Chromatin proteins. Chromatin proteins affect the binding of DNA dyes in the way that they 
themselves bind differently to relaxed/fragmented or supercoiled DNA. DNA supercoiling requires 
covalent binding of some nuclear matrix proteins and tighter ionic interactions between DNA and 
chromatin proteins to support negative supercoils (Benyajati and Worcel, 1976). Chromatin 
proteins in sperm nuclei with impaired DNA appear to be more accessible to binding with the 
acidic dye, as found by the AB test (Auger et al., 1990; Erenpreisa et al., 2001). An increase in the 
ability to stain sperm by acid AB indicates a looser chromatin packaging and increased accessibility 
of the basic groups of the nucleoprotein. This is due to the presence of residual histones (Terquem 
et al., 1983) and correlates well with the AOT (Liu and Baker, 1992). Chromomycin–A3 (CMA3) 
is another staining technique, which has been used as a measure of sperm chromatin condensation 
anomalies. CMA3 is a fluorochrome specific for GC-rich sequences and is believed to compete 
with protamines for association with DNA. The extent of staining is therefore related to the degree 
of protamination of mature spermatozoa (Bianchi et al., 1993; Manicardi et al., 1995).  
In turn, it can be inferred that the phosphate residues of sperm DNA in nuclei with loosely packed 
chromatin and/or impaired DNA will be more liable to binding with basic dyes. Such conclusions 
were also deduced from the results of staining with basic dyes, such as toluidine blue (TB), methyl 
green and Giemsa stain (Erenpreisa et al., 1992; Andreetta et al., 1995). The most widely used 
techniques for sperm chromatin structure assessment are the SCSA (Larson-Cook  et al., 2003; 
Bungum  et al., 2004), AO (Tejada et al., 1984; Hoshi et al., 1996) and TB tests (Erenpreiss  et al., 
2004; Beletti and Mello,  2004). 
2-8-2-1- 1- Acridine Orange Test (AOT) 
The acridine orange test (AOT) was introduced by Tejada et al., (1984). The AOT measures the 
susceptibility of sperm nuclear DNA to acid-induced denaturation in situ by quantifying the 
metachromatic shift of AO fluorescence from green (native or dsDNA) to red (denatured or 
ssDNA). AOT is inexpensive and simple but fading of the color occurs in a short time which 
requires fast evaluation. In recent studies by Chohan et al., (2006) and Martin et al., (2007a; b) it is 
found that AOT is not that much sensitive as TUNEL and SCSA for evaluating sperm DNA 
fragmentation. The percentage of DNA fragmentation, also referred to as DNA Fragmentation 
Index (DFI) is yielded by the ratio of red/red+green.  
In 1996, Hoshi et al., demonstrated that when > or = 50% of spermatozoa in semen samples 
exhibited green AO nuclear fluorescence, IVF was always successful and when green AO nuclear 
fluorescence was < 50%, only 39% of IVF treatment cycles were successful. When the incidence of 
green AO fluorescent spermatozoa was < 50%, no pregnancy resulted even though an average of 
26% of the oocytes could be fertilized by ICSI (Hoshi et al. 1996). Also, Virant-Klun et al., 2002; 
Shibahara et al., 2003; Cebesoy et al., 2006, indicated that the percentage of sperm showing > 56% 
red fluorescence is considered as the "cut-off" value to characterize an abnormal chromatin status. 
2-8-2-1- 2- Chromomycin–A3 Staining (CMA3) 
CMA3, a polymerase inhibitor that is used to evaluate the normal protaminosis by indirect 
approach, this assay is inversely correlated with the protamination state of spermatozoa based on 
the in situ competition with protamine (Bizzaro et al., 1998). A Chromomycin A3 is a guanine–
cytosine-specific fluorochrome that binds to the DNA as a Mg2+ -coordinated dimer at the minor 
groove of GC-rich DNA and prevent the accessibility of DNA polymerase I to the DNA and, 
almost none of the CMA3- negative spermatozoa present nicked DNA, as CMA3 is unable to access 
DNA in the presence of protamines and normally formed disulphide bonds (Manicardi et al., 1995; 
Lolis et al., 1996). 
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Evaluation of CMA3 is done by differentiation between spermatozoa nuclei with bright (CMA3 
positive) or dull yellow staining (CMA3 negative) or by comparing bright and dull yellow (CMA3 
positive) with spermatozoa nuclei counterstained blue with DAPI (CMA3 negative) or with bright 
or dull green if counterstain is not used. However, the disadvantage of this staining technique is the 
disability to discriminate whether the potential protamine deficiency is due to a lack of P1, P2 or a 
combination of both, and this can be solved by gel electrophoresis (Oliva, 2006). 
Sakkas et al., reported that semen samples with high CMA3 positivity (> 30%) may have 
significantly lower fertilization rates if used for ICSI (Sakkas et al., 1998). Also, the work of 
Tarozzi and her team demonstrated the good predictive value of CMA3 analysis in IVF outcome 
and the possibility of using this test as a prognostic tool for IVF patients. They propose a calculated 
threshold value for CMA3 staining (cutt-off value) equal 29.25% by using Raceiver Operating 
Characteristic (ROC) curve (Tarozzi et al., 2009). 
2-8-2-1- 3- Sperm chromatin structure assay (SCSA)  
The sperm chromatin structure assay (SCSA) depends on the fact that abnormal sperm chromatin 
has a greater susceptibility to the physical induction of partial DNA denaturation in situ (Agarwal 
and Said, 2004). The SCSA exploits the metachromatic properties of acridine orange (AO) to 
monitor the susceptibility of sperm chromatin to heat or acid-induced denaturation (Agarwal and 
Said, 2004; Fraser, 2004). Similar to AOT the percentage of DNA fragmentation, also referred to as 
DNA Fragmentation Index (DFI), is yielded by the ratio of red/red+green. The percentage of sperm 
showing > 56% red fluorescence is considered as the "cut-off" value to characterize an abnormal 
chromatin status (Virant-Klun et al., 2002; Shibahara et al., 2003 ; Cebesoy et al., 2006). 
Evenson et al., (1999) reported that if the proportion of sperm cells with DNA damage exceeds 
30% as detected by SCSA, then the probability of fertilization in vivo is almost zero for natural 
conception. Also, Larson et al., (2003) reported that no patients achieved pregnancy following IVF 
or ICSI if >27% of sperm in a sample of semen showed DNA fractionation in the SCSA (i.e. DNA 
fragmentation index (DFI) >27%). The same authors also observed that patients with 
morphologically abnormal sperm could achieve pregnancy following ICSI if the same sample of 
sperm had a DFI of 0–15%.  
2-8-2-1-4- DNA breakage detection–fluorescence in situ hybridization test (DBD-FISH) 
DNA breakage detection–fluorescence in situ hybridization (DBD-FISH) is a procedure that allows 
in situ detection and quantification of DNA breaks in the whole genome or within specific DNA 
sequence areas, cell by cell (Fernandez et al., 1998).  
Sperm cells embedded within an agarose matrix on a slide are exposed to an alkaline solution, 
which transforms DNA-strand breaks into single-stranded DNA (ssDNA) motifs. After neutralizing 
and protein removal, ssDNA is accessible to hybridization with whole genome or specific DNA 
probes. The probe highlights the chromatin area to be analyzed. Fluorescence intensity and surface 
area of the FISH signal increase as DNA breaks increase, which means the more ssDNA produced 
by the alkaline solution, the more the probe hybridizes (Fernandez et al., 2000). 
2-8-2-1- 5- Acidic Aniline Blue Assay (AB) 
The AB is an acidic stain, which distinguishes between lysine-rich histones and arginine/cysteine-
rich protamines (Hofmann and Hilschler, 1991). This assay gives a specific positive reaction for 
lysine and reveals differences in the basic nuclear protein composition of ejaculated human 
spermatozoa. Histones are rich in lysine while protamines are rich in arginine and cystine. 
Immature spermatozoa nuclei are rich in histones that are rich in lysine and will be stained blue. On 
the other hand, nuclei of mature spermatozoa are rich protamines that are rich in arginine and 
cysteine and contain relatively low levels of lysine, which means they will not be stained by aniline 
blue (Hammadeh et al., 2001). 
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The results of the work of Hammadeh et al., (1998) indicated  that chromatin condensation as 
visualized by aniline blue staining is a good predictor for IVF outcome, although it cannot 
determine the fertilization potential, cleavage, and pregnancy rate following ICSI. AB method is 
simple and inexpensive but has limited repeatability. 
2-8-2-1- 6- Toluidine blue Assay (TB) 
Toluidine blue is a basic nuclear dye used for metachromatic and orthochromatic staining of 
chromatin. It stains phosphate residues of the DNA of sperm nuclei with both loosely packed 
chromatin and fragmented (Erenpreisa et al., 2003). Sperm heads with good chromatin integrity 
stain light blue, and those of diminished integrity stain violet (purple). Nevertheless, TB staining 
may be considered a fairly reliable method for assessing the sperm chromatin. Like AB, TB method 
is simple and inexpensive but has limited repeatability. 
2-8-2-2- Tests for direct assessment of sperm DNA fragmentation 
2-8-2-2-1- In situ nick translation assay (ISNT) 
This in situ nick translation (ISNT) assay quantifies the incorporation of biotinylated-dUTP at 
ssDNA breaks in a reaction catalyzed by the template-dependant enzyme DNA polymerase I. The 
ISNT may detect spermatozoa that contain appreciable and variable levels of endogenous DNA 
damage. Currently, however, ISNT assay thresholds for post-fertilization embryo viability have not 
been established, which severely limits the clinical usefulness of this assay (Andrabi, 2007). 
ISNT test has the ability to indicate if there is damage arising from factors such as the generation of 
ROS following exposure to leukocytes within the male reproductive tract or heat exposure (Aitken 
et al., 1991; Setchell et al., 1998). Furthermore, it has a very clear relationship with sperm motility 
and morphology and, to a lesser extent, sperm concentration (Irvine et al. 2000; Tomlinson et al. 
2001).  
 2-8-2-2-2- Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-nick-
end  labeling assay (TUNEL) 
The TUNEL assay quantifies the incorporation of deoxyuridine triphosphate (dUTP) at single 
strand (ss)- and ds-DNA breaks in an enzymatic reaction by labeling the free 3′-OH terminal and 
modified nucleotides (5-bromo-2′-deoxyuridine-5′-triphosphate nucleotide) with terminal 
deoxynucleotidyl transferase. Sperm with normal DNA therefore have only background 
staining/fluorescence, while those with fragmented DNA (multiple 3′-OH ends) stain/fluoresce 
brightly (Gorczyza et al., 1993), which can be quantified by flow cytometry, or by fluorescent 
microscopy or light microscopy (Agarwal and Said, 2003). The microscopic TUNEL assay has 
been modified by some researchers to include a peroxidase enzyme labeling system that 
catalytically generates an intense signal from chromogenic substrates. This labeling technique 
eliminates the problems associated with fluorescence fading in the microscopic method, thereby 
giving operators more time to analyze a greater number of cells for more accuracy (Host et al., 
2000a; b). 
In 2000, Sergerie et al., demonstrated that the calculated threshold value “cut-off value“ for 
TUNEL assay to distinguish between fertile controls and infertile men was 20%. They 
demonstrated that sperm DNA fragmentation, as measured by TUNEL assay, is a highly valuable 
indicator of male fertility. In another study the proposed “cut-off value“ calculated from receiver 
operating characteristics (ROC) curve analysis for IVF patients was 36.5% and for ICSI patient 
24.3% (Henkel et al., 2003; 2004).  
2-8-2-2-3- COMET assay (Single Cell Gel Electrophoresis) Assay 
This assay was first introduced by Ostling and Johanson (1984), for the analysis of DNA damage in 
an individual cell. In this assay, spermatozoa are stained with a fluorescent DNA-binding dye. One 
of the principles of the comet assay is that nicked double-stranded DNA tends to remain in the 
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comet head, whereas short fragments of nicked double and single stranded DNA migrate into the 
tail area (Klaude et al., 1996). Therefore, spermatozoa with high levels of DNA strand breaks 
would show increased comet tail fluorescent intensity (Hughes et al., 1998) and comet tail length 
(Singh and Stephens, 1998). The results are interpreted by comparing the number of cells with 
comet tails with total number of spermatozoa (Anderson et al., 1997). Also the assay is classified as 
alkaline and neutral COMET assay depending on the type of damage being investigated (Klaude et 
al., 1996; Hughes et al., 1998). 
Regarding the alkaline COMET assay (pH>10), it denatures sperm DNA and therefore, identifies 
both ss and dsDNA breaks. Whereas, the neutral COMET assay may be more sensitive to dsDNA 
breaks and therefore, better able to identify DNA damage related to infertility as the conditions of 
the assay (pH 9) do not denature DNA. Neutral COMET assay is better able to identify DNA 
damage related to infertility (Fraser, 2004). The major problem with COMET assay is that it is a 
labor-intensive test. 
The assay has been successfully used in the evaluation of DNA damage after cryopreservation 
(Duty et al., 2002). It may also predict embryo development after IVF and ICSI, especially in 
couples with unexplained infertility (Morris et al., 2002). 
2-8-2-3- Sperm nuclear matrix assays 
2-8-2-3-1- Sperm chromatin dispersion assay (SCDA) 
More recently, sperm chromatin dispersion assay (SCDA) has been described as a simple and 
inexpensive method for analysis of mammalian sperm DNA fragmentation (Fernandez et al., 
2003). The SCDA is based on the principal that spermatozoa with non-fragmented DNA are 
immersed in an agarose matrix and exposed to lysing solution; the resulting deproteinized nuclei 
show extended halos of DNA dispersion as monitored by fluorescent or light microscopy. On the 
other hand, the SCDA does not give much information about the extent of spermatozoal DNA 
damage, since its endpoints consist of subjectively quantifying the percentage of spermatozoa with 
dispersed or non-dispersed nucleoids.  SCD test does not require the determination of color or 
fluorescence intensity; the test is simple, fast, and reproducible, and its results are comparable to 
those of the SCSA. Because the SCD test was recently introduced, little is known about its 
limitations and its clinical significance (Fernandez et al., 2003; Andrabi, 2007). 
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2-9- Aims of the study 
The aims of the present study were to: 
1- Investigate the relationship between the human sperm DNA integrity under oxidative stress and 
smoking using; TUNEL assay, Chromomycin A3 and protamine concentration by electrophoresis. 
2- Evaluate the level of oxidative DNA damage by measuring the reactive oxygen species (ROS), 
8-hydroxy-2’- deoxyguanosine, (8-OHdG) and of lipid peroxides (TBA, Malondialdehyde) in 
seminal plasma.  
3- Investigate the effect of smoking on sperm parameters including protamines and measuring the 
level of cotinine concentration in seminal plasma.  
4- Evaluate the consequence of oxidative stress on the fertilization and pregnancy rates of patients 
undergoing ICSI treatment. 
5- Determine the ratio of protamine 1 to protamine 2 in human spermatozoa and relate it to in 
intracytoplasmic sperm injection (ICSI) and standard semen parameters.
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3- Materials and Methods 
3-1- Materials 
3-1-1- Semen samples  
166 Semen samples were collected. Ejaculates from volunteers with normozoospermia (n =50) 
served as controls and ejaculates from unselected male partners (n=116 patients)
 
of couples 
consulting for infertility at department of obstetrics and gynaecology, university of 
Saarland/Homburg/Saar. Ejaculates were obtained in the early morning at the clinic (7.00–9.30 
AM) after three to five days of sexual abstinence.  
3-1-2- Chemicals and laboratory materials 
- Acetic Acid      Fluka, Neu-Ulm, Germany 
- Acetone      Merck, Darmstadt, Germany 
- Acrylamide-Stock solution:     Carl Roth GmbH, Karlsruhe, Germany 
  Rotiphorese
®
 Gel 30 
  Rotiphorese
®
 Gel 40 
- Ammonium Persulphate (APS)   Sigma, Munchen, Germany 
- Bovin-IgG protein     Bio-Rad, Munchen, Germany 
- Bradford Protein Assay Kit    Bio-Rad, Munchen, Germany 
- Chromomycin     Sigma, Munchen, Germany 
- Coomassie Blue Stain     Serva, Heidlberg, Germany 
   Brilliant R 250 
   Brilliant G 250 
- Disodium hydrogenphosphate   Merck, Darmstadt, Germany 
- Dithiothreitol (DTT)     Sigma, Munchen, Germany 
- Dry milk powder (non-fat_    J.M. Galber Saliter GmbH &  
        Co.KG, Obergunzburg, Germany 
- Eosin Y Stain     Sigma, Munchen, Germany 
- Ethanol Absolute     Merck, Darmstadt, Germany 
- Ethylene diamine tetraacetic acid   Sigma, Munchen, Germany 
  Disodium salt (EDETA)  
- Glycerin       Fluka, Neu-Ulm, Germany 
- Guanidine Hydrochloride    Sigma, Munchen, Germany 
- HAM’s F10 medium    PAN Biotech, Germany    
- Hexadecyltrimethylammonium bromide   Sigma, Munchen, Germany  
  (CTAB) 
- Hydrochloric acid     Merck, Darmstadt, Germany 
- Lumi-Light Western Blotting Substratee  Roche, Mannheim, Germany 
- ß-Mercaptoethanol      Merck, Darmstadt, Germany 
- Methanol      Merck, Darmstadt, Germany 
- Methyl Green     Sigma, Munchen, Germany 
- Paraformaldehyde     Merck, Darmstadt, Germany 
- Penylmethylsulfonyl fluoride (PMSF)  Sigma, Munchen, Germany 
- Potassium Acetate      Sigma, Munchen, Germany 
- Potassium Chloride     Merck, Darmstadt, Germany 
- Potassium dihydrogen phosphate   Merck, Darmstadt, Germany 
- Pure sperm gradient      Nidacon International AB, Sweden 
- PVDF membrane      Roche, Mannheim, Germany 
- Sodium Chloride     Merck, Darmstadt, Germany 
- tri-Sodium citrate. 2H2O    Merck, Darmstadt, Germany 
- Sodium Iodoacetate     Sigma, Munchen, Germany 
- Sucrose      Sigma, Munchen, Germany 
- N,N,N/,N/- Tetramethylendiamine   GA Healthcare, Freiburg 
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  (TEMED) 
- 1,1,3,3-Tetramethoxypropan   Sigma-Aldrich, Germany 
  (Malonaldehyde bis,dimethyl acetal, MDA) 
- Thiobarbituric acid (TBA)    Merck, Darmstadt, Germany    
- Trichloroacetic acid (TCA)    Sigma, Munchen, Germany 
- Tris(hydroxymethyl)aminomethane (Tris)  Sigma, Munchen, Germany 
- Triton X-100      Sigma, Munchen, Germany 
- Tween 20       Serva, Heidlberg, Germany 
- Urea       Sigma, Munchen, Germany 
3-1-3- Buffers and Solutions 
1. Ammonium Persulphate (APS) Solution 
- 1.6 % (w/v) Ammonium Persulphate  
2. Blocking Buffer 
 - 1 x PBS, pH 7.4 
 - 0.1% (v/v) Tween 20 
 - 5% (w/v) Non fat-Dry milk 
3. CMA3 Solution 
 - 0.25 gm/ml 
 - 1 x PBS, pH 7.4 
 - 10 mmol MgCl3 
4. Coomassei Blue Stain 
- 0.2% Brilliant R250 
- 0.01% Brilliant G250 
- 50% methanol 
- 10% acetic acid 
- 40% Disttild Water 
5. Decondensation Buffer 1 
  - 6 M Guanidine Hydrochloride (Gn-HCl) 
 - 575 mM Ditheothreitol (DTT)  
6. Decondensation Buffer 2 
 - 522 mM Sodium Iodoacetate  
7. Denaturing Solution  
 - 0.5 N HCl (Hydrochloric acid) 
8- Destaining buffer  
- 20 % methanol  
- 10 % acetic acid 
9. Electrophoresis Buffer 
 - 5% (v/v) Acetic acid 
10. Fixation Solution for CMA3 
 - 3 X Methanol 
 - 1 X Glacial acetic acid 
11.Fixation Solution for TUNEL 
- 4% Paraformaldehyde 
- PBS, pH 7.4 
12. Hypo Osmotic Solution 
 - 150 mmol/L Fructose (13.5 g/L) 
 - 150 m/mol/L Sodium Citrate.2H2O (7.35 g/L) 
13. Loading Buffer 
 - 0.375 M Potassium Acetate, pH 4.0  
 - 15% Succrose 
 - 0.05% Methyl Green (MG) 
14. Phosphate Buffer Saline (PBS), pH 7.4 
- 137 mM Sodium Chloride (NaCl) 
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- 2.7 mM Potassium Chloride (KCl) 
- 8 mM Disodium hydrogenphosphate (Na2HPO4) 
- 1.5 mM Potassium dihydrogen phosphate (KH2PO4) 
15. Permeability Solution 
- 0.10 % Triton X-100 
- 0.10 M Sodium citrate, pH 6.0 
16. Precipitating solution 
- 100% Trichloroacetic acid (TCA) 
17. Thiobarbituric acid - Trichloroacetic acid (TBA–TCA) Extraction reagent      
- 15% (w/v) TCA (Trichloroacetic acid)  
-  0.375% (w/v) TBA (Thiobarbituric acid) 
- 0.25N HCl (Hydrochloric acid) 
18. Transfer buffer  
 - 0.0009N Acetic acid 
19. Washing Buffer 1 
- mmol/L (1mM) phenylmethylsulfonyl fluoride (PMSF) 
20. Washing Buffer 2 
- 100 mM Tris, pH(8.0) (Tris(hydroxymethyl)aminomethane,  
- 1 mM phenylmethylsulfonyl fluoride 
- 20 mM EDTA (Ethylenediaminetetraacetic acid, EDETA). 
21. Washing Buffer 3 
 - 1 % β- Mercaptoethanol (β-MSH) 
 - 100 % Acetone 
22. Washing buffer 4 
- 1X PBS, pH 7.4 
 - 0.1 % (v/v) Tween 20 
 - 1 % (w/v) Non-Fat Dry milk 
23. Washing buffer 5 
- 1X PBS, pH 7.4 
 - 0.1 % (v/v) Tween 20 
 
3-1-4- Apparatus and Instruments 
Automatic Pipettes     Eppendorf, Hamburg, Germany 
Bio-Rad Microplate Reader 3550-UV  Bio-Rad, Munchen, Germany 
Electrophoresis Chamber    Home Made 
Enhance Chemilumenscece (ECL) system  Bio-Rad, Germany 
Eppendorf 5414C table centrifuge   Eppendorf, Hamburg, Germany 
pH-Meter: pH537     Carl Roth GmbH & Co, Karlsuhe, Germany 
Incubator with CO2     ZAPF Instrument, Germany 
Light Microscope     Olympus, 
Fluorescence Microscope    Zeiss, Oberkochen, Germany 
Macklar Counting Chamber    Macklar Co. 
Magnetic stirrer     Eppendorf, Hamburg, Germany 
Magnetic Bars      Eppendorf, Hamburg, Germany 
Power supply      Amersham Bioscience, Freiburg, Germany 
Simple beam photometer    Amersham Bioscience, Freiburg, Germany 
Ultrasonic bath Transonic 460   Elma GmbH, Singen, Germany 
Vortex       Elma GmbH, Singen, Germany 
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3-1-5- Antibodies    
3-1-5-1- Primary antibodies 
1- Protamine 1 (Hup 1N)    Mouse polyclonal antibody  
      (Gift from Prof Dr Rod Balhorn,  
      Lawrenece Livemore National Laboratory, USA) 
2- Protamine 2 (Hup 2B)    Mouse polyclonal antibody  
      (Gift from Prof Dr Rod Balhorn,  
      Lawrenece Livemore National Laboratory, USA) 
3-1-5-2- Secondary antibody 
- Western Blot     Horseradish peroxidase conjugated goat anti-
mouse antibody (Dianova, Hamburg, 
Germany) 
3-1-6- ELISA Kits 
Table 3. ELISA Kits 
Kit Company 
OxyStat ELISA, Reactive Oxygen Species 
(Peroxidase) 
Biomedica Medicine product GmbH & Co KG, 
Wien, Austria 
Cotinine ELISA Calbiotech, CA, USA 
8-Hydroxy-2-deoxy Guanosine (8-OH- dG) ELISA 
Kit 
Cayman Chemical Company, USA 
In Situ Cell Death Detection Kit, Fluorescein 
(TUNEL) 
Roche
 
Diagnostics GmbH, Mannheim, Germany 
 
3-2- Methods 
3-2-1- Ejaculates and Sperm Preparation  
The semen samples were prepared with modification as in previously thoroughly described by 
Hammadeh et al., (1996). Briefly: 
1- The semen ejaculates obtained by masturbation collected in separate polypropylene containers 
and assayed within 2 hours after collection. 
2- Semen ejaculates were kept at 37°C for 30 minutes until complete liquefaction had occurred. (If 
liquefaction is not completed, syringes were used to liquefy the samples). 
3- In all samples a standard semen analysis (semen volume, sperm concentration, total sperm count 
and motility) was performed within one hour of obtaining the sample according to the WHO 
criteria (WHO, 1999). Morphology evaluated according to strict criteria.  
4- The following volumes of seminal plasma were used to prepare smears: 
 - 10 μl to prepare smears (6 smears prepared) 
 - 100 μl  for Hypo-osmotic (HOS) test 
 - 5 μl for Eosin test 
 - 5 μl for MAR test 
5- Samples were prepared by discontinuous pure sperm gradient (Nidacon International AB, 
Sweden) by layering 1ml of each different concentration of pure sperm solution 80%, and 40% in a 
sterilized tube, beginning at the bottom of the tube with that of 80% density. 
6- Two ml of liquefied semen was placed on the surface of the pure sperm fraction of lowest 
density (40%). 
7- Centrifugation of the samples was done at room temperature (RT) for 25 minutes at 3000 rpm. 
8- After centrifugation, the supernatant (seminal plasma) was immediately separated, and examined 
before storage to rule out the presence of spermatozoa in the supernatant. The seminal plasma was 
aliquot into storage ampoules and stored at -80°C until used. 
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9- The 40% layer aspirated and discarded with Pasteur pipette.  
10- The final fraction that contains motile spermatozoa transferred into a new tube and washed by 
adding 4-5 ml HAM’s F10 medium using 10 min of centrifugation at 3000 rpm at room 
temperature.  
11- The pellet then was overlaid with 2-3 ml HAM’s F10 medium and counting the sperm 
numbers. 
12- Aliquot contains 20 - 40 X 106 sperm of each sample transferred into eppendorf and 
centrifugated for 10 min at 3000 rpm at room temperature, then the pellet stored at – 80 oC until 
used for sperm nuclear protein extraction.  
13- The rest of the sperms also treated the same and kept at – 80 oC. 
3-2-2- Assessment of Sperm Morphology 
Sperm morphology was evaluated according to Kruger's strict criteria (Kruger et al., 1986). 
1- Smears were prepared by spreading 10 μl of seminal plasma on a glass slide, dry at room 
temperature. 
2- The slides then were stained using Papnucleou method (WHO, 1999). 
3- A total of 100 spermatozoa from each slide were evaluated under oil immersion at a 
magnification of 1000 X using bright field illumination. At least 10 high power fields from 
different areas of the slide were evaluated.   
3-2-3- Assessment of Sperm Vitality (Eosin Test): 
Test was carried out according to the method described by Eliasson and Treich, (1971), briefly: 
1- On a glass slide, 5 μl of seminal fluid was mixed with 5 μl of 0.5% aqueous yellowish eosin Y 
solution. 
2- The mixture covered with a cover slide, then evaluated after 1-2 min by distinguishing between 
the dead spermatozoa (Red stained) and the live spermatozoa (not stained). 100 spermatozoa from 
each slide were evaluated. 
3-2-4- Assessment of the Sperm Membrane Integrity (Hypo-Osmotic Test; HOS) 
HOS test performed according to the method described by Jeyendran et al., (1984) in brief: 
1- 0.1 ml of fresh ejaculate was mixed with 1.0 ml of the hypo osmotic solution 
2- The mixture then incubated at 37°C for 30-60 minutes. 
3- A sample was evaluated by taking 10 μl of the mixture on a slide and examined under phase 
contrast microscope. A minimum of 200 spermatozoa were examined per slide. 
4- Calculate the percentage of spermatozoa that showed typical tail abnormalities (good sperms).  
Percentage of spermatozoa with tail swelling = [(number of spermatozoa with tail swelling) / (total 
number of spermatozoa counted)]* 100% 
3-2-5- Assessment of Chromatin Condensation (Chromomycin A3, CMA3) of Spermatozoa 
Chromomycin A3 (CMA3) performed as previously described by Bianchi et al, (1993).  
1- A semen aliquots were washed using Ca-Mg free phosphate buffered saline (PBS). 
2- Then samples were centrifuged at 3000 rpm at RT for 10 minutes.  
3- The spermatozoa then washed once again as in steps 1 and 2.  
4- Resuspended the spermatozoa in few drops of the PBS. 
5- Then 10 μl of each sample was smeared on microscopic slide and air dried.  
6. Smears were then fixed in Carnoy’s solution (methanol/glacial acetic acid, 3:1) at room 
temperature for 2 hours, then air dried. 
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7- Each slide was treated for 20 minutes with 100 μl of CMA3 solution at 25oC in the dark.  
8- Slides then were washed in PBS.  
9- Slides were covered by cover slips and mounted with buffered-glycerol. 
10- For evaluation, a total of 200 spermatozoa were analyzed on each slides, by distinguishing 
spermatozoa stained bright green (CMA3 positive, with bad chromatin condensation) from those 
stained dull green (CMA3 negative, with good chromatin condensation). A Zeiss Photomicroscope 
III, used for the fluorochrome evaluation via a combination of exciter dichromic barrier filter of BP 
436/10: FT 580: LP 470. 
3-2-6- DNA Fragmentation Analysis 
(Terminal deoxynucleotidyltransferase-mediated
 
dUTP nick end labeling, TUNEL Test) 
DNA fragmentation was assessed using the Terminal deoxyribonucleotidyl transferase-mediated 
dUTP nick-end labeling (TUNEL) assay as previously described (Borini et al., 2006). The TUNEL 
assay was performed using the In-Situ Cell Death Detection
 
Kit: Fluorescein following the 
manufacturer's guidelines (Roche
 
Diagnostics GmbH, Mannheim, Germany).   
1- Ejaculated sperm samples were washed from seminal plasma by slow speed centrifugation (250 
g for 10 minutes) 
2- Smears were prepared using 10 μL of sperm suspension on microscope slides, and allowed to air 
dried 
3- Smears were fixed with 4% paraformaldehyde phosphate–buffered saline, pH 7.4 at room 
temperature for tow hours then rinsed with PBS. 
4- Smears then permeabilized with 0.1% triton X-100 in 0.1% sodium citrate, pH 6.0 for 10 
minutes at RT.  
5- 50 μl of the TdT-labeled nucleotide mixture (50 μl of enzyme solution and 450 μl of label 
solution) was
 
added to each slide and incubated in a humidified chamber at
 
37°C overnight in the 
dark. Negative controls without TdT enzyme were run in each
 
replicate. 
6- Slides were rinsed
 
twice in PBS.  
7- Slides were covered by cover slips and mounted with buffered-glycerol. 
8- For evaluation, a total of 500 spermatozoa were analyzed on each slides, by distinguishing 
spermatozoa stained bright green (TUNEL positive, with bad chromatin condensation) from those 
stained dull green (TUNEL negative, with good chromatin condensation). A Zeiss 
Photomicroscope III, used for the fluorochrome evaluation via a combination of exciter dichromic 
barrier filter of BP 436/10: FT 580: LP 470. A negative control was performed for each sample by 
using fluorescein-isothiocyanate-labelled dUTP without enzyme. 
3-2-7- Protamine Quantification 
3-2-7-1- Determination of protein concentration according to Bradford 
A- Preparation of protein standard curve 
Bovin-IgG protein was used to prepare the standard curve as following:  
50 mg of IgG-bovine was dissolved in 5 ml of distilled water (DW) as a stock solution (A, 
10mg/ml =10 µg/µl)), then the standard concentrations were prepared by taking: 
- 700 µl of stock A in 1 ml DW, this will give a concentration of 7 µg/ml (solution B) 
- 500 µl of stock A in 1 ml DW, this will give a concentration of 5 µg/ml (solution C) 
- 300 µl of stock A in 1 ml DW, this will give a concentration of 3 µg/ml (solution D) 
- 200 µl of stock A in 1 ml DW, this will give a concentration of 2 µg/ml (solution E) 
- 100 µl of stock A in 1 ml DW, this will give a concentration of 1 µg/ml (solution F) 
B- Determination of protein concentration 
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Measuring the concentration of proteins in the extractions was performed using the Bio-Rad 
method which based on Bradford reagent as following: 
1- Reaction mixtures were prepared as following (table 4): each labelled tube contains: 
Table 4. Reaction mixtures used for preparing the protein standard curve.  
T.T. No. Volume of concentration (µl) D. H2O (µl) Protein assay reagent (µl) Final Volume  (µl ) 
1 1µl stock F (1 µg/ml)  799 200 1000 
2 1µl stock E (2 µg/ml) 799 200 1000 
3 1µl stock D (3 µg/ml) 799 200 1000 
4 1µl stock C (5 µg/ml) 799 200 1000 
5 1µl stock B (7 µg/ml) 799 200 1000 
6 1µl stock A (10 µg/ml) 799 200 1000 
7 1.5 µl stock A (15 µg/ml) 798.5 200 1000 
8 2 µl stock A (20 µg/ml) 798 200 1000 
9 2.51µl stock A (25 µg/ml) 797.5 200 1000 
Note: Concentrations prepared in triple  
2- Mixed by vortex and then incubated 5 minutes at room temperature.  
3- The absorbance was measured against blank of distilled water at wavelength 595 nm.  
(For measuring the proteins in the extraction, absorbance measured against blank with extraction 
buffer)  
3-2-7-2- Total Nuclear Protein Extraction: 
3-2-7-2-1- Tail Dissociation 
Sperm’s tail dissociation was done as previously described by Balhorn et al., (1977), with 
modifications as follows: 
 1- Sperms Aliquot contains 20 - 40 X 106 sperm prepared in section (3-2-1) was suspended in 200 
μl of 0,05 M Tris-HCl, pH 8.0 and 10 mM dithiothreitol (DTT) and sonicated for 10 seconds then 
incubated at 4 oC for 15 minutes.  
2- 50 μl of 5% Hexadecyltrimethylammonium bromide (CTAB) was added to obtain a final 
concentration of 1% CTAB and the sample was sonicated for 30 seconds, mixed and incubated for 
additional 30 minutes at 4 oC. 
3- The heads then pelleted by centrifugation at 3000 g and the supernatant discarded. 
4- The heads were washed twice in 0.5 ml of 1% CTAB in 0.01 M Tris-HCL, pH 8.0 and then 
twice in 0.5 ml of Tris-Saline. 
5- The supernatant discarded and the pellets then stored at – 80 oC until used for protein extraction. 
3-2-7-2-2- Protein Extraction 
Sperm nuclear proteins extraction of each sample (n= 166) was performed by using an established 
protein extraction protocol described by Carrell and Liu, (2001) with modifications as following: 
1- The heads pellets were taken out from – 80 oC and used.  
2- The pellets were washed in 1 ml of the washing buffer I containing 1 mM (mmol/L) of 
phenylmethylsulfonyl fluoride in distilled water (PMSF) and centrifuge at 3000 rpm for 5 minutes 
at room temperature. 
3- Then, each pellet was resuspended in 100 µl of the washing buffer 2 containing 20 mM EDTA, 1 
mM PMSF in 0.1 M Tris (pH 8.0) and mixed by vortex for 15 seconds at a high speed. 
4- 100 µl of the decondensation buffer 1 composed of 6 M guanidine and 575 mM dithiothreitol 
(DTT) was added and mixed by vortex for 15 seconds at a high speed.  
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5- Then, 200 µl of decondensation buffer 2 composed of 522 mM sodium iodoacetate was added 
to the mixture then mixed by vortex at high speed for 30 seconds. 
6- The mixture then incubated in dark place (protected from light) at room temperature for 30 min. 
7- 1 ml of ice cold absolute ethanol was added and after mixing incubated at – 20°C for one minute. 
8- The preparation then centrifuged at 13,000rpm for 10 min at 4°C and the supernatant discarded. 
(Repeat this step once). 
9- The pellet was resuspended in 0.8 ml of denaturing solution 0.5 M HCl, then mixed and 
incubated for 15 min at 37 oC. 
10- The preparation then centrifuged at 13,000rpm for 10 minutes at 4°C. 
11- Then the supernatant was transferred to another tube each contained 200 µl of 100% 
trichloroacetic acid (TCA). (The final concentration TCA should be 20%, adjust the volume as 
needed). 
12- The mixture was incubated in ice for 3 minutes and centrifuged at 13,000rpm for 10 min at 
4°C. 
13- Carefully, the supernatant was removed. (The precipitate may be invisible, do not disturb the 
precipitate).  
14- The precipitate then washed in 1 ml of washing buffer 3 containing 1% ß-mercaptoethanol in 
100% acetone then mixed by vortex for 15 seconds at a high speed. (Generally the precipitate can 
be seen). 
15- The preparation was centrifuged at 13,000rpm for 8 minutes at 4°C and the supernatant 
removed as much as possible. (Repeat this step once). 
16- The final pellet was air-dried at 4°C overnight and stored at -20 oC.  
3-2-7-3- Production of a Protamine Standard 
A human protamines standard was prepared as described by Mengual et al., (2003). Sperm samples 
of 20 known fertile donors were pooled to give a total of 1x109 sperm.  
1- The semen samples were centrifuged at 3000 rpm for 10 minutes at RT to remove the seminal 
plasma.  
2- The sperms then washed with PBS and then divided into eppendorfs each contained 1x108 
sperms then centrifuged at 3000 rpm for 10 minutes at RT and discarded the supernatant.  
3- The pellet of each sample was resuspended in 0.5 ml of the denaturing solution (0.5 M HCl) and 
incubated at 37 oC for 15 min.  
4- The samples then centrifuged at 3000 rpm for 5 min at RT then the supernatant removed.  
*NOTE: This incubation will extract the histone fraction from the sperm nuclei. 
5- The pellets washed with 0.25 ml of washing buffer 2 (20 mM EDTA, 1 mM PMSF in 0.1 M Tris 
(pH 8.0)) then centrifuged at 3000 rpm for 5 min at RT then discarded the supernatant.  
*NOTE: This step neutralizes the pH of the suspension for subsequent protamine extraction. 
6- Go back to step 2 in section “3-2-7-2, Total Nuclear Protein Extraction” and complete the 
extraction protocol. 
7- Each sample of the extracted protamines was resuspended in 50 µl sterile DW.  
8- All samples were collected in one tube.  
*NOTE: If precipitate was present, additional 100µL of DW added until completely soluble.  
9- The final protein concentration was determined by using the RC DC protein assay kit (BioRad 
Laboratories, USA). 
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10- The protamine extract was run using acid-urea polyacrylamide gel electrophoresis to 
determine the ratio of P1 and P2 (Refer to section 3-2-7-5 below). Bands of P1 and P2 can be seen 
in figure 24, lanes 6-9. 
11- The intensity of the P1 and P2 bands were used to draw the standard curve and to calculate the 
linear equation and the r2 value of the regression curve (Figure 26).  
3-2-7-4- Protein Extraction Control Sample 
Semen samples were pooled from 20 individuals treated as in standard preparation (3-2-7-3). 
1- A 40 x106 sperm aliquots prepared as in sample preparation and stored at at – 80 oC. 
2- One aliquot was extracted in tandem with test samples for every run. 
3- Follow total sperm extraction protocol as above (section 3-2-7-2). 
* Refere to figure 24, lane 10  
3-2-7-5- Acid-Urea Polyacrylamide Gel Electrophoresis (AU-PAGE) 
Protamine extracts were tested by using acetic acid-urea polyacrylamide gel electrophoresis (AU-
PAGE) method as described by Carrell and Liu, (2001) with modifications.  
3-2-7-5-1- AU-PAG preparation: 
1- Acid-urea polyacrylamide gel was prepared in a vertical stand. Tow glass plates and spacers 
were placed vertically and fixed between clamps in a sandwich module, making by spacers to fill 
the gel in. 
2- The resolving gel (20%) was prepared and filled in about 10 cm of the space (the glass plates). 
3- 400 μl of N-Butanol were added on the top of the resolving gel to avoid air bubbles. 
4- After polymerization, N-Butanol discarded and stacking gel (7.5%) was prepared and filled in 
the space. 
5- Then comb was placed to make columns to fill the protein extracts. 
6- After gel was polymerized it was kept in moist atmosphere in refrigerator until used. 
For resolving gel preparation we used an acrylamide solution with 40% (w/v) acrylamide and 0.8% 
(w/v) N,N′ -Methylenebisacrylamide, while for stacking gel we used an acrylamide solution with 
30% (w/v) acrylamide and 0.8% (w/v) N,N′ -Methylenebisacrylamide and 0.375M potassium 
acetate (pH 4.0). For both gels we used 2.5 M urea and 43% acetic acid. In addition, for 
polymerization we used 1.6% (w/v) ammonium persulphate for both and 0.5% and 2% (w/v) 
TEMED for resolving and stacking gels respectively. Table (5) summarizes the volumes of 
solutions used for preparing both gels. 
Table 5. Solution’s volumes used for preparing polyacrylamide gels. 
Resolving gel 20 % 
40 % polyacrylamide gel (19:1)  (ml) 9  
10 M Urea (ml) 4 (final concentration 2.5M) 
43 % Acetic Acid (ml) 2  
1.6 % Ammonium Persulphate (ml) 2 (freshly prepared)  
TEMED (μl) 80 
   
Stacking gel 7.5 % 
30 % polyacrylamide gel (19:1)  (ml) 1 
10 M Urea (ml) 1 (final concentration 2.5M) 
43 % Acetic Acid (ml) 1  
1.6 % Ammonium Persulphate (ml) 0.5 (freshly prepared)  
3 M Potassium Acetate (pH 4.0) (ml) 0.5 
TEMED (μl) 80 
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3-2-7-5-2-Electrophoresis 
Acid-Urea gel electrophoresis was performed using the vertical electrophoresis system (home 
made). Three steps (A, B, and C) separating process was applied. A reverse polarity and 5% acetic 
acid as running buffer were used in all steps.  
A- Pre-electrophoresis 
1- The AU-polyacrylamide gel was electrephorised before loading with samples. 
2- The electrophoresis conditions were 200 volts, 40 mA for 1.5 hours (reverse polarity was used). 
3- The running buffer discarded and a new one used for the next step. 
B- Slow run electrophoresis 
1- The extracted nuclear proteins were solublized in 80 µL sample loading buffer (0.375 M 
potassium acetate (pH 4.0), 15% sucrose, 0.05% Methyl Green). 
2- Lanes of each gel loaded with 10 µL of each sample, control sample and human protamine 
standards (0.25, 0.50, 1.00, 1.50, and 2.00 µg). 
3- The electrophoresis conditions were 100 volts, 40 mA for 45 minutes (reverse polarity was 
used). 
C- Fast run electrophoresis 
The same gels with the same running buffer used but the electrophoresis conditions were changed 
to be 200 volts, 80 mA for 5-6 hours (reverse polarity was used). 
3-2-7-5-3- Staining 
Gels were stained with Coomassie Blue stain. 
1- The gel was taking out of the glass plates. 
2- The stacking gel was cut away 
3- The gel was transferred to a container contains Coomassie Blue stain for 20 minutes at RT with 
shaking. 
4- The stain removed from the container and the gel was washed with water to remove the excess 
of the stain. 
5- The gels then destained using destaining buffer (20% methanol and 10% acetic acid) over night 
with shaking at RT. 
6- The staining buffer was removed and gel was washed in DW for 1-2 hours with shaking at RT. 
7- The gels then were scanned using a Bio-Rad scanner system. 
8- The intensity of the bands corresponding to P1 and P2 were quantified. Figure 24, lanes 1-5 and 
11-12 represents the bands of different sperm samples. 
9- P1 and P2 quantities were calculated against the standard curve generated from the human 
protamine standard as described above in section (3-2-7-3) (figure 26). 
3-2-7-6- Western Blot 
Proteins were transferred from gel to a PVDF- membrane (Roche, Germany). 
1- Gels were transferred to the transfer set contained a wetted PVDF- membrane (2 gels and 2 
membranes prepared). 
2- The transfer set then transferred to the blotting tank contained the transfer buffer (0.0009 N 
acetic acid). 
3- The transfer conditions were 150 mA, 75 V for 2 hours (reverse polarity was used) 
4- Then Membranes were blocked in blocking buffer (1X PBS, pH 7.4, 0.1% (v/v) Tween 20, and 
5% (w/v) non-fat dry milk) for 1 hour at room temperature (RT) with shaking. 
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5- The membranes then were washed with washing buffer 4 (1x PBS, pH 7.4, 0.1% (v/v) Tween 
20, 1% (w/v) non-fat dry milk) three times, each for 5 minutes with shaking at RT.  
6- The membranes were incubated with the primary antibody diluted in washing buffer 4 (1X PBS, 
pH 7.4, 0.1% (v/v) Tween 20, 1% (w/v) non-fat dry milk) overnight at 4 oC with shaking (two 
membranes used, each in a separated jar): 
- One membrane incubated with Hup 1N (anti-protamine 1) primary antibody diluted into 1:100000  
- Second membrane incubated with Hup 2B (anti-protamine 2) primary antibody diluted into 
1:500000 
7- The membranes were washed with washing buffer 4 three times, each for 5 minutes with shaking 
at RT. 
8- Then membranes were incubated with the horseradish peroxidase-conjugated secondary 
antibody diluted in washing buffer 5 for 1 hour at RT with shaking. (Horseradish peroxidase-
conjugated Goat anti-mouse secondary antibody was diluted into 1:10000). 
9- Then membranes were washed with washing buffer 5(1X PBS, pH 7.4, 0.1% (v/v) Tween 20) 
three times, each for 5 minutes with shaking at RT. 
10- Signals were developed by using the Lumi-light western blotting substrate 1 and 2 (1 ml of 
each for one minute) (Roche, Mannheim, Germany). 
11- Then the signals were visualized by using the Enhance Chemilumenscece (ECL) system (Bio-
Rad, Germany). 
* Figure 25 represents the replica of the gel of P1 (A) and replica of the gel of P2 (B).   
3-2-8- Reactive oxygen species measurement  
The concentration of ROS was measured by a colorimetric assay for the quantitative determination 
of peroxides in EDTA–plasma, serum and other biological fluids using ELISA kit (Oxy Stat; Cat. 
No. BI-5007 Biomedica Medicine product GmbH & Co KG, Wien, Austria).  
Principal of the assay: The peroxide concentration is determined by the reaction of the biological 
peroxides with peroxidase and a subsequent color–reaction using TMB (3, 3, 5, 5-
Tetramethylbenzidine) as a substrate. After the addition of the stop solution, the colored liquid was 
measured photometrically at 450nm. A calibrator was used to calculate the concentration of 
circulating biological peroxides in the sample (one point calibrator).   
Assay characteristics: The Biomedica Oxy Stat assay measures the total concentration of 
peroxides, which is formed in the propagation-phase of the low density lipoprotein oxidation 
process using peroxidase/TMB. 12x8 well microtiter plate format (96 tests per kit). Reference 
values EDTA plasma <400µmol/L, serum <350µmol/L. Measuring range 7-6000µmol/L; Detection 
limited 7µmol/L. Sample volume 10µL /test. Assay time 30 minutes.  
Assay protocol  
Following the manufacturer's guidelines: 
1- 10 µl of each control, calibrator and sample was added to respective well 
2- 100 µl of solution A (Sample Buffer) was added to each well and mixed mix.   
3- The absorbance was determined with ELISA reader at 450 nm (OD1) 
4- Then 100 µl of the freshly prepared ABC-reaction mixture (5 ml of solution A + 100 µl of 
solution B (reaction Buffer) + 5 µl of solution C (enzyme solution)) was added to each well and 
mixed. 
5- Plate then was incubated for 15 minutes at 37 oC. 
6- 100 µl of solution D (stop solution) was added to each well and mixed. 
7- The absorbance was determined with ELISA reader at 450 nm (OD2) 
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8- Calculate the concentration of peroxide (µ mol/L) according to the equation 
Peroxide (µ mol/L) = ([∆OD sample X (µ mol/L) calibrator]/ ∆OD calibrator) 
∆OD = OD2 – OD1 
3-2-10- [8-hydroxy-2-deoxyguanosine (8-OH-dG)] measurement 
8-OH-dG Enzyme immunoassay (EIA) kit (Cayman Chemical Company, USA) is a competitive 
assay that can be used for the quantification of 8-OHdG in urine, cell culture, plasma, and other 
sample matrices. The EIA utilizes the anti-mouse IgG-coated plate and tracer consisting of an 8-
OHdG-enzyme conjugate. This format has the advantage of providing low variability and increase 
sensitivity compared to assays that utilize an antigen-coated plate. This EIA typically display IC50 
(50%B/Bo) and IC80 (80%B/Bo) values of approximately 100 and 30 pg/ml, respectively.  
It is important to note that 8-OH-dG-antibody used in this assay recognizes both free 8-OHdG and 
DNA-incorporated 8-OHdG. Since complex samples such as plasma, cell lysates, and tissue are 
comprise mixtures of DNA fragments and free 8-OH-dG, concentrations of 8-OHdG reported by 
EIA methodology will not coincide with those reported by LC-MS where the single nucleoside is 
typically measured.  
Precision 
The intra- and inter-assay CV’s have been determined at multiple points on the standard curve. 
Table 7. Intra- and inter- assay variation. 
Dose (pg/ml) %CV* 
Intra-assay variation 
%CV* 
Inter-assay variation 
3000 6.2 8.4 
1333 6.1 4.6 
592.6 9.6 4.8 
263.4 4.7 5.5 
117.1 9.3 4.5 
52.0 11.6 10.7 
23.1 + + 
10.3 + + 
* %CV represents the variation in concentration as determined a reference standard curve. 
+ Outside of recommended usable range assay. 
 
Specificity 
Table 8. Specificity of 8-hydroxy-2-deoxy Guanosine monoclonal antibody. 
Compound Cross-reactivity 
8-hydroxy-2-deoxy Guanosine 100% 
8-hydroxy Guanosine 23% 
8-hydroxy Guanine 23% 
Guanosine <0.01% 
 
Assay Procedures 
Procedure applied below was followed in sequence following the manufacturer's guidelines: 
1- A 100 µl of the EIA buffer was added to Non-Specific Binding (NSB) wells. 
2- A 100 µl of the EIA buffer was added to Maximum Binding (Bo) wells. 
3- A 50 µl of each standard concentration (refer to standard preparation down) was added into the 
wells in duplicate. 
4- A 50 µl of seminal plasma was added into the wells in duplicate. 
5- Then 50 µl of 8-hydroxy-2-deoxy Guanosine AChE tracer was added to each well except the 
wells of Total Activity (TA), and the Blank (Blk) wells. 
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6- Then 50 µl of 8-hydroxy-2-deoxy Guanosine Monoclonal antibody was added to each well 
except the wells of Total Activity (TA), Non-Specific Binding (NSB), and the Blank (Blk) wells. 
7- The plate then was covered with plastic film and incubated for 18 hours at 4 °C.  
8- The wells then were empty and rinsed 5 times each with 300 µl with wash buffer. 
9- A 200 µl of Ellman’s Reagent was added to each well. 
10- A 5 µl of 8-hydroxy-2-deoxy Guanosine AChE tracer was added to the total activity wells.  
11- Then the plate was covered with plastic film and incubated for 1.5-2 hours at room temperature 
with shaking in dark. 
12- Absorbance was read on ELISA reader at 405- 420 nm. The plate should be read when the 
absorbance of Bo wells is in the range of 0.3-1.0 A.U. (blank subtracted). 
13- The concentrations of the samples were calculated using the equation obtained from the 
standard curve plot (Plot %B/Bo for standard (vertical, linear) versus 8-OH-dG concentrations 
(horizontal, Log). 
Standard preparation 
A 30 ng/ml bulk solution standard was prepared by transferring 100 µl from the tube that contains 
8-OH-dG EIA standard (300 ng/ml) into a clean test tube, then dilute it with 900 µl ultra pure 
water.    
To prepare the standard for use: eight clean test tubes were obtained and numbered them # 1 
through # 8. Then aliquot 900 µl of µl EIA buffer to tube # 1 and 500 µl EIA buffer to tube # 2 – 8. 
Then: 
- 100 µl from the bulk standard (30ng/ml) was transferred to tube # 1 and mix thoroughly (3000 
pg/ml). Then serial dilutions were prepared by transferring: 
- 400 µl from tube # 1 to tube # 2 and mix thoroughly, this will give 1333.0 pg/ml. 
- 400 µl from tube # 2 to tube # 3 and mix thoroughly, this will give 592.6 pg/ml. 
- 400 µl from tube # 3 to tube # 4 and mix thoroughly, this will give 263.4 pg/ml. 
- 400 µl from tube # 4 to tube # 5 and mix thoroughly, this will give 117.1 pg/ml. 
- 400 µl from tube # 5 to tube # 6 and mix thoroughly, this will give 52.0 pg/ml. 
- 400 µl from tube # 6 to tube # 7 and mix thoroughly, this will give 23.1 pg/ml. 
- 400 µl from tube # 7 to tube # 8 and mix thoroughly, this will give 10.3 pg/ml. 
3-2-11- Lipid Peroxidation Assay in Seminal Plasma 
(Measurement of Malondialdehyde, MDA)  
Lipid peroxidation level of biological samples (serum, sperm, seminal plasma, and follicular fluid) 
was measured by determining the Malondialdehyde (MDA) production, using a modified 
thiobarbituric acid (TBA) from the method of Buege and Aust (1978) and of Suleiman et al., 
(1996).  
Briefly,  
1- Take 250 µl of seminal plasma in a clean glass tube. 
2- Add 2.0 ml of the extraction reagent (section 3-1-3) and mix by vortex 15 sec. 
3- Boil samples at 95 oC for 30 min in water bath. 
4- Coal the samples at room temperature. 
5- Centrifuge the samples at 3000 rpm for 10 min at RT. 
6- Take the supernatant and read the absorbance at wave length 535 nm against blank. 
7- Calculate the concentration of MDA from the standard curve equation.  
For Standard Curve preparation, the same procedures applied using a 250 µl sample of each 
standard concentration in duplicate.  
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Standard Solutions 
Malondialdehyde standard was prepared by modifying the method described by Sangalli et al., 
(2003). Briefly,  
10 mM stock solution (A) was prepared by mixing 25.97 μl of 1,1,3,3-tetramethoxypropane  (6 M) 
with 1M hydrochloric acid at 37 oC 30 minutes. This solution was then further diluted with distilled 
water to prepare various working standard solutions as following: 
- 50 µl of stock A in 5 ml DW, this will give a conc. of 100 µM (solution B) 
- 500 µl of stock B in 5 ml DW, this will give a conc. of 10 µM (solution C) 
- 375 µl of stock B in 1 ml DW, this will give a conc. of 7.5 µM (solution D) 
- 250 µl of stock B in 1 ml DW, this will give a conc. of 5 µM (solution E) 
- 125 µl of stock B in 1 ml DW, this will give a conc. of 2.5 µM (solution F) 
- 50 µl of stock B in 1 ml DW, this will give a conc. of 1.0 µM (solution G) 
- 25 µl of stock B in 1 ml DW, this will give a conc. of 0.5 µM (solution H) 
* Standard solutions stored at 4 ◦C. 
3-2-9- Cotinine measurement 
Summary and Explanation 
The Calbiotec Cotinine Direct Elisa Kit (Calbiotech, CA, USA) is design to detect the presence of 
Cotinine in serum and urine. It can also be adapted for other fluids.  
Principles of the test  
The calbiotech cotinine kit is a solid phase competitive ELISA. The samples and cotinine enzyme 
conjugate are added to the wells coated with anti-cotinine antibody. Cotinine in the samples 
competes with a cotinine enzyme (Horse Radish Peroxidase, HRP) conjugate for binding sites. 
Unbound cotinine and cotinine enzyme conjugate is washed off by washing step. Upon the addition 
of the substrate, the intensity of colour is inversely proportional to the concentration of Cotinine in 
the samples. A standard curve is prepared relating colour intensity to the concentration of the 
Cotinine. 
Performance Characteristics 
Accuracy 
20 urine samples from non smokers were screened with this cotinine ELISA method. All 20 
samples screened negative with the ELISA method. 15 samples from smokers which contained 
various amounts of cotinine were screened with this cotinine direct ELISA Kit. All 15 samples 
showed a presence of Cotinine at a level greater than 500ng/ml. Three urine samples submitted by 
individuals exposed to passive inhalation for over 30 days all showed levels of 5 to 10 ng/ml of 
Cotinine when extrapolated of a dose response curve. 
Sensitivity 
Assay sensitivity based on the minimum cotinine concentration required to produce a three 
standard deviation from assay Ao is 1 ng/ml. 
Specificity 
The specificity of this Cotinine ELISA was determined by generating inhibition curves for each of 
the compounds listed below and the antisera cross-reactivity below: 
Table 6. Specificity of cotinine antibody   
Compound Approximal ng/ml equivalent to  
100 ng cotinine/ml 
Cross-reactivity 
Cotinine 100 100 
Nicotine >10000 <1 
Nicotinamide >10000 <1 
Nicotinic acid >10000 <1 
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Assay Procedures  
All reagents must be brought to room temperature (18-26 °C) before use. The procedure described 
below was followed in sequence using manual pipettes. Following the manufacturer's guidelines: 
1. 10 µl of standards, controls and specimens were pipette into selected well in duplicate. 
2. Then 100 µl of the Enzyme Conjugate was added to each well. Then the plate was shacked for 
10-30 seconds to ensure proper mixing. 
3. The plate then incubated for 60 minutes at room temperature (18-26° C) in the dark. 
4. The wells were washed 6 times with 300 µl distilled water (take care not to cross contaminate 
wells). 
5. The plate was inverted and vigorously slapped dry on absorbent paper to ensure all residual 
moisture was removed. This step was critical to ensure that residual enzyme conjugate, did not 
skew results.  
6. Then 100 µl of Substrate reagent was added to each well. 
7. Plate was incubated for 30 minutes at room temperature in the dark. 
8. 100 µl of Stop Solution was added to each well and the plate was shacked gently to mix the 
solution. 
9. Absorbance was read on ELISA reader at 450nm with in 15 minutes after adding the stopping 
solution. 
10- The concentration of cotinine was calculated against the standard curve generated from the 
standards (0.0, 5.0, 10, 25, 50, 100 ng/ml) applied in the kit in the same plate (Absorbance for 
cotinine standards (vertical axis) versus cotinine standards concentrations (horizontal axis)). 
Samples with concentrations higher than 100 ng/ml were diluted and measured once more. 
3.2.12. Statistical analysis 
Data analysis was performed using the personal computer of the local area computer network of the 
Institute of Medical Biometrics and Medical Information, University of Saarland, Homburg/Saar, 
Germany, using the SPSS 17 for Windows Software Package (SPSS Inc., Chicago, IL, USA). Data 
were expressed as mean ± SD and range. The relationship between protamines 1 and 2, P1/P2, 
ROS, cotinine, 8-hydroxy-2-deoxy-Guanosine, MDA, DNA integrity, chromatin condensation, 
sperm viability, membrane integrity, concentration, motility and morphology and seminal volume 
were analyzed using nonparametric correlation (Spearman's test). Furthermore, semen 
characteristics, ROS, MDA, 8-OHdG and cotinine concentrations were analyzed in seminal plasma 
in smokers and non-smokers and their effect on ART results were analyzed using parametric and 
nonparametric methods. The Mann-Whitney (U-test) was used for non–paired data. One way-
ANOVA was used to compare different parameters within groups of protamines ratios; Post HOC 
Test- Bonferroni test was used. The results were presented by the mean ± SD values. Correlations 
were analyzed by means of chi-square test or exact Fisher-test and by Spearman's test. They were 
considered statistically significant when p<0.050 and highly significant when p<0.010.  
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4- Results 
Semen samples were collected from an unselected group of patients consulting for infertility and 
from a cohort of volunteer donors. In all samples, data on semen quality, ROS production, seminal 
plasma TBAR substances (MDA), Cotinine, and 8-OHdG, and sperm DNA fragmentation were 
collected of 50 normal volunteer donors and of 116 male patients (Fig. 7). In addition, protamine 1, 
protamine 2, and P1/P2 ratios data were collected for all samples. All members of the donor group 
had normal values for sperm concentration (more than 20 X 106/mL), overall motility (40% 
motile), and normal morphology (30%) (WHO, 1999). 
 
 
 
Figure 7. The distribution of samples (n=166) into normal volunteers (n=050) and patients 
(n=116). 
4-1- Semen and Sperm Parameters for all Participants 
Table 9. Statistical data for all participants 
 Mean ± STD Minimum Maximum 25 % 50 % 75 % 
Age (year) 34.14 ± 7.81 18.0 51.0 26.8 35.5 40.0 
Volume (ml) 3.42 ± 1.63 0.0 10.0 2.0 3.5 4.1 
pH 8.66 ± 0.38 8.0 10.0 8.5 8.5 9.0 
Count  (mill/ml) 67.08 ± 31.23 10.0 100.0 36.0 70.0 100.0 
Motility  (% motile) 30.33 ± 13.61 5.0 75.0 20.0 30.0 40.0 
Sperm vitality (Eosin) (%) 37.83 ± 17.81 5.0 80.0 20.0 37.5 50.0 
Membrane integrity (HOS) (%)%  47.59 ± 19.79 5.0 90.0 30.0 50.0 60.0 
Leukocytes (%) 2.53 ± 1.48 1.0 3.0 2.0 2.0 3.0 
Chromatin condensation (positive  CMA3) (%)  30.00 ± 9.01 11.9 75.5 24.6 30.0 35.2 
DNA Fragmentation (positive TUNEL) (%)   12.77 ± 5.89 2.2 33.7 8.2 12.4 16.8 
Morphologically Normal spermatozoa (%) 34.77 ± 14.92 5.0 76.0 25.0 34.0 44.3 
Malondialdehyde (MDA) (μM) 7.21 ± 1.77 3.18 13.84 6.1 7.2 8.1 
Reactive oxygen species (ROS) (μmol/l) 87.80 ± 50.85 7.0 255.6 47.1 87.8 118.3 
Cotinine (ng/ml) 41.86 ± 58.18 1.0 233.3 1.2 5.9 73.4 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 1.59 ± 1.47 0.02 8.02 0.5 1.2 2.2 
Protamine 1 (P1) (ng/106 sperm) 404.81 ± 102.37 171.8 656.8 324.3 396.8 476.1 
Protamine 2 (P2) (ng/106 sperm) 358.69 ± 105.08 84.8 615.0 282.6 344.6 435.9 
P1/P2 ratio 1.18 ± 0.33 0.63 3.63 0.99 1.17 1.32 
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Table 9 demonstrated the means ± standard deviations data of all sperm and seminal plasma 
parameters for all participants (n=166). A normal semen volume (ml) and sperm concentration 
(mill/ml) were indicated (3.42 ± 1.63; 67.08 ± 31.23 respectively). Sperm motility (%) was ranged 
from 5.0 % to 75.0 % while sperm vitality (Eosin, %) (5.0-80.0 %) and sperm membrane integrity 
(HOS, %) (5.0-90.0 %). Besides, the percentages of chromatin condensation (CMA3 %, bad sperm) 
was (30.00 ± 9.01%), and DNA fragmentation (Tunel %, bad sperm) (12.77 ± 5.89 %%). in 
addition, the percentage of morphologically normal sperm was 34.77 ± 14.92%. Besides, the 
seminal plasma parameters MDA (μM), ROS (μmol/l), Cotinine (ng/ml), and 8-OHdG (ng/ml) 
concentrations were (7.21 ± 1.77, 87.80 ± 50.85, 41.86 ± 58.18, and 1.59 ± 1.47 respectively). 
Protamine 1 concentration (ng/106 sperm) was ranged (171.8-656.8), while minimum concentration 
of Protamine 2 (ng/106 sperm) was 84.8 and the maximum was 615.0. The P1/P2 ratio was ranged 
from 0.63 to 3.63. 
Table 10a: Correlation coefficient of sperm parameters of all participant samples (n=166)  
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Sperm vitality (Eosin) (%) R = 0.160
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P = 0.039 0.000 . 0.000 0.000 0.001 0.003 0.421 0.949 0.074 
Membrane integrity (HOS) 
(%)% 
R = 0.113 0.446** 0.598** 1.000 -0.384** -0.330** 0.378** 0.090 0.146 -0.168* 
P = 0.146 0.000 0.000 . 0.000 0.000 0.000 0.251 0.060 0.031 
Chromatin condensation  
(positive  CMA3) (%) 
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spermatozoa (%) 
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P = 0.524 0.002 0.074 0.031 0.001 0.003 0.001 0.002 0.000 . 
 
Table 10a, 10b, and 10c illustrated the correlation coefficients between all parameters of semen and 
sperm quality of all participant samples (n=166). In table 10a, a significantly positive correlation 
was found between sperm concentrations (mill. /ml) with sperm motility (r=0.194, p<0.050), sperm 
vitality (r=0.16, p<0.050), and morphologically normal sperm (r=0.250, p<0.010), whereas, a 
significant negative correlation was demonstrated with chromatin condensation (CMA3 positivity, 
r=-0.289, p<0.010). The mean percentage of the sperm motility showed significantly positive 
(p<0.100) correlations with sperm vitality (Eosin-test, r=0.494), sperm membrane integrity (HOS-
test, r=0.446), and morphologically normal sperm (r=0.479). In contrast, sperm motility showed 
highly negative significant correlations (p<0.010) with chromatin condensation, (CMA3-test), DNA 
integrity as assessed by Tunel-test, and P1/P2 ratios, (r=-0.458; r=-0.406; r=-0.235; respectively). 
In addition, a significant increased (p<0.010) correlations observed between sperm vitality with 
membrane integrity (r=0.598), and morphologically normal sperm (r=0.229), and significantly 
decreased correlations were found with non-condensed chromatin (r=-0.343, p<0.010), and DNA 
fragmentation (r=-0.263, p<0.010).  
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The mean percentage of the sperm membrane integrity was correlated significantly positive with 
sperm morphologically normal sperm (r=0.378, p<0.010), with non-condensed chromatin (%) (r=-
0.384, p<0.010), and DNA fragmentation (%) (r=-0.330, p<0.010). P1/P2 ratios showed significant 
negative correlations (r=-0.168, p<0.050). 
Figure 8 represents the significant positive correlations between the sperm non-condensed 
chromatin (CMA3) and DNA fragmentation (Tunel), while figure 9 represents the significantly 
negative correlation with morphologically normal sperm. Also, sperm chromatin condensation 
showed positive significant correlation with P1/P2 ratio. It was introduced that sperm DNA 
integrity was correlated significantly positive with P1/P2 ratios (r=227, p<0.010), and correlated 
negatively with morphologically normal sperm (r=-0.509, p<0.010). 
The mean percentage of morphologically normal sperm showed a high negative significant 
correlation with P1/P2 ratios (r=-0.384, p<0.010) and negative significant correlation with P1 
concentration also observed (r=-0.189, p<0.050). In addition, the correlations between protamines 1 
and 2 (P1, P2) and P1/P2 ratios were found to be highly significant positive (p<0.010) between P1 
with P2, and P1/P2 ratios (r=0.650; r=0.237 respectively). Whereas, P2 showed a decreased 
significant correlation with P1/P2 ratios (r=-0.525, p<0.010). 
Table 10b. Correlation coefficient of semen parameters of all participant samples (n=166) 
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Volume (ml) r = 
1.000 -0.025 -0.012 0.170 -0.176 -0.151 -0.193* 
p = . 0.751 0.882 0.072 0.062 0.110 0.040 
pH r = 
-0.025 1.000 -0.049 0.015 0.011 0.044 -0.049 
p = 0.751 . 0.534 0.876 0.911 0.641 0.604 
Leukocytes (%) r = 
-0.012 -0.049 1.000 0.170 0.170 0.042 0.027 
p = 0.882 0.534 . 0.072 0.072 0.656 0.775 
Malondialdehyde (MDA) (μM) 
 (N=113) 
r = -0.205* 0.015 0.170 1.000 0.645** 0.632** 0.580** 
p = 0.030 0.876 0.072 . 0.000 0.000 0.000 
Reactive oxygen species (ROS) (μmol/l)  
(N=113) 
r = -0.176 0.011 0.077 0.645** 1.000 0.737** 0.580** 
p = 0.062 0.911 0.417 0.000 . 0.000 0.000 
Cotinine (ng/ml)   
 (N=113) 
r = -0.151 0.044 0.042 0.632** 0.737** 1.000 0.786** 
p = 0.110 0.641 0.656 0.000 0.000 . 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) 
(ng/ml) (N=113) 
r = -0.193* -0.049 0.027 0.580** 0.580** 0.786** 1.000 
p = 0.040 0.604 0.775 0.000 0.000 0.000 . 
 
Table 10b showed that the pH and concentration of leukocytes in semen had no significant effect 
on other parameters. On the contrary, volume (ml) of semen showed a significant negative 
correlations (p<0.050 with MDA (μM) and 8-OHdG (ng/ml) (r=-0.205; r=-0.193), and ROS 
(μmol/l) (r=-0176, p=0.062). 
Moreover, the concentration of MDA (μM) showed a significant positive correlations (p<0.010) 
with ROS (μmol/l), cotinine (ng/ml), 8-OHdG (ng/ml) (Figures 10, 112, and 12 respectively), and 
P1/P2 ratios of spermatozoa. ROS (μmol/l) was correlated significantly (p<0.010) with 
concentrations of cotinine (ng/ml) (r=0.737), and 8-OHdG (ng/ml) (r=0.580). Cotinine (ng/ml) and 
the 8-OHdG (ng/ml) of the spermatozoa showed similar correlation (r=0.786, p<0.010).  
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Table 10c. Correlation coefficient of sperm and semen parameters of all participant samples 
(n=166)  
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Volume (ml) R = 0.073 0.118 0.084 0.075 -0.166
* -0.159* 0.224** 0.088 0.115 -0.061 
P = 0.348 0.129 0.281 0.338 0.033 0.041 0.004 0.258 0.141 0.437 
pH R = -0.219
** -0.134 -0.085 -0.039 0.106 0.092 -0.095 -0.054 -0.050 -0.008 
P = 0.005 0.085 0.278 0.617 0.174 0.239 0.222 0.487 0.520 0.917 
Leukocytes (%) R = 0.001 -0.010 0.026 -0.106 0.071 0.009 0.013 -0.045 -0.115 0.110 P = 0.994 0.902 0.741 0.172 0.362 0.903 0.872 0.562 0.141 0.160 
Malondialdehyde (MDA) 
(μM)  (N=113) 
R = -0.069 -0.513** -0.309** -0.362** 0.555** 0.624** -0.514** 0.140 -0.052 0.384** 
P = 0.465 0.000 0.001 0.000 0.000 0.000 0.000 0.140 0.581 0.000 
Reactive oxygen species 
(ROS) (μmol/l) (N=113) 
R = -0.133 -0.537** -0.298** -0.343** 0.629** 0.630** -0.547** 0.065 -0.141 0.410** 
P = 0.160 0.000 0.001 0.000 0.000 0.000 0.000 0.496 0.137 0.000 
Cotinine (ng/ml)   
 (N=113) 
R = -0.137 -0.489** -0.322** -0.356** 0.549** 0.627** -0.555** 0.074 -0.127 0.411** 
P = 0.148 0.000 0.001 0.000 0.000 0.000 0.000 0.438 0.180 0.000 
8-hydroxy-2-deoxyguanisine 
(8-OH-dG) (ng/ml) (N=113) 
R = -0.169 -0.532** -0.373** -0.335** 0.545** 0.600** -0.513** -0.028 -0.221* 0.393** 
P = 0.073 0.000 0.000 0.000 0.000 0.000 0.000 0.771 0.019 0.000 
 
Table 10c demonstrated that there are an adverse correlations (p<0.010) between sperm motility 
and MDA (μM), ROS (μmol/l) (Fig. 13), cotinine (ng/ml), and 8-OHdG (ng/ml) concentrations in 
seminal plasma (r=-0.513, r=-0.537, r=-0.489, and r=-0.532 respectively). Moreover, significant 
negative correlations (p<0.010) were found between sperm vitality and MDA (r=-0.309), ROS (r=-
0.298), cotinine (r=-0.322), and 8-OHdG (r=-0.373). Sperm membrane integrity also was 
negatively correlated (p<0.010) with MDA, ROS, cotinine, and 8-OHdG (r= -0.362, r=-0.343, r=-
0.356, and r=-0.335 respectively). Likewise, a significant negative correlation (p<0.010) found 
between morphologically normal spermatozoa with MDA (Fig. 15), ROS, cotinine, and 8-OHdG 
(Fig. 14; Table 10c). However, the percentage of sperms with reduced chromatin condensation 
showed significant positive correlations (p<0.010) with MDA (Fig. 15), ROS, cotinine, and 8-
OHdG (Fig. 16) (r=0.555, r=0.629, r=0.549, r=0.545 respectively). Besides, Sperm DNA 
fragmentation was correlated positively (p<0.010) with MDA (r=0.624), ROS (r=0.630, cotinine 
(r=0.627), and 8-OHdG (r=0.600) (Fig. 17). However, “but not significant” positive correlation 
observed between Protamine 1 concentrations with MDA, ROS, and cotinine, and negative 
correlation with 8-OHdG. whereas, protamine 2 concentration showed negative correlations with 
MDA, ROS, and cotinine, and significant negative correlation with 8-OHdG (r=-0.221, p<0.050). 
On the opposite side P1/P2 ratios showed significant positive correlations (p<0.010) with MDA, 
ROS (Fig. 18), cotinine, and 8-OHdG (r=0.384, r=0.410, r=0.411, r=0.393 respectively). 
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Figure 8: Scatter plot of correlation between sperm chromatin condensation (CMA3, %) and sperm 
DNA fragmentation (Tunel, %) of all participants. A significant positive correlation was found 
(r=0.479, p<0.010). 
 
 
 
 
Figure 9: Scatter plot of correlation between sperm chromatin condensation (%) and 
morphologically normal spermatozoa of all participants. A significant negative correlation was 
detected (r=-0.514, p<0.010). 
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Figure 10: Scatter plot of correlation between MDA (μM) and ROS (μmol/l) concentrations in 
seminal plasma of all participants. A significant positive correlation was found (r=0.645, p<0.010). 
 
 
 
 
Figure 11: Scatter plot of correlation between MDA (μM) and cotinine (ng/ml) concentrations in 
seminal plasma of all participants. A significant positive correlation was illustrated (r=0.632, 
p<0.010). 
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Figure 12: Scatter plot of correlation between MDA (μM) and 8-OHdG (ng/ml) concentrations in 
seminal plasma of all participants. A significant positive correlation, was found (r=0.580, p<0.010). 
 
 
 
Figure 13: Scatter plot of correlation between sperm motility (%) and ROS (μmol/ml) 
concentration in seminal plasma of all participants. A significant negative correlation was found 
(r=-0.537, p<0.010). 
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Figure 14: Scatter plot of correlation between the mean percentage of morphologically normal 
spermatozoa (%) and MDA (μM) concentration in seminal plasma of all participants. A significant 
negative correlation (r=-0.514, p<0.010) was found.  
 
 
Figure 15: Scatter plot of correlation between the mean percentage of chromatin condensation 
spermatozoa (CMA3, %) and MDA (μM) concentration in seminal plasma concentration of all 
participants. A significant positive correlation was demonstrated (r=0.555, p<0.010). 
 
 74 
 
Figure 16: Scatter plot of correlation between the mean percentage of chromatin condensation 
spermatozoa (CMA3, %) and 8-OHdG (ng/ml) concentration in seminal plasma of all participants. 
A significant positive correlation (r=0.545, p<0.010) was found.  
 
 
Figure 17: Scatter plot of correlation between the mean percentage of sperm DNA fragmentation 
(%) as assessed by Tunel and 8-OHdG (ng/ml) concentration in seminal plasma of all participants. 
A significant positive correlation (r=0.600, p<0.010) was showed. 
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Figure 18: Scatter plot of correlation between P1/P2 ratios of the spermatozoa and ROS (μmol/ml) 
concentration in seminal plasma of all participants. A significant positive correlation (r=0.410, 
p<0.010) was found. 
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4-2- Normal volunteers versus Patients 
Table 11 illustrated the mean ± standard deviation and the p-values of the semen and sperm 
characteristics of 166 semen samples; normal volunteers (n=50) and patients (n=116) (refer to 
Figure 7), who underwent therapy in the IVF laboratory. Samples were analyzed according to the 
WHO criteria with the exception of morphology which evaluated by strict criteria. The results 
include the sperm concentration, motility, morphology, DNA integrity, DNA fragmentation, 
protamines concentrations, and ROS, MDA, cotinine and 8-OHdG concentrations in seminal 
plasma.  
Table 11. Comparison of semen and sperm parameters between all normal volunteers (n=50) and 
all patients (n=116) participants.  
 Parameters Normal  Patients  p-value 
Samples 50 116  
Age (year) 25.5 ± 4.5 37.9 ± 5.7 0.000 
Volume (ml) 3.9 ± 1.4 3.2 ± 1.7 0.004 
pH 8.6 ± 0.3 8.7 ± 0.4 0.060 
Count  (mill/ml) 80.2 ±27.5 61.4 ± 31.1 0.000 
Motility  (% motile) 37.1 ± 14.7 27.4 ± 12.0 0.000 
Sperm vitality (Eosin) (%) 45.2 ± 16.9 34.7 ± 17.3 0.001 
Membrane integrity (HOS) (%)%  53.4 ± 15.8 45.1 ± 20.8 0.010 
Leukocytes (%) 2.4 ± 0.5 2.6 ± 1.7 0.959 
Chromatin condensation (positive  CMA3) (%)  23.3 ± 7.0 32.9 ± 8.2 0.000 
DNA Fragmentation (positive TUNEL) (%)   9.6 ± 5.4 14.2 ± 5.6 0.000 
Morphologically Normal spermatozoa (%) 45.9 ± 13.9 29.4 ± 12.7 0.000 
Malondialdehyde (MDA) (μM) 6.45 ± 1.43  7.82 ± 1.79 (n=63) 0.000 
Reactive oxygen species (ROS) (μmol/l) 67.6 ± 42.2 103.85 ± 5.68 (n=63) 0.000 
Cotinine (ng/ml) 27.30 ± 40.17 53.42 ± 67.33 (n=63) 0.014 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 1.15 ± 0.82 1.95 ± 1.76 (n=63) 0.027 
Protamine 1 (P1) (ng/106 sperm) 378.20 ± 100.00 416.30 ± 101.70 0.007 
Protamine 2 (P2) (ng/106 sperm) 347.30 ± 77.30 363.60 ± 114.9 0.424 
P1/P2 ratio 1.10 ± 0.20 1.22 ± 0.36 0.012 
 
A significant (p<0.050 or p<0.010) differences were noticed between all semen and sperm 
parameters between normal volunteers and patients except for the pH and concentrations of the 
leukocytes and protamine 2 (p>0.050). 
Sperm’s concentrations, motility, and semen volumes were significantly higher (p<0.010) in 
normal volunteers (80.2 ±27.5, 37.1 ± 14.7, 3.9 ± 1.4) compare to that of patients (61.4 ± 31.1, 27.4 
± 12.0, 3.2 ± 1.7). Similar were obtained for sperm vitality (Eosin) and the sperm membrane 
integrity (HOS), (45.2 ± 16.9, 53.4 ± 15.8, vs. 34.7 ± 17.3, 45.1 ± 20.8, p<0.010 respectively. 
However, chromatin condensation (positive CMA3), P1 and P1/P2 ratios of the patient’s sperms 
(32.9 ± 8.2, 416.30 ± 101.70, 1.22 ± 0.36) were lower than that of normal volunteers (23.3 ± 7.0, 
378.20 ± 100.00, 1.10 ± 0.20). Moreover, DNA fragmentation (Tunel) was significantly higher 
(p<0.010) in patients (14.2 ± 5.6), in comparison to volunteers group (9.6 ± 5.4). Likewise, the 
mean percentage of morphologically normal spermatozoa was significantly higher (p<0.010) in 
volunteers than that in patients group (45.9 ± 13.9 vs. 29.4 ± 12.7). In contrast, MDA, ROS, 
Cotinine, and 8-OHdG concentrations in seminal plasma were significantly higher (p<0.010) in 
patients in comparison to volunteers group (Table 11). 
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4-2-1- Normal Volunteers 
The correlation coefficients for sperm and seminal plasma characteristics for normal volunteers 
were illustrated in tables 12a; 12b and 12c. 
Table 12a. Correlation coefficient of sperm parameters of normal volunteer samples (n=50)  
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Count (mill/ml) r = 1.000 0.144 -0.209 -0.178 -0.138 -0.011 0.225 0.193 0.053 0.184 p = . 0.319 0.145 0.216 0.339 0.940 0.116 0.180 0.716 0.202 
Motility (%motile) r = 0.144 1.000 0.361
** 0.366** -0.563** -0.541** 0.548** 0.101 0.153 -0.237 
p = 0.319 . 0.010 0.009 0.000 0.000 0.000 0.487 0.289 0.098 
Sperm vitality (Eosin) (%) r = -0.209 0.361
** 1.000 0.600** -0.272 -0.147 0.031 0.015 0.069 -0.179 
p = 0.145 0.010 . 0.000 0.050 0.309 0.832 0.919 0.632 0.213 
Membrane integrity (HOS) 
(%) 
r = -0.178 0.366** 0.600** 1.000 -0.314* -0.289* 0.179 0.173 0.314* -0.193 
p = 0.216 0.009 0.000 . 0.026 0.042 0.213 0.228 0.026 0.180 
Chromatin condensation  
(positive  CMA3) (%) 
r = -0.138 -0.563** -0.272* -0.314* 1.000 0.589** -0.469** -0.091 -0.097 0.128 
p = 0.339 0.000 0.050 0.026 . 0.000 0.001 0.530 0.505 0.375 
DNA Fragmentation 
(positive TUNEL) (%)   
r = -0.011 -0.541** -0.147 -0.289* 0.589** 1.000 -0.560** -0.053 -0.161 0.296* 
p = 0.940 0.000 0.309 0.042 0.000 . 0.000 0.716 0.265 0.037 
Morphologically Normal 
spermatozoa (%) 
r = 0.225 0.548** 0.031 0.179 -0.469** -0.560** 1.000 0.038 0.114 -0.240 
p = 0.116 0.000 0.832 0.213 0.001 0.000 . 0.796 0.432 0.094 
Protamine 1 
(ng/ 106 sperm) 
r = 0.193 0.101 0.015 0.173 -0.091 -0.053 0.038 1.000 0.699** 0.481** 
p = 0.180 0.487 0.919 0.228 0.530 0.716 0.796 . 0.000 0.000 
Protamine 2  
(ng/ 106 sperm) 
r = 0.053 0.153 0.069 0.314* -0.097 -0.161 0.114 0.699** 1.000 -0.214 
p = 0.716 0.289 0.632 0.026 0.505 0.265 0.432 0.000 . 0.136 
P1/P2 Ratios r = 0.184 -0.237 -0.179 -0.193 0.128 0.296
* -0.240 0.481** -0.214 1.000 
p = 0.202 0.098 0.213 0.180 0.375 0.037 0.094 0.000 0.136 . 
 
Analysis of the semen samples of the normal volunteers showed that (Table 12a) sperm motility 
was significantly positive correlations (p<0.010) with sperm vitality (Eosin-test) (r=0.362), sperm 
membrane integrity (HOS-test), (r=0.366), and morphologically normal sperm (Fig.19). In contrast, 
motility showed significant negative correlations (p<0.010) with chromatin condensation, (positive 
CMA3-test), DNA fragmentation (Tunel-test), (r=-0.458, r=-0.406 respectively). P1/P2 ratios 
showed correlations but not significant (r=-0.237, p=0.098) with motility. Besides, perm vitality 
showed positive significant correlation with sperm membrane integrity (r=0.600, p<0.010) and a 
negative significant difference with chromatin condensation (r=-0.272, p<0.050). In addition, a 
significant negative correlations (p<0.050) were found between sperm membrane integrity with 
non- condensed chromatin and DNA fragmentation (r=-0.314; r=-0.289 respectively). Moreover, 
positive significance correlation between sperm vitality with P2 concentration (r=0.314, p<0.050) 
was shown. Figure 20 illustrated the correlation between sperm non- condensed chromatin and 
DNA fragmentation, while Figure 21 showed the negative coefficient correlation with 
morphologically normal sperm. 
Sperm DNA integrity was correlated negatively with morphologically normal sperm (r=-0.506, 
p<0.010), and correlated significantly with P1/P2 ratios (r=0.296, p<0.050). P1 concentration 
showed a positive correlations (p<0.010) with P2 concentrations and P1/P2 ratios (Table 12a). 
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Table 12b. Correlation coefficient of semen parameters of normal volunteer samples (n=50)  
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Volume (ml) r = 
1.000 -0.037 -0.206 -0.140 -0.296* -0.256 -0.250 
p = . 0.798 0.151 0.334 0.037 0.072 0.079 
pH r = 
-0.037 1.000 -0.107 -0.055 0.030 -0.022 -0.065 
p = 1.000 . 0.459 0.705 0.837 0.879 0.655 
Leukocytes (%) r = 
-0.206 -0.107 1.000 0.149 0.022 -0.173 -0.048 
p = 0.151 0.459 . 0.303 0.882 0.229 0.739 
Malondialdehyde (MDA) (μM) 
 (N=113) 
r = -0.140 -0.055 0.149 1.000 0.527** 0.614** 0.557** 
p = 0.334 0.705 0.303 . 0.000 0.000 0.000 
Reactive oxygen species (ROS) (μmol/l)  
(N=113) 
r = -0.296* 0.030 0.022 0.527** 1.000 0.673** 0.611** 
p = 0.037 0.837 0.882 0.000 . 0.000 0.000 
Cotinine (ng/ml)   
 (N=113) 
r = -0.256 -0.022 -0.173 0.614** 0.673** 1.000 0.752** 
p = 0.072 0.879 0.229 0.000 0.000 . 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 
 (N=113) 
r = -0.250 -0.065 -0.048 0.557** 0.611** 0.752** 1.000 
p = 0.079 0.655 0.739 0.000 0.000 0.000 . 
 
In table 12b, normal volunteers semen volumes (ml) correlated significantly negative with 
concentration of ROS (μmol/l), (r=-0.296, p<0.050) and non-significantly with concentrations of 
cotinine (ng/ml) and 8-OHdG (ng/ml) (r=-0.256, r=-0.250; p=0.072, p=0.079 respectively). The pH 
and the concentration of leukocytes showed no significant correlations. A positive significant 
correlations (p<0.010) were showed between the concentrations of MDA (μM) with ROS (μmol/l), 
(r=0.527), cotinine (ng/ml) (r=0.614) and 8-OHdG (ng/ml) (r=0.577). The same results showed 
between ROS with cotinine and 8-OHdG (r=0.673; r=0.611 respectively. In addition cotinine and 
8-OHdG showed positive significant correlation (r=0.752, p<0.010). 
Table 12c. Correlation coefficient of semen parameters of normal volunteer samples (n=50)  
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Volume (ml) r = 0.291
* 0.346* -0.013 0.006 -0.165 -0.111 0.387** 0.206 0.126 0.040 
p = 0.040 0.014 0.928 0.968 0.252 0.444 0.005 0.151 0.382 0.781 
pH r = -0.263 -0.158 -0.093 -0.034 0.172 0.021 -0.055 -0.156 -0.146 0.012 p = 0.065 0.272 0.523 0.814 0.234 -0.112 -0.029 0.280 0.311 0.934 
Leukocytes (%) r = -0.131 -0.202 -0.085 -0.117 0.019 -0.112 -0.029 -0.078 -0.092 -0.026 p = 0.365 0.159 0.555 0.418 0.897 0.439 0.843 0.588 0.526 0.858 
Malondialdehyde (MDA) 
(μM)  (N=113) 
r = 0.090 -0.580** -0.040 -0.093 0.527** 0.536** -0.455** 0.146 0.075 0.281* 
p = 0.536 0.000 0.785 0.522 0.000 0.000 0.001 0.311 0.605 0.048 
Reactive oxygen species 
(ROS) (μmol/l) (N=113) 
r = 0.101 -0.632** -0.248 -0.196 0.636** 0.577** -0.555** 0.020 -0.030 0.262* 
p = 0.486 0.000 0.083 0.173 0.000 0.000 0.000 0.889 0.834 0.046 
Cotinine (ng/ml)   
 (N=113) 
r = -0.035 -0.584** -0.255 -0.300* 0.559** 0.657** -0.565** 0.125 0.045 0.315* 
p = 0.811 0.000 0.074 0.034 0.000 0.000 0.000 0.386 0.755 0.026 
8-hydroxy-2-
deoxyguanisine (8-OH-dG) 
(ng/ml) (N=113) 
r = -0.091 -0.667** -0.283* -0.303* 0.588** 0.694** -0.573** 0.034 -0.119 0.337* 
p = 0.528 0.000 0.047 0.032 0.000 0.000 0.000 0.814 0.410 0.017 
 
Table 12c demonstrated that the four seminal plasm parameters MDA (μM), ROS (μmol/l), 
(cotinine (ng/ml), and 8-OHdG (ng/ml) concentrations were correlated  significantly negative 
(p<0.010) with motility. A negative significant correlation was observed between sperm vitality 
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and 8-OHdG (r=-0.283, p=0.047), while low significance noteced with ROS and cotinine (r=-
0.248, p=0.083; r=-0.255, p=0.074). Moreover, significant negative correlatios (p<0.050) were 
found between sperm membrane integrity with cotinine and 8-OHdG (r=-0.300, r= -0.303 
respectively). In contrast, a positive correlations (p<0.010) were found between the seminal plasma 
parameters and non-condensed chromatin and DNA fragmentation. P1/P2 ratios also showed a 
significant correlation (p<0.050) with the four parameters (Table 12c).  
 
Figure 19: Scatter plot of correlation between sperm motility (%) and the mean percentage of 
morphologically normal spermatozoa of volunteers. A significant positive correlation was indicated 
(r=0.548; p<0.010). 
 
 
Figure 20: Scatter plot of correlation between the percentages of sperm chromatin condensation 
evaluated by CMA3 and sperm DNA fragmentation (TUNEL) of volunteers. A significant positive 
correlation (r=0.598, p<0.010) was found. 
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Figure 21: Scatter plot of correlation between the percentage of sperm chromatin condensation 
(CMA3) and the mean percentage of morphologically normal spermatozoa of volunteers. A 
significantly negative correlation (r=-0.469, p<0.010) was found. 
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4-2-2-Patients 
Table 13a, b, and c illustrated the correlation coefficient of patient’s sperm and semen parameters.  
Table 13a. Correlation coefficient of sperm parameters of patient samples (n=116)  
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Count (mill/ml) r = 1.000 0.096 0.191
* 0.139 -0.208* 0.021 0.115 0.203* 0.160 -0.063 
p = . 0.305 0.040 0.136 0.025 0.825 0.220 0.029 0.086 0.500 
Motility (%motile) r = 0.096 1.000 0.501
** 0.417** -0.260** -0.219* 0.299** 0.031 0.082 -0.138 
p = 0.305 . 0.000 0.000 0.005 0.018 0.001 0.738 0.380 0.140 
Sperm vitality (Eosin) (%) r = 0.191
* 0.501** 1.000 0.559** -0.226* -0.162 0.134 0.011 -0.010 -0.040 
p = 0.040 0.000 . 0.000 0.015 0.082 0.152 0.907 0.918 0.668 
Membrane integrity (HOS) 
(%) 
r = 0.139 0.417** 0.559** 1.000 -0.342** -0.266** 0.377** 0.121 0.132 -0.107 
p = 0.136 0.000 0.000 . 0.000 0.004 0.000 0.196 0.157 0.255 
Chromatin condensation  
(positive  CMA3) (%) 
r = -0.208* -0.260** -0.226* -0.342** 1.000 0.213* -0.323** -0.167 -0.208* 0.182 
p = 0.025 0.005 0.015 0.000 . 0.022 0.000 0.074 0.025 0.051 
DNA Fragmentation 
(positive TUNEL) (%)   
r = 0.021 -0.219* -0.162 -0.266** 0.213* 1.000 -0.356** -0.136 -0.035 0.062 
p = 0.825 0.018 0.082 0.004 0.022 . 0.000 0.146 0.711 0.508 
Morphologically Normal 
spermatozoa (%) 
r = 0.115 0.299** 0.134 0.377** -0.323** -0.356** 1.000 -0.080 -0.004 -0.154 
p = 0.220 0.001 0.152 0.000 0.000 0.000 . 0.395 0.962 0.100 
Protamine 1 
(ng/ 106 sperm) 
r = 0.203* 0.031 0.011 0.121 -0.167 -0.136 -0.080 1.000 0.623** 0.105 
p = 0.029 0.738 0.907 0.196 0.074 0.146 0.395 . 0.000 0.261 
Protamine 2  
(ng/ 106 sperm) 
r = 0.160 0.082 -0.010 0.132 -0.208* -0.035 -0.004 0.623** 1.000 -0.638** 
p = 0.086 0.380 0.918 0.157 0.025 0.711 0.962 0.000 . 0.000 
P1/P2 Ratios r = -0.063 -0.138 -0.040 -0.107 0.182 0.062 -0.154 0.105 -0.638
** 1.000 
p = 0.500 0.140 0.668 0.255 0.051 0.508 0.100 0.261 0.000 . 
 
In Table 13a the concentration of sperms was shown to be correlated significantly (p<0.050) with 
sperm vitality and P1 concentration (r=0.191; r=0.203 respectively), and negatively with chromatin 
condensation (r=-0.208, p<0.050). However, the motility of the patient sperms was positively 
correlated with sperm vitality (r=0.501, p<0.010), membrane integrity (r=0417, p<0.010), and 
morphologically normal sperm (r=0.299, p<0.010). Besides a significantly negative correlations 
with chromatin condensation (r=-0.260, p<0.010) and DNA fragmentation (r=-0.219, p<0.050) 
were found. The sperm membrane integrity correlated negatively (p<0.010) with chromatin 
condensation and DNA fragmentation (r=-0.342, r=-0.266 respectively), whereas, a positive 
correlation with morphologically normal sperm (r=0.377, p<0.010) was observed. On the other 
hand, chromatin condensation (CMA3) correlated positively with DNA integrity (Tunel) and 
significantly negative with P2 values (r=0.213, p<0.050; r=-0.208, p<0.050) and morphologically 
normal sperm (r=-0.323, p<0.010). DNA integrity (Tunel) in its return, showed a significant 
negative correlation with morphologically normal sperm (r=-0.356, p<0.010). In addition P1 
correlated significantly positive with P2 (r=0.623, p<0.010). Whereas, significantly negative 
correlation was found between P2 and P1/P2 ratios (r=-0.638, p<0.010, Table 13a). 
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Table 13b. Correlation coefficient of semen parameters of patient samples (n=116)  
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Volume (ml) r = 
1.000 0.021 0.057 -0.116 0.029 -0.001 -0.090 
p = . 0.825 0.546 0.363 0.819 0.995 0.485 
pH r = 
0.021 1.000 -0.030 0.004 -0.076 0.057 -0.071 
p = 0.825 . 0.746 0.975 0.554 0.655 0.578 
Leukocytes (%) r = 
0.057 -0.030 1.000 0.183 0.154 0.210 0.081 
p = 0.546 0.746 . 0.152 0.228 0.098 0.526 
Malondialdehyde (MDA) (μM) 
 (N=113) 
r = -0.116 0.004 0.183 1.000 0.595** 0.619** 0.590** 
p = 0.363 0.975 0.152 . 0.000 0.000 0.000 
Reactive oxygen species (ROS) (μmol/l)  
(N=113) 
r = 0.029 -0.076 0.154 0.595** 1.000 0.733** 0.502** 
p = 0.819 0.554 0.228 0.000 . 0.000 0.000 
Cotinine (ng/ml)   
 (N=113) 
r = -0.001 0.057 0.210 0.619** 0.733** 1.000 0.761** 
p = 0.995 0.655 0.098 0.000 0.000 . 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml)  
(N=113) 
r = -0.090 -0.071 0.081 0.590** 0.502** 0.761** 1.000 
p = 0.485 0.578 0.526 0.000 0.000 0.000 . 
 
Table 13b: No significant correlations were detected between the volume of the semen, the pH, and 
the concentration of leukocytes with other parameters. However, a significantly positive 
correlations (p<0.010) were found between MDA levels and ROS (r=0.595), cotinine (r=0.619) and 
8-OHdG (r=0.590) in seminal plasma. Moreover a significantly positive correlations (p<0.010) 
were observed between ROS with cotinine and 8-OHdG (r=0.733, r=0.562, respectively). Similar 
correlation was found between cotinine and 8-OHdG (r=0.761, p<0.010). 
Table 13c. Correlation coefficient of sperm and semen parameters of patient samples (n=116)  
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Volume (ml) r = -0.107 -0.049 0.038 0.048 -0.081 -0.044 0.069 0.152 0.123 -0.019 p = 0.252 0.600 0.683 0.611 0.387 0.635 0.460 0.104 0.190 0.840 
pH r = -0.151 -0.076 -0.025 -0.005 0.023 0.049 -0.008 -0.069 -0.034 -0.044 p = 0.106 0.418 0.792 0.954 0.809 0.604 0.930 0.459 0.716 0.637 
Leukocytes (%) r = 0.057 0.051 0.061 -0.114 0.113 0.060 0.015 -0.041 -0.129 0.157 p = 0.544 0.586 0.518 0.223 0.226 0.521 0.873 0.664 0.169 0.093 
Malondialdehyde (MDA) 
(μM) (N=113) 
r = -0.076 -0.249* -0.239 -0.340** 0.351** 0.517** -0.428** -0.034 -0.189 0.345** 
p = 0.552 0.049 0.060 0.006 0.005 0.000 0.000 0.789 0.137 0.006 
Reactive oxygen species 
(ROS) (μmol/l) (N=113) 
r = -0.183 -0.248* -0.133 -0.280* 0.510** 0.402** -0.371** -0.122 -0.299* 0.368** 
p = 0.151 0.050 0.299 0.027 0.000 0.001 0.003 0.342 0.017 0.003 
Cotinine (ng/ml)   
 (N=113) 
r = -0.102 -0.208 -0.207 -0.276* 0.451** 0.500** -0.514** -0.049 -0.268* 0.411** 
p = 0.426 0.102 0.104 0.028 0.000 0.000 0.000 0.702 0.034 0.001 
8-hydroxy-2-deoxyguanisine 
(8-OH-dG) (ng/ml) (N=113) 
r = -0.145 -0.346** -0.305* -0.233* 0.432** 0.497** -0.445** -0.161 -0.301* 0.374** 
p = 0.255 0.006 0.015 0.046 0.000 0.000 0.000 0.206 0.017 0.003 
 
Table 13c illustrated an inverse correlation (p<0.050) between motility and concentrations of MDA 
and ROS (r=-0.249; r=-0.248 respectively). In addition motility was significantly reduced as 
concentration of 8-OHdG increase (r=-0.346, p<0.010). Sperm vitality significantly reduced as 
concentration of 8-OHdG increase (r=-0.305, p<0.050). Similar an inverse significant correlation 
was shown between concentration of MDA, ROS, cotinine and 8-OHdG in seminal plasma and 
sperm membrane integrity (Table 13c). In contrast a significantly positive correlations (p<0.010) 
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were found between the MDA, ROS, cotinine, and 8-OHdG in seminal plasma and chromatin 
condensation (bad sperm), as well as with high DNA fragmentation. The concentrations of MDA, 
ROS, cotinine, and 8-OHdG showed inverse effects on Protamine 2 (r=-0.189, r=-0.299, r=-0.268, 
r=-0.301 respectively). In contrast, P1/P2 ratios of spermatozoa showed a positive correlations 
(p<0.010) with seminal plasma parameters.  
4-3- Non-smokers versus Smokers 
4-3-1- All participants 
Table 14. Comparison of semen and sperm parameters for all participants (normal and patients) 
dividing into nonsmokers and smokers.  
 Parameters All Participants Non Smokers Smokers p-value 
Samples 166 94 72  
Age (year) 34.1 ± 7.8 33.3 ± 7.7 35.2 ± 7.9 0.165 
Volume (ml) 3.4 ± 1.6 3.6 ± 1.6 3.1 ± 1.6 0.027 
pH 8.7 ± 0.4 8.7 ± 0.4 8.7 ± 0.4 0.927 
Count  (mill/ml) 67.1 ± 31.2 68.4 ± 31.2 65.4 ± 31.5 0.641 
Motility  (% motile) 30.3 ± 13.6 35.8 ± 14.6 23.4 ± 8.0 0.000 
Sperm vitality (Eosin) (%) 37.8 ± 17.8 41.2 ± 17.3 33.5 ± 17.6 0.005 
Membrane integrity (HOS) (%)%  47.6 ± 19.8 54.1 ± 18.4 39.2 ± 18.4 0.000 
Leukocytes (%) 2.5 ± 1.5 2.4 ± 0.6 2.8 ± 2.1 0.036 
Chromatin condensation (positive  CMA3) (%)  30.0 ± 9.0 26.4 ± 8.0 34.6 ± 8.1 0.000 
DNA Fragmentation (positive TUNEL) (%)   12.8 ± 5.9 9.6 ± 4.3 16.8 ± 5.1 0.000 
Morphologically Normal spermatozoa (%) 36.8 ± 15.2 41.4 ± 13.7 26.6 ± 12.0 0.000 
Malondialdehyde (MDA) (μM) 7.21 ± 1.77 (n=113) 6.10 ± 1.18 (n=62) 8.51 ± 1.43 (n=51) 0.000 
Reactive oxygen species (ROS) (μmol/l) 87.80 ± 50.85 (n=113) 52.89 ± 28.48 (n=62) 128.75 ± 39.46 (n=51) 0.000 
Cotinine (ng/ml) 41.86 ± 58.18 (n=113) 2.34 ± 2.20 (n=62) 88.22 ± 58.05 (n=51) 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 1.59 ± 1.47 (n=113) 0.71 ± 0.53 (n=62) 2.63 ± 1.54 (n=51) 0.000 
Protamine 1 (P1) (ng/106 sperm) 404.81 ± 1024.37 402.63 ± 93.96 407.60 ± 128.80 0.804 
Protamine 2 (P2) (ng/106 sperm) 358.69 ± 105.08 376.81 ± 97.36 335.60 ± 110.60 0.030  
P1/P2 ratio 1.18 ± 0.33 1.09 ± 0.18 1.30 ± 0.42 0.000 
 
The distribution of all participants into non-smokers (n=94) and smokers (n=72) groups was 
reported in figure 22, while table 14 reported the semen and sperm characteristics. Significant 
differences (p<0.050) were found in volume of the semen sample, number of leukocytes and 
concentration of P2 between the two groups. A significant higher differences were found between 
other investigated parameters (p<0.010), except for age, pH, count of the sperms and the 
concentration of P1 which showed no statistical differences (p>0.050) between the two groups.   
The seminal plasma concentrations of MDA, ROS, cotinine and 8-OHdG were significantly higher 
in smokers group (8.51 ± 1.43, 128.75 ± 39.46, 88.22 ± 58.05, and 2.63 ± 1.54) in comparison to 
that of non-smokers group (6.10 ± 1.18, 52.89 ± 28.48, 2.34 ± 2.20, and 0.71 ± 0.53).  
Moreover, the mean percentage of chromatin condensed spermatozoa was significantly lower 
(p<0.010) in smokers (bad sperms =34.6 ± 8.1%) in comparison to the value of the non-smokers 
(bad sperms =26.4 ± 8.0%). Whereas, the mean percentage of DNA fragmentation of smokers was 
higher than that of non-smokers (16.8 ± 5.1 vs. 9.6 ± 4.3, p<0.010).  Also, P1/P2 ratios were 
significantly (p<0.010) higher in smokers (1.30 ± 0.42) than non-smokers (1.09 ± 0.18) (Figure 23). 
There were no significant correlations between the pH, the concentration of sperms, and P1 
concentrations among the two groups 
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Figure 22. The distribution of all samples (n=166) into non-smokers (n=94) and smokers (n=72). 
 
 
 
 
 
 
Figure 23. Box-plots showing the mean, median, and range of P1/P2 of both smokers and non-
smokers. P1/P2 was significantly higher in smokers in comparison to non-smokers group (1.30 ± 
0.42 VS 1.09 ± 0.18; p<0.010). 
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4-3-2- Normal volunteers  
Table 15. Comparison of semen analysis parameters for all normal participants including 
nonsmokers and smokers.  
 
Table 15 showed that concentrations of MDA, ROS, cotinine and 8-OHdG in seminal plasma of 
normal volunteers smokers were significantly higher (p<0.010) in comparison to that of the non-
smokers (7.66 ± 0.9, 111.82 ± 28.66, 68.55 ± 38.58, 2.02 ± 0.51 vs. 5.71 ± 1.17, 40.47 ± 20.45, 
2.02 ± 2.03, 0.61 ± 0.40 respectively). In contrast, the mean percentages of motility, and 
morphologically normal spermatozoa were significantly lower (p<0.010) in smokers (24.7 ± 8.2, 
34.4 ± 10.3 respectively), in comparison to non-smokers (44.7 ± 12.5, 52.9 ± 10.8 respectively), 
while P1/P2 ratios were higher in smokers than in non-smokers (1.19 ± 0.27 vs. 1.04 ± 0.11, 
p<0.010). In contrast, a significantly lower chromatin condensed spermatozoa and significantly 
higher DNA fragmentation was found in smokers in comparison to non-smokers (Table 15). Other 
parameters showed a non-significant correlations. 
Table 16a, b demonstrated the correlation coefficients for sperm and seminal plasma characteristics 
for smokers group of normal volunteers. 
 Parameters All Normal  Non Smokers Smokers p-value 
Samples 50 31 19  
Age (year) 25.5 ± 4.5 25.7 ± 5.2 25.2 ± 3.4 0.944 
Volume (ml) 3.9 ± 1.4 4.1 ± 1.5 3.4 ± 1.0 0.062 
pH 8.6 ± 0.3 8.6 ± 0.3 8.6 ± 0.2 0.787 
Count  (mill/ml) 80.2 ±27.5 81.0 ± 27.6 78.9 ± 28.2 0.956 
Motility  (% motile) 37.1 ± 14.7 44.7 ± 12.5 24.7 ± 8.2 0.000 
Sperm vitality (Eosin) (%) 45.2 ± 16.9 47.6 ± 15.3 41.3 ± 19.1 0.165 
Membrane integrity (HOS) (%)%  53.4 ± 15.8 56.6 ± 14.5 48.2 ± 16.8 0.080 
Leukocytes (%) 2.4 ± 0.5 2.5 ± 0.5 2.4 ± 0.6 0.963 
Chromatin condensation (positive  CMA3) (%)  23.3 ± 7.0 19.6 ± 4.8 29.4 ± 5.5 0.000 
DNA Fragmentation (positive TUNEL) (%)   9.6 ± 5.4 6.1 ± 1.8 15.1 ± 4.5 0.000 
Morphologically Normal spermatozoa (%) 45.9 ± 13.9 52.9 ± 10.8 34.4 ± 10.3 0.000 
Malondialdehyde (MDA) (μM) 6.45 ± 1.43 5.71 ± 1.17 7.66 ± 0.9 0.000 
Reactive oxygen species (ROS) (μmol/l) 67.6 ± 42.2 40.47 ± 20.45 111.82 ± 28.66 0.000 
Cotinine (ng/ml) 27.30 ± 40.17 2.02 ± 2.03 68.55 ± 38.58 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 1.15 ± 0.82 0.61 ± 0.40 2.02 ± 0.51 0.000 
Protamine 1 (P1) (ng/106 sperm) 378.20 ± 100.00 367.60 ± 80.00 395.60 ± 125.90 0.743 
Protamine 2 (P2) (ng/106 sperm) 347.30 ± 77.30 352.9 ± 69.3 338.10 ± 90.20 0.682 
P1/P2 ratio 1.10 ± 0.20 1.04 ± 0.11 1.19 ± 0.27 0.016 
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Table 16a. Correlation coefficient of sperm parameters of smoker samples of normal volunteers 
(n=19) 
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Count (mill/ml) r = 1.000 0.017 -0.565
* -0.548* 0.142 0.356 0.338 0.126 -0.133 0.187 
p = . 0.945 0.012 0.015 0.563 0.135 0.157 0.607 0.587 0.444 
Motility (%motile) r = 0.017 1.000 0.060 0.058 0.111 0.392 0.169 0.259 0.313 0.014 p = 0.945 . 0.808 0.815 0.650 0.097 0.490 0.285 0.192 0.954 
Sperm vitality (Eosin) (%) r = -0.565
* 0.060 1.000 0.725** -0.347 -0.273 -0.285 -0.004 0.230 -0.334 
p = 0.012 0.808 . 0.000 0.146 0.257 0.237 0.989 0.343 0.163 
Membrane integrity (HOS) 
(%) 
r = -0.548* 0.058 0.725** 1.000 -0.198 -0.343 -0.225 0.117 0.402 -0.368 
p = 0.015 0.815 0.000 . 0.416 0.150 0.355 0.633 0.088 0.121 
Chromatin condensation  
(positive  CMA3) (%) 
r = 0.142 0.111 -0.347 -0.198 1.000 0.278 0.271 -0.269 -0.125 -0.076 
p = 0.563 0.650 0.146 0.416 . 0.249 0.261 0.265 0.611 0.756 
DANN Fragmentation 
(positive TUNEL) (%)   
r = 0.356 0.392 -0.273 -0.343 0.278 1.000 0.347 -0.100 -0.351 0.307 
p = 0.135 0.097 0.257 0.150 0.249 . 0.145 0.684 0.141 0.201 
Morphologically Normal 
spermatozoa (%) 
r = 0.338 0.169 -0.285 -0.225 0.271 0.347 1.000 -0.173 -0.042 -0.139 
p = 0.157 0.490 0.237 0.355 0.261 0.145 . 0.478 0.866 0.571 
Protamine 1 
(ng/ 106 sperm) 
r = 0.126 0.259 -0.004 0.117 -0.269 -0.100 -0.173 1.000 0.574* 0.463* 
p = 0.607 0.285 0.989 0.633 0.265 0.684 0.478 . 0.010 0.046 
Protamine 2  
(ng/ 106 sperm) 
r = -0.133 0.313 0.230 0.402 -0.125 -0.351 -0.042 0.574* 1.000 -0.370 
p = 0.587 0.192 0.343 0.088 0.611 0.141 0.866 0.010 . 0.119 
P1/P2 Ratios r = 0.187 0.014 -0.334 -0.368 -0.076 0.307 -0.139 0.463
* -0.370 1.000 
p = 0.444 0.954 0.163 0.121 0.756 0.201 0.571 0.046 0.119 . 
 
In table 16a, the concentration of the sperms was correlated significantly (p<0.050) negative with 
sperm vitality and membrane integrity (r=-0.565; r=-0.548 respectively). Whereas, the sperm 
vitality was correlated significantly positive with membrane integrity of the sperms (r=0.725, 
p<0.010). Other parameters showed a correlations but not significant.  
Table 16b. Correlation coefficient of semen parameters of smoker samples of volunteers (n=19) 
 
V
ol
um
e 
(m
l) 
pH
 
Le
uk
oc
yt
es
 (%
) 
M
al
on
di
al
de
hy
de
 
(M
D
A
) 
(μ
M
) 
(N
=1
13
) 
R
ea
ct
iv
e 
ox
yg
en
 
sp
ec
ie
s (
R
O
S)
 
(μ
m
ol
/l)
 (N
=1
13
) 
C
ot
in
in
e 
 
(n
g/
m
l) 
 
(N
=1
13
) 
8-
hy
dr
ox
y-
2-
de
ox
yg
ua
ni
si
ne
  
(8
-O
H
-d
G
) 
(n
g/
m
l) 
(N
=1
13
) 
Volume (ml) r = 
1.000 0.081 -0.007 0.232 -0.010 -0.355 -0.008 
p = . 0.742 0.977 0.339 0.967 0.136 0.972 
pH r = 
0.081 1.000 -0.519* -0.145 0.129 0.181 0.071 
p = 0.742 . 0.023 0.554 0.600 0.458 0.772 
Leukocytes (%) r = 
-0.007 -0.519* 1.000 0.356 -0.027 -0.498* -0.319 
p = 0.977 0.023 . 0.135 0.914 0.030 0.182 
Malondialdehyde (MDA) (μM) 
 (N=113) 
r = 0.232 -0.145 0.356 1.000 0.193 -0.515* -0.528* 
p = 0.339 0.554 0.135 . 0.428 0.024 0.020 
Reactive oxygen species (ROS) (μmol/l)  
(N=113) 
r = -0.010 0.129 -0.027 0.193 1.000 -0.171 -0.283 
p = 0.967 0.600 0.914 0.428 . 0.483 0.241 
Cotinine (ng/ml)   
 (N=113) 
r = -0.355 0.181 -0.498* -0.515* -0.171 1.000 0.389 
p = 0.136 0.458 0.030 0.024 0.483 . 0.099 
8-hydroxy-2-deoxyguanisine (8-OH-dG) 
 (ng/ml) (N=113) 
r = -0.008 0.071 -0.319 -0.528* -0.283 0.389 1.000 
p = 0.972 0.772 0.182 0.020 0.241 0.099 . 
Table 16b showed a significantly negative correlations between the pH with leukocytes 
concentration (r=-0.519, p<0.050) and concentrations of leukocytes with cotinine (r=-0.498, 
p<0.050). Whereas, the concentration of MDA showed a significant negative correlation with 
cotinine and 8-OHdG (r=-0.515, r=-0.578; p<0.050 respectively).  
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4-3-3-Patients 
Table 17. Comparison of semen analysis parameters for all patients participating in the study, 
including nonsmokers and smokers.  
 Parameters All Patients Non Smokers Smokers p-value 
Samples 116 63 53  
Age (year) 37.9 ± 5.7 37.1 ± 5.7 38.8 ± 5.6 0.185 
Volume (ml) 3.2 ± 1.7 3.4 ± 1.6 3.1 ± 1.8 0.169 
pH 8.7 ± 0.4 8.7 ± 0.4 8.7 ± 0.4 0.923 
Count  (mill/ml) 61.4 ± 31.1 62.1 ± 31.1 60.6 ± 31.4 0.904 
Motility  (% motile) 27.4 ± 12.0 31.3 ± 13.6 23.0 ± 8.0 0.001 
Sperm vitality (Eosin) (%) 34.7 ± 17.3 38.1 ± 17.5 30.7 ± 16.4 0.030 
Membrane integrity (HOS) (%)%  45.1 ± 20.8 52.9 ± 20.1 36.1 ± 18.1 0.000 
Leukocytes (%) 2.6 ± 1.7 2.3 ± 0.6 2.9 ± 2.4 0.014 
Chromatin condensation (positive  CMA3) (%)  32.9 ± 8.2 29.8 ± 7.1 36.4 ± 8.1 0.000 
DNA Fragmentation (positive TUNEL) (%)   14.2 ± 5.6 11.3 ± 4.2 17.4 ± 5.3 0.000 
Morphologically Normal spermatozoa (%) 29.4 ± 12.7 36.1 ± 9.0 23.4 ± 10.1 0.000 
Malondialdehyde (MDA) (μM)  7.82 ± 1.79 (n=63)  6.51 ± 1.06 (n=31) 9.01 ± 1.46 (n=32) 0.000 
Reactive oxygen species (ROS) (μmol/l) 103.85 ± 5.68 (n=63) 65.74 ± 30.16 (n=31)  138.49 ± 41.85 (n=32) 0.000 
Cotinine (ng/ml) 53.42 ± 67.33 (n=63) 2.68 ± 2.36 (n=310 99.55 ± 64.58 (n=32) 0.000 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 1.95 ± 1.76 (n=63) 0.81 ± 0.63 (n=31) 2.99 ± 1.82 (n=32) 0.000 
Protamine 1 (P1) (ng/106 sperm) 416.30 ± 101.70 420.2 ± 95.8 411.80 ± 108.80 0.750 
Protamine 2 (P2) (ng/106 sperm) 363.60 ± 114.9 388.8 ± 107.2 334.7 ± 117.7 0.030 
P1/P2 ratio 1.22 ± 0.36 1.11 ± 0.20 1.34 ± 0.46 0.000 
 
In the group of patients (n=116, Table 17), the mean numbers of morphologically normal 
spermatozoa, motility, and membrane integrity were significantly lower (p<0.010) in smokers (23.4 
± 10.1, 23.0 ± 8.0, 36.1 ± 18.1) in comparison to non-smokers (36.1 ± 9.0, 31.3 ± 13.6, 52.9 ± 
20.1). Whereas, the mean percentage of chromatin condensation (CMA3), and DNA fragmentation 
(Tunel) were significantly lower in non-smokers than that of smokers (bad sperms: 29.8 ± 7.1, 11.3 
± 4.2 vs. 36.4 ± 8.1, 17.4 ± 5.3 respectively, p<0.010). 
Protamine 2 was significantly higher in non-smokers (388.8 ± 107.2) than smokers (334.7 ± 117.7, 
p<0.050), on the opposite side, P1/P2 ratios of non-smokers were significant lower than in smokers 
(1.11 ± 0.20, 1.34 ± 0.46, p<0.010). Whereas, P1 showed no significant difference between the two 
groups (420.2 ± 95.8, 411.80 ± 108.80, p<0.050).  
Furthermore, smokers levels of MDA (9.01 ± 1.46), ROS (138.49 ± 41.85), cotinine (99.55 ± 
64.58), and 8-OHdG (2.99 ± 1.82) were significantly higher than those values observed in non-
smokers group (6.51 ± 1.06, 65.74 ± 30.16, 2.68 ± 2.36, 0.81 ± 0.63, p<0.010). A significant 
differences (p<0.051) were demonstrated between the non-smokers versus smokers groups for the 
sperm vitality (38.1 ± 17.5, 30.7 ± 16.4), and leukocytes concentration (2.3 ± 0.6, 2.9 ± 2.4). Other 
parameters showed a non-significant correlation.         
Table 18a, b demonstrated the correlation coefficients for sperm and seminal plasma characteristics 
for smokers group of patients (n=53) 
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Table 18a. Correlation coefficient of sperm parameters of smoker patients samples (n=53) 
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Count (mill/ml) r = 1.000 0.185 0.501
** 0.399** -0.320* 0.084 -0.042 0.326* 0.116 0.015 
p = . 0.184 0.000 0.003 0.019 0.548 0.763 0.017 0.407 0.916 
Motility (%motile) r = 0.185 1.000 0.454
** 0.130 -0.067 0.040 -0.039 0.081 0.176 -0.179 
p = 0.184 . 0.001 0.353 0.634 0.776 0.780 0.564 0.208 0.199 
Sperm vitality (Eosin) (%) r = 0.501
** 0.454** 1.000 0.526** -0.120 -0.046 -0.167 0.240 0.249 -0.151 
p = 0.000 0.001 . 0.000 0.391 0.741 0.231 0.083 0.072 0.282 
Membrane integrity (HOS) 
(%) 
r = 0.399** 0.130 0.526** 1.000 -0.175 0.033 0.021 0.164 0.174 -0.180 
p = 0.003 0.353 0.000 . 0.211 0.814 0.881 0.241 0.213 0.198 
Chromatin condensation  
(positive  CMA3) (%) 
r = -0.320* -0.067 -0.120 -0.175 1.000 0.011 -0.062 -0.263 -0.150 0.042 
p = 0.019 0.634 0.391 0.211 . 0.940 0.657 0.057 0.284 0.768 
DNA Fragmentation 
(positive TUNEL) (%)   
r = 0.084 0.040 -0.046 0.033 0.011 1.000 -0.248 -0.122 -0.039 0.051 
p = 0.548 0.776 0.741 0.814 0.940 . 0.074 0.384 0.782 0.716 
Morphologically Normal 
spermatozoa (%) 
r = -0.042 -0.039 -0.167 0.021 -0.062 -0.248 1.000 -0.114 -0.115 -0.002 
p = 0.763 0.780 0.231 0.881 0.657 0.074 . 0.416 0.410 0.991 
Protamine 1 
(ng/ 106 sperm) 
r = 0.326* 0.081 0.240 0.164 -0.263 -0.122 -0.114 1.000 0.554** 0.072 
p = 0.017 0.564 0.083 0.241 0.057 0.384 0.416 . 0.000 0.610 
Protamine 2  
(ng/ 106 sperm) 
r = 0.116 0.176 0.249 0.174 -0.150 -0.039 -0.115 0.554** 1.000 -0.686** 
p = 0.407 0.208 0.072 0.213 0.284 0.782 0.410 0.000 . 0.000 
P1/P2 Ratios r = 0.015 -0.179 -0.151 -0.180 0.042 0.051 -0.002 0.072 -0.686
** 1.000 
p = 0.916 0.199 0.282 0.198 0.768 0.716 0.991 0.610 0.000 . 
 
Table 18b. Correlation coefficient of semen parameters of smoker patients samples (n=53) 
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Volume (ml) r = 
1.000 -0.183 0.044 -0.081 0.005 0.123 0.002 
p = . 0.191 0.752 0.658 0.979 0.504 0.991 
pH r = 
-0.183 1.000 0.007 0.067 -0.274 0.259 -0.032 
p = 0.191 . 0.961 0.716 0.129 0.152 0.863 
Leukocytes (%) r = 
0.044 0.007 1.000 -0.194 0.064 0.246 -0.140 
p = 0.752 0.961 . 0.288 0.730 0.175 0.444 
Malondialdehyde (MDA) (μM) 
 (N=113) 
r = -0.081 0.067 -0.194 1.000 0.007 -0.052 0.285 
p = 0.658 0.716 0.288 . 0.972 0.779 0.114 
Reactive oxygen species (ROS) (μmol/l)  
(N=113) 
r = 0.005 -0.274 0.064 0.007 1.000 0.069 -0.254 
p = 0.979 0.129 0.730 0.972 . 0.709 0.160 
Cotinine (ng/ml)   
 (N=113) 
r = 0.123 0.259 0.246 -0.052 0.069 1.000 0.099 
p = 0.504 0.152 0.175 0.779 0.709 . 0.589 
8-hydroxy-2-deoxyguanisine (8-OH-dG) 
(ng/ml) (N=113) 
r = 0.002 -0.032 -0.140 0.285 -0.254 0.099 1.000 
p = 0.991 0.863 0.444 0.114 0.160 0.589 . 
In table 18a, the concentration of sperms correlated significantly with sperm vitality (r=0.501, 
p<0.010), membrane integrity (r=0.399, p<0.010), and with P1 (r=0.326, p<0.050). Besides, it was 
correlated significantly negative with chromatin condensation (r=-0.320, p<0.050).  
A significant correlations (p<0.010) were detected between sperm viability with sperm motility and 
membrane integrity (r=0.454, r=0.526 respectively). Others, a significant correlation was found 
between P1 and P2 (r=0.574, p<0.010) and between P2 with P1/P2 ratios (r=0.686, p<0.010). Other 
semen parameters (Table 18b) showed no significant correlations within the group.   
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4-3-4- Normal smokers versus patient smokers 
Table 19. Comparison of semen analysis parameters for normal smokers and patients smokers.  
 Parameters Normal Smokers Patients Smokers p-value 
Samples 19 53  
Age (year) 25.2 ± 3.4 38.8 ± 5.6 0.000 
Volume (ml) 3.4 ± 1.0 3.1 ± 1.8 0.128 
pH 8.6 ± 0.2 8.7 ± 0.4 0272 
Count  (mill/ml) 78.9 ± 28.2 60.6 ± 31.4 0.020 
Motility  (% motile) 24.7 ± 8.2 23.0 ± 8.0 0.401 
Sperm vitality (Eosin) (%) 41.3 ± 19.1 30.7 ± 16.4 0.041 
Membrane integrity (HOS) (%)%  48.2 ± 16.8 36.1 ± 18.1 0.024 
Leukocytes (%) 2.4 ± 0.6 2.9 ± 2.4 0.305 
Chromatin condensation (positive  CMA3) (%)  29.4 ± 5.5 36.4 ± 8.1 0.000 
DNA Fragmentation (positive TUNEL) (%)   15.1 ± 4.5 17.4 ± 5.3 0.094 
Morphologically Normal spermatozoa (%) 34.4 ± 10.3 23.4 ± 10.1 0.000 
Malondialdehyde (MDA) (μM) 7.66 ± 0.90 9.01 ± 1.46 (n=33) 0.000 
Reactive oxygen species (ROS) (μmol/l) 111.82 ± 28.66 138.49 ± 41.85 (n=33) 0.047 
Cotinine (ng/ml) 68.55 ± 38.58 99.55 ± 64.58 (n=33) 0.066 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 2.02 ± 0.51 2.99 ± 1.82 (n=33) 0.094 
Protamine 1 (P1) (ng/106 sperm) 395.60 ± 125.90 411.80 ± 108.80 0.348 
Protamine 2 (P2) (ng/106 sperm) 338.10 ± 90.20 334.7 ± 117.7 0.934 
P1/P2 ratio 1.19 ± 0.27 1.34 ± 0.46 0.335 
 
Table 19 demonstrated the standard semen parameters in both normal smoker and patient smoker 
groups. Sperm count, motility, vitality, membrane integrity, and morphologically normal sperm 
were significantly higher in volunteer’s smokers than in patients smokers, the results were as 
follow: for volunteer’s smokers (78.9 ± 28.2, 24.7 ± 8.2, 41.3 ± 19.1, 48.2 ± 16.8, 34.4 ± 10.3) and 
the corresponding results in patients smokers were (60.6 ± 31.4, 23.0 ± 8.0, 30.7 ± 16.4, 36.1 ± 
18.1, 23.4 ± 10.1). Chromatin condensation of volunteers smokers was significantly higher than 
patient smokers (bad sperms: 29.4 ± 5.5 vs. 36.4 ± 8.1, p<0.010), besides, sperm DNA 
fragmentation. P1, P2, P1/P2 ratios showed no significant difference (p>0.050).  
Semen parameters MDA and ROS were significant higher in patients group in comparison to 
volunteers group (9.01 ± 1.46, 138.49 ± 41.85 vs. 7.66 ± 0.90, 111.82 ± 28.66, p<0.010, p<0.050 
respectively). Besides low significant difference were observed for cotinine and 8-OHdG between 
the two groups. 
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4-4- Protamines Quantification 
The mean ± standard deviation of P1, P2, and P1/P2 ratios for all participants were (404.81 ± 
1024.37, 358.69 ± 105.08, 1.18 ± 0.33 respectively) 
 
P1
P2
1       2       3       4       5       6      7        8       9      10      11    12
Figure 24. Analysis of protamine 1 (P1), protamine 2 (P2). 
Proteins extracted from spermatozoa, separated on a polyacrylamide-
acetic acid-urea gel and stained with Coomassie Blue. Lanes 6–9 
correspond to increasing amounts of a human protamine standard (0.50, 
1.00, 1.50 and 2.00 μg) included in each lane. Lane 10 correspond to 
control sample. Lanes 1-5, 11-12 correspond to different sperm samples 
from patients. (Each lane loaded with 10 μl of protein extracts)
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P1
P2
B CA
Figure 25. Analysis of protamine 1 (P1), protamine 2 (P2). 
(A) Western blot, corresponding to a replica of the gel shown in C, 
using an antibody specific to the P1.
(B) Western blot, corresponding to a replica of the gel shown in C, 
using an antibody specific to the P2.
(C) Proteins extracted from spermatozoa, separated on a 
polyacrylamide-acetic acid-urea gel and stained with Coomassie Blue. 
Lanes 1–4 correspond to increasing amounts of a human protamine 
standard (0.50, 1.00, 1.50 and 2.00 μg) included in each gel.
1  2  3  4 1      2     3     4 1     2     3     4
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Figure 26. Representative standard curves used to calculate the concentrations of P1 and P2. The 
loaded concentrations were (0.25, 0.50, 1.00, 1.50, and 2.00 μg) 
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4-4-1- Volunteers versus Patients 
Table 20. Compare the mean ± standard deviation of the P1, P2, and P1/P2 ratios between normal 
volunteers and patient samples  
 Parameters Normal  Patients  p-value 
Samples 50 116  
Protamine 1 (ng/ 106 sperm) 378.20 ± 100.00 416.30 ± 101.70 0.007 
Protamine 2 (ng/ 106 sperm) 347.30 ± 77.30 363.60 ± 114.9 0.424 
P1/P2 ratios 1.10 ± 0.20 1.22 ± 0.36 0.012 
 
Protamine quantification revealed (Table 20, Fig. 27) that the mean P1 concentrations in the sperms 
of normal volunteers was significantly lower (p<0.010) than that in patients, they were 378.20 ± 
100.00 vs. 416.30 ± 101.70 ng/106 sperm (Fig. 28). However, P2 concentrations in volunteers were 
347.30 ± 77.30 and the corresponding values in patients were 363.60 ± 114.9 ng/106 sperm, 
(p>0.050, Fig. 29). The P1/P2 ratios were significantly higher in patients (1.22 ± 0.36) than that in 
normal (1.10 ± 0.20, p<0.050, Fig. 30).  
 
 
 
300
320
340
360
380
400
420
440
Protamine 1 Protamine 2 
C
on
ce
nt
ra
tio
n 
(n
g/
10
6 
sp
er
m
Normal 
Patients 
 
Figure 27. P1 and P2 content in the sperms of volunteers and patients.  
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Figure 28. Box-plots showing the mean, median, and range of P1 of both normal and patients. P1 
was significantly higher in patients group in comparison to normal group (416.30 ± 101.70, 378.20 
± 100.00 ng/106 sperm, p<0.010). 
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Figure 29. Box-plots showing the mean, median, and range of P2 of both normal and patients. P2 
concentration showed no significant difference between patients group in comparison to normal 
group, it was higher in patients (363.60 ± 114.9) than normal (347.30 ± 77.30) ng/106 sperm, 
p<0.010. 
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Figure 30. Box-plots showing the mean, median, and range of P1/P2 ratios of both normal and 
patients. P1/P2 ratio was significantly higher in patients group in comparison to normal group (1.22 
± 0.36, 1.10 ± 0.20, p<0.010). 
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4-4-2- Non-smokers versus smokers 
Table 21. Compare the mean ± standard deviation of the P1, P2, and P1/P2 ratios between all 
participant non-smokers and smokers samples.  
 Parameters Non Smokers Smokers p-value 
Samples 94 72  
Protamine 1 (ng/106 sperm) 402.63 ± 93.96 407.60 ± 128.80 0.804 
Protamine 2 (ng/106 sperm) 376.81 ± 97.36 335.60 ± 110.60 0.030 
P1/P2 ratios 1.09 ± 0.18 1.30 ± 0.42 0.000 
 
Table 21 demonstrated the concentrations of P1, P2, and P1/P2 ratios for all non-smokers (n=94) 
and all smokers (n=72). P1 concentrations in both groups non-smoker and smokers were closely 
similar (402.63 ± 93.96; 407.60 ± 128.80, p>0.050 respectively). On the contrary, P2 
concentrations in non-smokers group (376.81 ± 97.36) were significantly higher (p<0.050) than in 
smokers group (335.60 ± 110.60). Highly significance difference was demonstrated in P1/P2 ratios 
for both groups, where it was (1.09 ± 0.18) for non-smokers group and (1.30 ± 0.42) for smokers 
group, (p<0.010), (Fig. 31). 
 
 
 
 
Figure 31. Box-plots showing the mean, median, and range of P1/P2 ratios of both all smokers and 
all non-smokers groups. P1/P2 ratio was significantly higher in smokers group in comparison to 
non-smokers group (1.30 ± 0.42, 1.09 ± 0.18, p<0.010). 
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4-4-2-1-Volunteers non-smokers versus smokers 
Table 22. Compare the mean ± standard deviation of the P1, P2, and P1/P2 ratios between 
volunteer’s non-smokers and smokers samples.  
 Parameters All Volunteers Non Smokers Smokers p-value 
Samples 50 31 19  
Protamine 1 (ng/106 sperm) 378.20 ± 100.00 367.60 ± 80.00 395.60 ± 125.90 0.743 
Protamine 2 (ng/106 sperm) 347.30 ± 77.30 352.90 ± 69.30 338.10 ± 90.20 0.682 
P1/P2  1.10 ± 0.20 1.04 ± 0.11 1.19 ± 0.27 0.016 
 
Neither P1 nor P2 showed a significant difference (p>0.050) between non-smokers (367.60 ± 
80.00, 352.9 ± 69.3) and smokers (395.60 ± 125.90, 338.10 ± 90.20) in volunteers group. Whereas, 
a significant increase in P1/P2 ratios of smokers compared to non-smokers were observed (1.19 ± 
0.27 vs. 1.04 ± 0.11, p<0.050) (Table 22, Fig. 32).    
 
 
 
 
Figure 32. Box-plots showing the mean, median, and range of P1/P2 ratios of both smokers and 
non-smokers of volunteers. P1/P2 ratio was significant higher in smokers in comparison to non-
smokers (1.19 ± 0.27, 1.04 ± 0.11, p<0.050). 
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4-4-2-2-Patients non-smokers versus smokers 
Table 23. Compare the mean ± standard deviation of the P1, P2, and P1/P2 ratios between patient’s 
non-smokers and smokers samples.  
 Parameters All Patients Non Smokers Smokers p-value 
No. Samples 116 63 53  
Protamine 1 (ng/106 sperm) 416.30 ± 101.70 420.2 ± 95.8 411.80 ± 108.80 0.750 
Protamine 2 (ng/106 sperm) 363.60 ± 114.9 388.8 ± 107.2 334.7 ± 117.7 0.030 
P1/P2  1.22 ± 0.36 1.11 ± 0.20 1.34 ± 0.46 0.000 
 
Table 23 illustrated the concentrations of P1, P2, and P1/P2 ratios of all patients undergoing ICSI 
therapy, including non-smokers and smokers. P1 concentrations were closely similar (p>0.050) in 
smokers (411.80 ± 108.80) and non-smokers (420.2 ± 95.8), whereas, P2 concentration and P1/P2 
ratios showed a significant difference between smokers (334.7 ± 117.7; 1.34 ± 0.46) and non-
smokers (388.8 ± 107.2; 1.11 ± 0.20). (Table 23; Fig. 33). 
 
 
 
Figure 33. Box-plots showing the mean, median, and range of P1/P2 ratios of both smokers and 
non-smokers of patients. P1/P2 ratio was significant higher in smokers in comparison to non-
smokers (1.34 ± 0.46, 1.11 ± 0.20, p<0.010). 
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4-4-2-3- Patients smokers versus volunteers smokers 
Table 24. Compare the mean ± standard deviation of the P1, P2, and P1/P2 ratios between all 
normal volunteers’ smokers and patients’ smoker’s samples.  
 Parameters Volunteers Smokers Patients Smokers p-value 
No. Samples 19 53  
Protamine 1 (ng/ 106 sperm) 395.60 ± 125.90 411.80 ± 108.80 0.348 
Protamine 2 (ng/ 106 sperm) 338.10 ± 90.20 334.7 ± 117.7 0.934 
P1/P2  1.19 ± 0.27 1.34 ± 0.46 0.335 
P1 levels in patients smokers were higher volunteers smokers (411.80 ± 108.80, vs. 395.60 ± 
125.90, p>0.050), in contrast, P2 levels were higher in volunteers smokers in comparison to 
patients smokers (338.10 ± 90.20 vs. 334.7 ± 117.7, p>0.050) and P1/P2 ratios were non-significant 
higher (p>0.050) in patients smokers (1.34 ± 0.46) than volunteers (1.19 ± 0.27) (Table 24). 
4-4-3- P1/P2 ratio grouping  
Depending on the values of P1/P2 ratios the participants were divided into three groups; low P1/P2 
ratio (<0.90), normal P1/P2 ratio (0.90 – 1.10), and high P1/P2 ratio (>1.10). The P1/P2 ratios for 
all participants found to be (1.18 ± 0.33), and for volunteers and patients were (1.10 ± 0.20 and 
1.22 ± 0.36 respectively). 
Table 25. Distribution of all participants, volunteers and patients according to the P1/P2 ratios 
values  
Parameters All Participants  
(n=166) 
Volunteers 
(n=50) 
Patients 
(n=116) 
p-value 
Total P1/P2 1.18 ± 0.33 1.10 ± 0.20 1.22 ± 0.36 0.012 
Low P1/P2 (< 0.90) 15.1% (6) 12.0%  (6) 16.4% (19) 
0.000 Normal P1/P2  (0.90-1.10) 21.7% (36) 42.0% (21) 12.9% (15) 
High P1/P2  (> 1.10) 63.3% (105) 46.0% (23) 70.7% (82) 
 
All participant samples were divided into the three P1/P2 ratios groups (low, normal, and high). By 
comparing P1/P2 ratios of the volunteers and patients samples distributed within these groups, the 
Chi square values showed a significant difference (p<0.010), (Table 25). These results revealed that 
70.7 % (82/116) of the patients have high P1/P2 ratio, 16.4 % (19/116) have low ratio and 12.9 % 
(15/116) have normal ratios. Meanwhile, 46.0% (23/50) of the volunteers have high ratios, 12.0% 
(6/50) have low ratios and 42.0% (21/50) have normal ratios. 
These results indicated that in volunteers group 58.0% revealed protamine abnormality (high and 
low P1/P2 ratios) and remaining 42.0% were normal. In contrast, in patients underwent ICSI 
therapy the corresponding values were 87.1% and 12.9% respectively. In addition, these results 
indicated that 78.4% of all participants have abnormal P1/P2 ratios while only 21.3% have normal 
ratios. 
Table 26. Distribution of volunteer’s non-smokers and smokers according to the P1/P2 ratios 
values 
Parameters All volunteers  
samples (n=50) 
Non smokers 
(n=31) 
Smokers 
(n=19) 
p-value 
Total P1/P2 1.10 ± 0.20 1.04 ± 0.11 1.19 ± 0.27 0.016 
Low P1/P2 (< 0.90) 12.0%  (6) 6.5% (2) 21.1% (4) 
0.002 Normal P1/P2  (0.90-1.10) 42.0% (21) 61.2% (19) 10.5% (2) 
High P1/P2  (> 1.10) 46.0% (23) 32.3% (10) 68.4% (13) 
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Furthermore, evaluation of the smoking effect (Table 26) for volunteers within P1/P2 ratio 
groups revealed a significant difference (p<0.010) between the non-smokers and smokers groups. 
Smokers group showed that 68.4%, (13/19) are within high P1/P2 ratio, 21.1%, (4/19) within low 
P1/P2 ratio and 10.5%, (2/19) normal P1/P2 ratio versus (32.3%, 10/31) of the non-smokers within 
high P1/P2 ratio, (6.5%, 2/31) within low P1/P2 ratio (6.5%, 2/31) and (61.3%, 19/31) within 
normal P1/P2 ratio. It was shown that 89.5% of smokers revealed abnormal P1/P2 ratios (low and 
high), whereas, in non-smokers only 38.8% presented abnormal ratios.  
Table 27. Distribution of patient’s non-smokers and smokers according to the P1/P2 ratios values 
Parameters All patients 
samples (n=116) 
Non smokers 
(n=63) 
Smokers 
(n=53) 
p-value 
Total P1/P2 1.22 ± 0.36 1.11 ± 0.20 1.34 ± 0.46 0.000 
Low P1/P2 (< 0.90) 16.4% (19) 17.5% (11) 15.1% (8) 
0.000 Normal P1/P2 (0.90-1.10) 12.9% (15) 23.8% (15) 0.0% (0) 
High P1/P2 (> 1.10) 70.7% (82) 58.7% (37) 84.9% (45) 
 
Furthermore, in table 27, patients group (n=116) was divided into two groups: The first group 
(smokers) 100% protamine abnormality was found. While 76.2% showed such abnormality in the 
second group (non-smokers).  
Table 28. Distribution of all participants’ non-smokers and smokers according to the P1/P2 ratios 
values 
Parameters All samples 
(n=166) 
Non smokers 
(n=94) 
Smokers 
(n=72) 
p-value 
Total P1/P2 1.18 ± 0.33 1.09 ± 0.18 1.30 ± 0.42 0.000 
Low P1/P2 (< 0.90) 15.1% (6) 13.8% (13) 16.7% (12)  
 
0.000 
Normal P1/P2 (0.90-1.10) 21.7% (36) 36.2% (34) 2.8% (2) 
High P1/P2 (> 1.10) 63.3% (105) 50.0% (47) 63.3% (58) 
 
The participants underwent in the present study divided into non-smokers (n=94) and smokers 
(n=72) (Table 28). A highly significant difference (p<0.010) was found by comparing the all non-
smokers groups with that of smokers. By analyzing the data the results were as follow: 97.4% of 
smokers showed protamine abnormality, besides, 63.8% of non-smokers were found to have 
abnormal protamination.  
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4-4-3-1- Relationship between P1/P2 ratios and seminal parameters 
4-4-3-1-1- All participants 
Table 29. Comparison of semen analysis parameters between all participant samples (n=166). 
According to the P1/P2 ratios distribution.  
Parameters Low P1/P2 
(< 0.90) 
1 
Normal P1/P2 
(0.90-1.10) 
2 
High P1/P2 
(> 1.10) 
3 
p-value 
Samples 25 37 104  
Age (year) 34.2 ± 8.1 31.2 ± 8.3 35.2 ± 7.4 0.049 2-3 
Volume (ml) 3.3 ± 1.7 3.6 ± 1.7 3.4 ± 1.6 0.658 
pH 8.7 ± 0.4 8.7 ± 0.3 8.7 ± 0.4 0.820 
Count  (mill/ml) 63.0 ± 32.4 73.1 ± 32.2 65.9 ± 30.6 0.406 
Motility  (% motile) 31.0 ± 16.3 35.8 ± 13.5 28.2 ± 12.5 0.027 2-3 
Sperm vitality (Eosin) (%) 38.8 ± 17.9 39.6 ± 15.7 37.0 ± 18.6 0.664 
Membrane integrity (HOS) (%)%  49.8 ± 21.4 52.0 ± 17.6 41.5 ± 20.0 0.192 
Leukocytes (%) 2.9 ± 3.6 2.5 ± 0.5 2.4 ± 0.6 0.347 
Chromatin condensation (positive  CMA3) (%)  30.5 ± 6.9 24.8 ± 7.9 31.7 ± 9.2 0.000 1-2,2-3 
DNA Fragmentation (positive TUNEL) (%)   14.7 ± 4.6 8.5 ± 4.1 13.8 ± 6.0 0.000 1-2,2-3 
Morphologically Normal spermatozoa (%) 33.4 ± 11.9 48.1 ± 13.0 31.7 ± 14.0 0.000 1-2,2-3 
Malondialdehyde (MDA) (μM) 7.17 ± 1.66 (n=14) 6.31 ± 1.26 (n=33) 7.76 ± 1.78 (n=66) 0.000 1-2,2-3 
Reactive oxygen species (ROS) (μmol/l) 87.05 ± 33.00 (n=14) 49.80 ± 26.10 (n=33) 106.96 ±52.87 (n=66) 0.000 1-2,2-3 
Cotinine (ng/ml) 36.11 ± 43.41 (n=14) 7.44 ± 23.34 (n=33) 60.30 ± 65.06 (n=66) 0.000 1-2,2-3 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 2.03 ± 1.63 (n=14) 0.70 ± 0.55 (n=33) 1.95 ± 1.57 (n=66) 0.000 1-2,2-3 
Protamine 1 (P1) (ng/106 sperm) 371.31 ± 75.73 373.14 ± 78.12 424.13 ± 110.94 0.009 1-3,2-3 
Protamine 2 (P2) (ng/106 sperm) 480.79 ± 91.55 370.55 ± 71.07 325.12 ± 95.72 0.000 1-2,1-3,2-3 
P1/P2 ratio 0.77 ± 0.07 1.01 ± 0.05 1.35 ± 0.30 0.000 1-2,1-3,2-3 
 
Table 29 illustrated the means ± standard deviations and the p-values of the semen and sperm 
parameters of the 166 semen samples. According to P1/P2 ratio groups, samples were divided into 
three group’s low, normal and high groups (section 4-4-3). A correlation between these parameters 
within the P1/P2 ratios was detected.  Motility showed significant difference (p<0.050) between the 
normal and high groups. Whereas, a significant differences (p<0.010) detected for sperm’s 
chromatin condensation, DNA fragmentation, morphologically normal sperm and P1 between 
normal group with low and high groups. Similarly, the seminal plasma parameters MDA, ROS, 
cotinine, and 8-OHdG showed significance differences (p<0.010) between normal with low and 
high groups. A significant differences (p<0.010) were found within all groups P2 and P1/P2 ratios. 
Figures 34 to 44 illustrated these correlation differences.  
Other parameters showed that: volume of the semen in low and high P1/P2 ratios was lower than 
that of normal P1/P2 ratio (34.2 ± 8.1, 3.4 ± 1.6 and 3.6 ± 1.7, for low, high and normal, p>0.050 
respectively). Sperm concentrations were reduced in low and high group compared to normal (63.0 
± 32.4. 65.9 ± 30.6, 73.1 ± 32.2, p>0.050 respectively). Sperm vitality was almost the same in the 
three groups while membrane integrity was higher in normal group participants (52.0 ± 17.6) than 
that low and high P1/P2 ratios (49.8 ± 21.4, 41.5 ± 20.0). These results revealed that participants 
with normal P1/P2 ratios (0.90-1.10) have sperm and seminal plasma parameters better than that of 
those within low (<0.90) and high (>1.10) P1/P2 ratios. These results indicated an inverse effect of 
abnormal protamination on sperm and semen parameters.  
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4-4-3-1-2- Smokers 
The comparison between means ± standard deviations for the sperm and semen parameters for all 
smokers (n=72, normal and patients smokers) within P1/P2 ratios showed that smokers with normal 
P1/P2 ratios have sperm’s vitality, membrane integrity and morphologically normal sperm higher 
than that of those with low and high ratios. Similarly, chromatin condensation and DNA integrity 
were higher in smokers with normal P1/P2 ratios. 
The concentrations of seminal plasma parameters MDA, ROS, and 8-OHdG of the smokers with 
normal P1/P2 ratios (7.40 ± 0.10, 101.63 ± 19.55, 1.81 ± 0.16 respectively) were lower than those 
with low P1/P2 ratios (8.11 ± 1.13, 105.59 ± 20.98, 2, 83 ± 1.70 respectively) and those with high 
P1/P2 ratios (8.66 ± 1.51, 132.92 ± 40.25, 2.67 ± 1.56 respectively). Whereas cotinine levels for 
normal, low and high ratios were (91.09 ± 49.27, 61.00 ± 23.47, 95.14 ± 59.86 respectively). These 
results showed a higher oxidative stress in samples of smokers with abnormal P1/P2 ratios, which 
reflect the negative effect of smoking on sperm and semen parameters. Moreover, protamines 
levels showed that P1, P2, and P1/P2 ratio for smokers with normal P1/P2 ratios were (304.76 ± 
5.37, 320.14 ± 10.31, 0.95 ± 0.01), while that for those with low P1/P2 ratios showed an increase in 
P1 levels (343.50 ± 50.80) and P2 levels (462.02 ± 76.13) and low P1/P2 ratio (0.75 ± 0.07). 
Smokers with high P1/P2 ratios results were (425.61 ± 117.97, 310.71 ± 101.44, 1.43 ± 0.73) 
respectively. These protamine results showed that smokers with low ratio have higher P2 level than 
those with normal ratio, whereas higher P1 level and lower P2 level observed in smokers with high 
level. These results indicated an over expression of P1 and under expression of P2 within the 
abnormal ratios groups. 
Protamines evaluation in volunteers smoker’s showed that those with low P1/P2 ratios have similar 
P1 (304.32 ± 51.14) level, higher P2 level (398.69 ± 63.49) and lower P1/P2 ratio (0.76 ± 0.02) in 
comparison to those with normal P1/P2 ratios (304.76 ± 5.37, 320.14 ± 10.31, 0.95 ± 0.01). On the 
contrary, volunteers smokers with high P1/P2 ratios showed a higher P1 level (437.72 ± 130.54), 
similar P2 level (322.16 ± 98.10), and higher ratio (1.36 ± 0.10). These findings revealed that over 
expression of P2 and P1 are responsible for the protamination abnormality (low and high P1/P2 
ratio).   
Furthermore, none of the patient’s smokers showed normal P1/P2 ratio. Smokers with Low P1/P2 
ratios P1, P2, and P1/P2 ratio was (363.04 ± 40.23, 493.68 ± 62.78, 0.74 ± 0.09) and those with 
high P1/P2 ratios was (422.11 ± 115.43, 307.39 ± 103.23, 1.45 ± 0.42). Over production of P2 and 
P1 were indicated in patients’ smokers with low and high P1/P2 ratios respectively. 
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Figure 34. Box-plots showing the mean, median, and range of the sperm motility compared 
between the P1/P2 ratios groups (low, normal, and high) for all participant samples. A significant 
difference was found between normal and high groups of P1/P2 ratios (35.8 ± 13.5, 28.2 ± 12.5, 
p<0.050). 
 
 
Figure 35. Box-plots showing the mean, median, and range of the mean percentage of chromatin 
condensation (positive CMA3) compared between the P1/P2 ratios groups (low, normal, and high) 
for all participant samples. A significant differences between normal with low and high groups of 
P1/P2 ratios were found (24.8 ± 7.9, 30.5 ± 6.9, 31.7 ± 9.2, p<0.010). 
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Figure 36. Box-plots showing the mean, median, and range of the mean percentages of DNA 
fragmentation compared between the P1/P2 ratios groups (low, normal, and high) for all participant 
samples. A significant differences between normal with low and high groups of P1/P2 ratios (8.5 ± 
4.1, 14.7 ± 4.6, 13.8 ± 6.0, p<0.010) were observed. 
 
 
Figure 37. Box-plots showing the mean, median, and range percentages of the morphologically 
normal spermatozoa compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between normal with low and high groups of P1/P2 
ratios were observed (48.1 ± 13.0, 33.4 ± 11.9, 31.7 ± 14.0, p<0.010). 
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Figure 38. Box-plots showing the mean, median, and range of the ROS (μmol/l) concentrations in 
seminal plasma compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between normal with low and high groups of P1/P2 
ratios were observed (49.80 ± 26.10, 87.05 ± 33.00, 106.96 ±52.87, p<0.010). 
 
 
Figure 39. Box-plots showing the mean, median, and range of the 8-OHdG (ng/ml) concentrations 
in seminal plasma compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between normal with low and high groups of P1/P2 
ratios were observed (0.70 ± 0.55, 2.03 ± 1.63, 1.95 ± 1.57, p<0.010). 
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Figure 40. Box-plots showing the mean, median, and range of the Cotinine (ng/ml) concentrations 
in seminal plasma compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between normal with low and high groups of P1/P2 
ratios were found (7.44 ± 23.34, 36.11 ± 43.41, 60.30 ± 65.06, p<0.010). 
 
 
 
Figure 41. Box-plots showing the mean, median, and range of the MDA (μM) concentrations in 
seminal plasma compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between normal with low and high groups of P1/P2 
ratios were detected (6.31 ± 1.26, 7.17 ± 1.66, 7.76 ± 1.78, p<0.010). 
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Figure 42. Box-plots showing the mean, median, and range of the P1 (ng/106 sperm) 
concentrations of sperm compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant difference between normal and high groups of P1/P2 ratios was 
found (373.14 ± 78.12, 424.13 ± 110.94, p<0.010). 
 
 
Figure 43. Box-plots showing the mean, median, and range of the P2 (ng/106 sperm) 
concentrations of sperm compared between the P1/P2 ratios groups (low, normal, and high) for all 
participant samples. A significant differences between the three groups of P1/P2 ratios were found 
(370.55 ± 71.07, 480.79 ± 91.55, 325.12 ± 95.72, p<0.010). 
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Figure 44. Box-plots showing the mean, median, and range of the P1/P2 ratios compared between 
the P1/P2 ratios groups (low, normal, and high) for all participant samples. A significant difference 
between the three groups of P1/P2 ratios were found (0.77 ± 0.07, 1.01 ± 0.05, 325.12 ± 95.72, 
p<0.010). 
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4-5- Clinical Data 
27 women with average age 35.2 ± 4.4 years underwent ICSI therapy. The mean numbers of 
retrieved, fertilized, and transferred oocytes were 8.0 ± 4.4, 4.6 ± 3.9, and 2.2 ± 0.8 respectively. 
The rate of fertilization was 57.4 ± 26.9 %, the rate of pregnancy per embryo was 10.34 % (no. of 
pregnancies divided by no. of transferred embryos, 6/58), and the ongoing pregnancy rate was 
22.22%.  
Table 30. Correlation coefficient of semen and sperm parameters of all participant samples with 
fertilization rate and pregnancy of women underwent ICSI (n=27)  
 
Fe
rti
liz
at
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n 
(%
)  
Pr
eg
na
nc
y 
Volume (ml) r = 0.063 0.295 p = 0.754 0.135 
pH r = 0.113 0.298 p = 0.573 0.131 
Count (mill/ml) r = 0.509
** -0.300 
p = 0.007 0.128 
Motility (% motile) r = 0.275 0.275 p = 0.165 0.165 
Sperm vitality (Eosin) (%) r = 0.267 0.110 p = 0.178 0.586 
Membrane integrity (HOS) (%) r = 0.140 0.191 p = 0.488 0.340 
Leukocytes % r = 0.292 0.000 p = 0.139 1.000 
Chromatin condensation (positive  CMA3) (%) 
r = -0.450* 0.160 
p = 0.019 0.425 
DNA Fragmentation (positive TUNEL) (%)   r = 0.055 0.080 
p = 0.784 0.691 
Morphologically Normal spermatozoa (%) r = -0.044 -0.084 
p = 0.892 0.796 
Malondialdehyde (MDA) (μM) 
  (N=12) 
r = -0.234 0.168 
p = 0.464 0.603 
Reactive oxygen species (ROS) (μmol/l  
(N=12) 
r = -0.208 0.000 
p = 0.516 1.000 
Cotinine (ng/ml)   
 (N=12) 
r = -0.138 -0.028 
p = 0.669 0.931 
8-hydroxy-2-deoxyguanisine (8-OH-dG) (ng/ml) 
(N=12) 
r = -0.164 -0.038 
p = 0.413 0.911 
Protamine 1 
(ng/ 106 sperm) 
r = -0.154 0.194 
p = 0.433 0.331 
Protamine 2  
(ng/ 106 sperm) 
r = -0.231 -0.092 
p = 0.246 0.650 
P1/P2 Ratios 
 
r = 0.128 0.172 
p = 0.526 0.392 
Fertilization rate (%) 
 
r = 1.000 -0.241 
p = . 0.225 
Pregnancy rate r = -0.241 1.000 
p = 0.225 . 
 
Table 30 illustrated the correlation coefficients of the fertilization rates (%) and pregnancy rates of 
the women underwent ICSI with male sperm and semen parameters. Fertilization rates showed a 
highly positive correlations with the concentration of sperms (r=0.509, p<0.010, Fig. 45), and 
negative significant correlation with non-condensed chromatin (r=-0.450, p<0.050, Fig. 46). A non-
significant negative (p>0.050) correlations were observed with morphologically normal sperm, 
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oxidative biomarkers (MDA, ROS, 8-OHdG), cotinine P1, and P2. On the contrary, a positive 
correlations were detected with other parameters. Meanwhile, pregnancy rates showed negative but 
non-significant correlations with morphologically normal sperm, cotinine and 8-OHdG, whereas, 
positive but also non-significant correlations observed with other sperm and semen parameters.    
 
   
 
Figure 45: Scatter plot of correlation between the concentrations of sperms (mill. /ml) and the 
oocytes fertilization rate (%). A significant positive correlation was found (r=0.509, p<0.010). 
 
 
Figure 46: Scatter plot of correlation between mean percentage of sperm chromatin condensation 
(CMA3) and the oocytes fertilization rate (%). A significant negative correlation was found (r=-
0.450, p<0.010). 
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Negative
 
Figure 47: Fluorescence assay of sperm chromatin condensation using Chromomycin A3 (CMA3). 
                   Condensed sperm chromatin showed dull green (good sperm) and Non-condensed 
sperm  
                   chromatin showed bright green (bad sperm).  
Negative
Positive
 
 
Figure 48: Fluorescence assay of sperm DNA fragmentation using TUNEL. 
      Sperms with fragmented DNA showed bright green and Sperms with non-fragmented 
DNA  
                  Showed dull green.  
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5-Discussion 
Male-factor infertility accounts for up to half of all cases of infertility (Moriss et al., 2002) and 
affects one in twenty in the general population (McLachlan and de Kretser, 2001). Accumulating 
evidence now suggesting that reactive oxygen species (ROS) mediated damage to sperm is 
significantly contributing pathology in 30-80% of cases (Iwasaki and Gagnon, 1992; Shekarriz et 
al., 1995; Agarwal et al., 2006). Jones et al., (1979) reported that ROS –induced peroxidation of 
sperm membrane decreases its flexibility and therefore tail motion. Besides direct ROS damage to 
mitochondrial, decreasing energy availability may impede sperm motility (de Laminarde et al., 
1994) resulting in less sperm reaching the oocytes for fertilization (Whittington et al., 1999; Kao et 
al., 2008). 
Evaluation of male-factor infertility is becoming more important and informative as new diagnostic 
techniques and therapeutic options become available (Kao et al., 2008). DNA damage may result 
from aberrant chromatin packaging during spermiogenesis (Zini and Libman, 2006), defective 
apoptosis before ejaculation (Moustafa et al., 2004) or excessive production of ROS in the ejaculate 
(Aitken and Krausz, 2001). In addition, extra testicular factors such as age (Schmid et al., 2007), 
drugs (Stahl et al., 2006), cigarette smoking (Gaur et al., 2007), genital tract inflammation (Ozmen 
et al., 2007), hormonal factors (Ozmen et al., 2007), varicocele and testicular hyperthermia (Naser-
Esfahani et al., 2009) may be reasons for DNA damage. 
In addition ROS have the ability to directly damage sperm DNA by attacking the purine and 
pyrimidine bases and the deoxyribose backbone. Infertile men often exhibit deficit protamination, 
leaving the sperm DNA particularly vulnerable to ROS attack (Oliva, 2006). 
Several investigators (reviewed by Tremellen et al., 2008) have now found a link between 
oxidative stress and sperm DNA damage using various techniques such as sperm chromatin 
structure assay (SCSA), terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling 
(TUNEL) and 8-hydroxydeoyguanosine  (8-OHdG). Smoking results in a 48% increase in seminal 
plasma leukocytes concentration and a 107% increase in seminal ROS levels (Saleh et al., 2002a), 
and decreasing seminal plasma antioxidants (Fraga et al., 1996; Mostafa et al., 2006), placing their 
sperm at additional risk of oxidative damage. In the present study, the link between smoking and 
oxidative stress and their effect on DNA strand breaks, DNA protamination, and other sperm 
parameters were analyzed. In addition, the consequences of these parameters on the ICSI results 
were investigated. 
5-1- Sperm DNA Integrity and Semen Parameters (CMA3 and TUNEL) 
While male infertility has been traditionally evaluated by sperm density, motility and morphology, 
sperm DNA quality has been recognized as one of the most important determinants of male 
reproductive potential (Lewis and Aitken, 2005; Ozmen et al., 2007; Tarozzi et al., 2007). The 
analysis of sperm DNA integrity is being used with increasing frequency as independent 
parameters of semen quality as it offers more accurate diagnostic and prognostic information than 
the traditional parameters of semen evaluation. There is now some evidence to suggest that markers 
of sperm DNA integrity may help differentiate fertile from infertile men, but the clinical value of 
sperm DNA integrity testing remains to be defined (Spano et al., 2000; Zini et al., 2001). Different 
studies reported either weak or no correlation between conventional semen parameters and sperm 
DNA damage. Other studies reported that spermatozoa from patients with abnormal sperm count, 
morphology and motility showed an increase of DNA damage (Erenpreiss et al., 2006). A 
substantial number of researchers have reported a negative relationship between the degree of DNA 
damage and the fertilization rate, embryo cleavage rate, implantation rate, pregnancy rate, and live 
birth of rate of offspring (Host et al., 2000a; Morris et al., 2002; Benchaib et al., 2003; Agarwal 
and Allamaneini, 2004; Agarwal et al., 2005). Recently a meta-study carried by Evenson and 
Wixon, 2008 have now confirm the link between sperm DNA damage and failure to achieve natural 
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conception. However, a few researchers showed no correlations between sperm DNA damage 
and pregnancy (Gandini et al., 2004; Huang et al., 2005). 
The spermatozoa of subfertile males revealed  structural changes in their DNA organization such as 
epigenetic alterations, single or double DNA strand breaks, wrong number of chromosomes and/or 
chromosome Y microdeletions (reviewed by Seli and Sakkas, 2005).   
In particular, abnormalities in protamination make the sperm DNA susceptible to DNA damage 
especially by oxidative stress (Ozmen et al., 2007). Evidence has been presented suggesting that 
defects in protamination may therefore be a cause of sperm DNA damage (Naser-Esfahani et al., 
2005; Aoki et al., 2006b; Torregrosa et al., 2006; Carrell et al., 2007; Tarrozi., et al., 2009). Both 
sperm DNA damage and protamine deficiency are related to infertility (reviewed by Oliva, 2006).  
However, DNA damage occurred under the effect of endogenous or exogenous factors. During late 
spermiogenesis, DNA nicks and ligations are induced by the topoisomerase II (topo II) in order to 
facilitate protamination (McPherson and Longo, 1993a, b). Marcon and Boissoneault (2004) have 
suggested that DNA damage may be the result of incorrect repair of transient DNA nicks that are 
introduced during spermiogenesis (the nicks are introduced to relieve the torsional strain on the 
DNA helix during the exchange of histones to protamines). A second mechanism proposed for 
DNA damage is DNA nicks through apoptosis (Gorczyca et al., 1993). 
Protamine deficiency occurred during late stages of spermiogenesis may decrease the fertilization 
rate (Manicardi et al., 1995). Histone-protamine exchange is a late spermiogenesis event, along 
with acrosome formation, membrane remodeling and other significant morphological and 
biochemical events that are necessary for normal sperm function (Nasr-Esfahani et al., 2004a). 
Premature chromosomal condensation in spermatozoa, induced by protamine deficiency may be 
another cause for decreased fertilization rate in protamine-deficient spermatozoa after ICSI. The 
percentage of premature chromosomal condensation has been reported to be higher in semen 
samples with high CMA3 positivity compared to those with low CMA3 positivity (Nasr-Esfahani et 
al., 2004b). Moreover, around 60% of the variations in DNA damage can be accounted for by the 
quality of protamination as measured by chromomycin CMA3 (Aitken, 2007)  
Evaluation of protamine deficiency by chromomycin A3 (CMA3), and evaluating of DNA 
fragmentation by TUNEL had been applied to configure the relationship between protamine and 
DNA integrity. A correlation between under-expression of protamines, DNA damage and lack of 
viability was detected using many techniques (TUNEL assay, CMA3 and Aniline Blue staining 
assays) (Manicardi et al., 1995; Hammadeh et al., 2001; Aoki et al., 2006b). 
Moreover, abnormal sperm chromatin packaging evaluated
 
by CMA3 staining has been correlated 
with the presence of DNA damage, decreased
 
sperm penetration, the absence of sperm 
decondensation within
 
the oocyte and IVF and ICSI failure (Esterhuizen et al.,
 
2002; Razavi et al., 
2003). It also reported that a sperm DNA fragmentation index (DFI) (predictive threshold of 27 %, 
detected by SCSA), is necessary to obtain a successful pregnancy both by IVF and ICSI (Larson et 
al., 2000; Larson-Cook et al., 2003).
 
 
In the current study, significant differences were found between the normal volunteers and patients 
samples regarding the non-condensed chromatin (23.3 ± 7.0 vs. 32.9 ± 8.2, p<0.010), and DNA 
damage (9.6 ± 5.4 vs. 14.2 ± 5.6, p<0.010). Besides, abnormal protamination evaluated by 
chromatin condensation test for all participant samples showed significant negative correlations 
(p<0.010) with sperm concentration, motility, vitality, membrane integrity and morphology (Fig. 9, 
Table 10a). Moreover a significant positive correlation was observed between non-condensed 
chromatin (CMA3–assay) and sperm DNA fragmentation, as assessed by TUNEL assay (p< 0.010, 
Fig. 8). There was also a negative correlation between TUNEL and other sperm parameters; 
motility, vitality, membrane integrity, and morphologically normal sperm, and sperm concentration 
(Table 10a).  
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In volunteers samples (Table 12a), chromatin condensation was negatively correlated with 
sperm concentrations (r=-0.138, p>0.050), sperm motility (r=-0.563, p<0.010), morphologically 
normal sperm (r=-0.469, p<0.010, Fig 21), sperm vitality (r=-0.272, p<0.050) and membrane 
integrity (r=-0.314, p<0.050). Besides, DNA fragmentation was correlated negatively with sperm 
concentration and vitality (r=-.011; r=-0.147, p>0.050), and showed significantly negative 
correlation with membrane integrity (r=-0.289, p<0.050), sperm motility (r=-0.514, p<0.010) and 
morphologically normal sperm (r=-0.560, p<0.010). Figure (20) showed significantly positive 
correlation between non-condensed chromatin and DNA fragmentation (r=598, p<0.010). 
Similarly, patients samples analysis (Table 13a) of both chromatin condensation (CMA3) and DNA 
fragmentation (Tunel) showed significantly negative correlations with other sperm parameters; 
concentration, vitality, motility, membrane integrity and morphologically normal sperm. Whereas, 
non-condensed chromatin was significantly positive with DNA fragmentation (r=213, p<0.050). 
Results in this study are in accordance with that of Tarrozi et al., (2009), who found significant 
negative correlations (p<0.050) between CMA3 positivity and sperm concentration, motility, and 
morphology. They showed a significant positive correlation between CMA3 positivity and sperm 
DNA fragmentation. The present data are in accordance with results of other previous studies 
analyzing the relationship between abnormal protamination and traditional sperm parameters 
(Carrell and Liu, 2001; Mengual et al., 2003; Aoki et al., 2005a; Torregrosa et al., 2006; Borini et 
al., 2006; Tarrozi., et al., 2009), and between under-protamination and sperm DNA fragmentation 
(Manicardi et al., 1995; Aoki et al., 2005b, 2006b; Torregrosa et al., 2006; Tarrozi., et al., 2009). 
However, a connection between abnormal protamination and diminished semen quality parameters 
is reasonable depending on whether the regulation of protamine exchange is linked to a broader 
control of spermatogenesis (Carrell et al., 2007). Two main hypotheses had been discussed by 
Carrell and colleagues about this topic: (i) protamines may act as a ‘checkpoint’ during 
spermatogenesis, and abnormal protamine expression leads to an increased level of apoptosis that 
results in diminished semen quality; or (ii) abnormal protamine expression may be indicative of a 
general alteration of spermatogenesis, possibly due to an abnormal function of a transcriptional or 
translational regulator. The strong link between abnormal protamination and sperm DNA 
fragmentation can also account for the important function of protamines in the protection of the 
paternal genome from chemical and physical damage, conferring a high level of compactness to the 
sperm nucleus (Barone et al., 1994; Braun, 2001); so a potential consequence of under-
protamination may be the greater susceptibility to DNA damage. 
Moreover, this study demonstrated that chromatin condensation (CMA3 positivity) showed 
significantly negative correlation with fertilization rates (p<0.050, Fig. 46). Therefore, the influence 
of sperm protamine abnormality seems to be a good prognostic tool for predicting ICSI 
fertilization. The concentrations of P1, and P2 (Table 21) also showed negative correlation but were 
non-significant with the fertilization rate. This result indicates that abnormal protamination effects 
on assisted reproduction outcomes are related to the effect of protamines on spermiogenesis. Carrell 
et al., also postulated that the selection of morphologically normal sperm for treatment decreases 
the risk of using a sperm with less condense chromatin (Carrell et al., 2007). However, these results 
are related to that of previous studies using the same kind of protamine detection (Carrell and Liu, 
2001; Aoki et al., 2005b). 
The recommended values of sperm DNA fragmentation to discriminate between good and poor 
prognosis patients show a high degree of variability (reviewed in Tesarik et al., 2006). The data of 
sperm DNA fragmentation assay (TUNEL) correlated with fertilization rate and pregnancy rate. 
This finding indicated that DNA fragmentation test is not a prognostic tool for predicting ICSI 
fertilization, which may be due to the low number of cases. This result is in conflict with some 
published data (Saleh et al., 2003a; Boe-Hansen et al., 2006; Evenson and Wixon, 2006a), but 
agreed with others who found no relationship between DNA fragmentation and reproductive 
outcome in either IVF or ICSI patients (Gandini et al., 2004; Huang et al., 2005). Also similar are 
the results of Borini et al. (2006), and Tarrozi., et al, (2009), who found that a DNA fragmentation 
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test is not a prognostic tool for IVF outcome. To overcome these conflicted findings, it is 
important to consider the following factors; the techniques used applied for DNA fragmentation 
tests (SCSA, TUNEL, comet assay, or in-situ nick translation), the testing models applied 
(microscopy or flow cytometry), type of samples (treated or raw samples), or others. For example; 
the predictive value of DNA damage test decreases when applying the test after treating the cell by 
density gradient centrifugation (Sakkas et al., 2000; Tomlinson et al., 2001; O’Connell et al., 2003; 
Seli and Sakkas, 2005). The effect of DNA damage on the reproductive outcomes affected by other 
variables like the status of both male and female (maternal age, presence of pathological conditions, 
ability of the oocytes to repair the sperm DNA damage, which is related to maternal age) (Menezo, 
2006). The small but statistically significant association between sperm DNA integrity test results 
and pregnancy in IVF and ICSI cycles is not strong enough to provide a clinical indication for 
routine use of these tests in infertility evaluation of men. It is possible that yet to be determined 
subgroups of infertile couples may benefit from sperm DNA integrity testing (Collins et al., 2008).    
Sperm DNA fragmentation is affected by many factors; it may be a result of oxidative stress 
resulted from high concentration of reactive oxygen species produced by the sperm mitochondria, 
leukocytes and or others. Abortive apoptosis also may affect (Aitken and De Iuliis, 2007).   
5-2-Oxidative stress 
Reactive oxygen species (ROS) are produced by the defective spermatozoa, sperm mitochondria 
and leukocytes that protect against pathogenic germs (Vernet et al., 2001; Zini and Libman, 2006). 
Other ROS-generating systems are the enzymes nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase (NOX5) that is potentially capable of generating ROS in the presence of calcium 
and NADPH (Aitken et al., 1997; Banfi et al., 2001), lipoxygenase (Oliw and Sprecher, 1989), 
tumor-associated cell surface NADH oxidase (tNOX) (Morré and Morré, 2003) and cytochrome 
P450 reductase (Baker et al., 2004).  
Recently, the over-production of ROS in the male reproductive tract has become a real concern. 
Oxidative stress is resulted from an imbalance between the productions of ROS and the antioxidant 
capacity (Sharma and Agarwal, 1996). Oxidative damage to spermatozoa, induced by excessive 
production of free oxidants or impairment of the native antioxidant mechanisms, has been 
identified as a parameter of male subfertility (Sikka et al., 1995). Many studies showed that 
oxidative stress appears to be the major cause of DNA damage in the male germ line (Saleh et al., 
2003a; Aitken et al., 2003a). However, physiological levels of ROS are necessary for protein 
activities and for sperm proliferation, differentiation and function (Gagnon et al., 1991; Aitken, 
1999). H2O2 and .O2‾ promote sperm capacitation and acrosome reaction, as well as hyperactivation 
and oocyte fusion (de Lamirande and Gagnon, 1995; Zini et al., 1996). Besides, hydrogen peroxide 
and superoxide anion are necessary for controlling the tyrosine phosphorylation events, which is 
important for sperm capacitation (Aitken et al., 1991; Aitken et al., 1998a). 
A strong positive correlation exists between immature spermatozoa and ROS production, which in 
turn negatively affects the sperm quality (Said et al., 2004). The excessive production of ROS that 
exceeds critical levels can overwhelm all the antioxidant defense systems of spermatozoa and 
seminal plasma causing oxidative stress (de Lamirande et al., 1997).  
In addition, ROS generation by defective spermatozoa can be increased by the removal of seminal 
plasma, which has endogenous antioxidant mechanisms during sperm preparation for ART. 
Centrifugation of sperm during preparation also plays a role in rapid production of ROS (Gagnon et 
al., 1991) and may enhance the generation of ROS 2-5 fold above baseline, within 5 minutes, 
which can damage sperm membrane and DNA. Oxidative stress has also been correlated with high 
frequencies of single and double DNA strand breaks (Twigg et al., 1998a: b; Aitken and Krausz, 
2001). Sperm are particularly susceptible to oxidative stress due to
 
the high content of unsaturated 
fatty acids in their membranes,
 
as well as their limited stores of antioxidant enzymes (Bakera and 
Aitken, 2005).  
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Tight DNA packaging and high levels of antioxidants present in seminal plasma protects the 
sperm from oxidative stress (Twigg et al., 1998b). Infertile men with poor sperm
 
motility and 
morphology have increased DNA fragmentation compared
 
with individuals with normal semen 
parameters (Lopes et al., 1998; Irvine et al., 2000; Zini et al., 2001). Oxidative stress is suggested 
as the main factor responsible for DNA damage in ejaculated sperm (Sakkas et al., 1999b; Greco et 
al., 2005; Evenson and Wixon, 2006a). Sperm DNA damage has been associated with high levels 
of ROS (approximately 25% of infertile men have high levels of semen ROS (Zini et al., 1993; 
Irvine et al., 2000). 
5-2-1- Oxidative Stress and Semen Parameters 
ROS are related to poor sperm parameters. Head of the sperm is rich in polyunsaturated fatty acids 
that make up approximately 40 % of the lipids in the sperm head, which are important for 
membrane fluidity, sperm motility, capacitation, and sperm binding to the egg zona pellucida. 
These polyunsaturated fatty acids are extremely susceptible to oxidative damage. Lipid 
peroxidation under the effect of high ROS concentrations will impair the motility of the sperm 
(Armstrong et al., 1999).  
Negative correlations were shown between ROS concentration in seminal plasma and sperm 
vitality, membrane integrity, sperm density, chromatin condensation, and DNA single stand breaks 
in both IVF and ICSI groups (Hammadeh et al., 2008a). Furthermore, it has been shown that ROS 
can damage DNA by causing deletions, mutations, and other lethal genetic effects (Tominga et al., 
2004). Damage of the sperm DNA by free radicals induces activation of the poly (ADP ribose) 
synthetase enzyme. This splits NAD+ to aid the repair of DNA. Depletion of the NAD+ 
concentration will disrupt the function of the cells and cause cell death. The relative proportion of 
ROS–producing immature sperm was directly correlated with nuclear DNA damage value in 
mature sperm and inversely correlated with recovery of motile, mature sperm (Aitken et al., 
1998b). 
The data from this study showed significant differences between the sperm parameters of normal 
volunteers and patients (Table 11). A sperm’s concentrations (80.2 ± 27.5 vs. 61.4 ± 31.1, 
p<0.010), motility (37.1 ± 14.7% vs. 27.4 ± 12.0%, p<0.010), semen volume (3.9 ± 1.4 vs. 3.2 ± 
1.7, p<0.010), sperm vitality (Eosin) (45.2 ± 16.9% vs. 34.7 ± 17.3%, p<0.010), sperm membrane 
integrity (HOS) (53.4 ± 15.8% vs. 45.1 ± 20.8%, p<0.010), the non-condensed chromatin (23.3 ± 
7.0% vs. 32.9 ± 8.2%, p<0.010), DNA damage (9.6 ± 5.4% vs. 14.2 ± 5.6%, p<0.010), and 
morphologically normal sperm (45.9 ± 13.9% vs. 29.4 ± 12.7%, p<0.010). Furthermore, the 
seminal plasma concentrations of oxidative biomarkers MDA, ROS, Cotinine, and 8-OHdG of 
patients were higher than normal volunteers; MDA (6.45 ± 1.43 vs. 7.82 ± 1.79, p<0.010), ROS 
(67.6 ± 42.2 vs. 103.85 ± 5.68, p<0.010), cotinine (27.30 ± 40.17 vs. 53.42 ± 67.33, p<0.050), and 
8-OHdG (1.15 ± 0.82 vs. 1.95 ± 1.75, p<0.050). 
For both groups (volunteers and patients) (Table 10c) concentrations of oxidative biomarkers 
MDA, ROS, and 8-OHdG in seminal plasma showed significantly negative correlations (p<0.010) 
with sperm motility (r=-0.513, r=-0.537, r=-0.532), vitality (r=-0.309, r=-0. 298, r=-0.373), 
membrane integrity (r= -0.362, r= -0.343, r=-0.335), and morphologically normal sperm (r=-0.514, 
r=-0.547, r=-0.513). In contrast, concentrations of MDA, ROS, and 8-OHdG in seminal plasma 
showed significant positive correlations (p<0.010) with non-condensed chromatin (r=0.555, 0.629, 
and 0.545, respectively), and sperm DNA fragmentation (r=0.624, r=0.630, r=0.600, respectively).   
The data of normal volunteers group (Table 12c) demonstrated that the mean percentage value of 
sperm motility showed significantly negative correlation (p<0.010) with seminal plasma 
concentrations of MDA (r=-0.580), ROS (r=-0.632), and 8-OHdG (r=-667). A significant negative 
correlation was found between 8-OHdG with sperm vitality (r=-0.283, p<0.050), and sperm 
membrane integrity (r=-0.303, p<0.050). A low significance correlation noticed between sperm 
vitality and ROS (r=-0.248, p=0.083). Whereas, positive correlations (p<0.010) were found 
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between the MDA, ROS, and 8-OHdG with non-chromatin condensation (r=0.527, 0.636, 0.588 
respectively) and with DNA fragmentation (r=0.536, 0.577, and 0.694 respectively).  
In the patients groups (Table 13c), the motility of the sperm was significantly decreased as the 
concentration of oxidative biomarkers MDA, ROS and 8-OHdG increase. An inverse significant 
correlation was found between sperm vitality and concentration of 8-OH-dG (p<0.050). Also, 
sperm membrane integrity significantly decreased (p<0.010) as concentration of MDA, ROS, and 
8-OHdG increased. Whereas, significant positive correlations (p<0.010) were found between 
MDA, ROS, and 8-OHdG concentrations with non-condensed chromatin and DNA fragmentation.  
Our study showed similarities with that conducted by Moein et al., (2007). They showed that the 
level of ROS in seminal fluid of infertile men was significantly higher than fertile donors. 
These results are in agreement with that of Hammadeh et al., (2006), who studied the effect of ROS 
on seminal plasma and sperm parameters of male partners of patients who underwent IVF/ICSI 
therapy. They found that increase ROS concentration in seminal plasma correlated negatively with 
sperm vitality, morphology, DNA fragmentation, and sperm concentrations. Moreover, from the 
same group, they demonstrated a negative correlation between ROS concentration in seminal 
plasma and sperm vitality, membrane integrity, sperm density, chromatin condensation, and DNA 
single stand breaks in both IVF and ICSI groups (Hammadeh et al., 2008a). Many other studies 
reported a correlation between sperm concentration and increased production of ROS in patients 
(Henkel and Schill, 1998). Also, these results are in accordance with those (Zorn et al., 2003, Aziz 
et al., 2004) who found that ROS concentration in seminal fluid was negatively correlated with 
progressive motility, and normal morphology.  
It was reported that overproduction of ROS in semen of infertile males may cause abnormal and 
immature spermatozoal morphology, motility and concentration (Gyun and Edward et al., 2006). 
Moreover, a negative correlation was found between levels of ROS production in semen and 
percentage of normal spermatozoa form (Ollero et al., 2001). ROS causes a decrease in sperm 
motility as a result of lipid peroxidation and loss of membrane PUFA particularly docosahexanoic 
acid (Connor et al., 1998). Lipid peroxidation plays a significant role in disrupting sperm functions 
and semen quality especially sperm motility and morphology and may account for some cases of 
male infertility. 
Overproduction of ROS in semen, mainly by leukocytes and abnormal spermatozoa, especially 
high concentrations of hydrogen peroxide that induced lipid peroxidation and result in cell death 
could be a cause for infertility (de Lamirande and Gagnon, 1995). Also, increased ROS production 
by spermatozoa is associated with a decreased mitochondrial membrane potential (MMP). The 
patients with abnormal semen parameters had a significantly lower MMP (Wang et al., 2003). The 
same group also indicated that oxidative stress is associated with increased apoptosis leading to 
spermatozoa DNA damage in patients with male-factor infertility. High levels of cytochrome c, and 
caspases 9 and 3, had been detected in those patients. 
The results related to lipid peroxidation (MDA) induced by ROS are in agreement with many 
previous studies (Geva et al. 1996; Fraczek et al. 2001). The same compatible results with that of 
Hsieh et al., et al., (2006) showed that seminal MDA concentrations were negatively correlated 
with sperm concentration and motility, and might provide a simple and useful tool in predicting 
sperm parameters. In addition, Nabil et al., (2008), found that ROS-induced lipid peroxidation 
induces significant sperm membrane damage and markedly influences sperm motility and 
morphology, and may account for male infertility.  
These findings suggested that the lipid peroxidation effect (MDA activity), might compromise the 
sperm viability. So, increased MDA level might represent the pathologic lipid peroxidation of 
spermatozoa membrane and the following inhibition of sperm motility and viability (Hsieh et al., 
2006). 
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In addition, 8-OHdG concentration effects on semen and sperm parameters in our data are in 
convenience with that of Kao et al., (2008) who found a significantly higher levels of 8-OHdG in 
spermatozoa with poor motility and with asthenozoospermia and oligospermia. Besides, a 
significant negative correlation was found between sperm motility and 8-OHdG. 
Oxidized deoxynucleoside, 8-OHdG, in human sperm DNA had been detected as a biomarker of 
oxidative modification (Loft et al., 2003). If not repaired, 8-OHdG modifications in DNA are 
mutagenic and may cause embryonic loss, malformations, or childhood cancers (Aitken and Baker, 
2006). The mutagenic potential of 8-OHdG is reflected in its miscoding properties. Oxidative 
attack on dGTP creates 8-OHdGTP. This damaged 8-OHdGTP is incorporated at sites opposite to 
A, giving rise to A:T/G:C transversions (Loft et al., 2003; Nakabeppu et al., 2006 )   
In this study the oxidative stress biomarkers (MDA, ROS, and 8-OHdG) and fertilization rate 
showed a negative correlation (r=-0.234, r=-0.208, r=-0.164 respectively, p>0.050). These results 
indicated that oxidative stress inversely affects the quality of sperm that may affect the 
(concentration, motility, morphology, and DNA integrity), (discussed above) and hence its 
fertilization capacity, which in turn may lead to decrease pregnancy rate.  
5-3- Smoking and infertility 
Cigarette smoking become a serious health and social problem, and also presents challenging for 
the physicians. Smoking has been established as a number one preventable cause of death and 
diseases in the world (Zavos et al., 1998). Cigarette smoke contains a large number of hazardous 
substances, including nicotine, carbon monoxide and recognized carcinogens and mutagens such as 
radioactive polonium, benzopyrene, dimethylbenzanthracene, dimethylnitrosamine, naphthalene 
and methanphthalene (Zavos et al., 1998; Wong et al., 2000). These substances may be found in 
seminal plasma of smokers via various modes of diffusion and active transport (Zavos et al., 1998). 
Therefore, smoking negatively affects male fertility, but this relationship remains controversial.  
Despite the high prevalence of cigarette smoking in the general population, our knowledge of its 
impact on male reproductive function is still very limited. In a meta-analysis, smoking was only 
found to have an adverse effect on sperm concentration and motility in healthy volunteers and 
sperm donors, but not in infertility patients (Vine et al., 1994). Vine, (1996) suggested that the 
effects of cigarette smoking on sperm parameters would be more important in the general 
population than in infertile patients.  
Moreover, some studies found that tobacco adversely affects sperm quality in variables such as 
concentration, motility and normal morphology (Handelsman et al., 1984; Sofikitis et al., 1995; 
Mak et al., 2000). Other studies with many samples found no relationship between cigarette 
smoking and sperm quality, although they were conducted on men with fertility problems (Dikshit 
et al., 1987; Trummer et al., 2002). Several studies have observed that cigarette smoking has an 
effect on the semen quality, especially in those who are heavy smokers or who have been smoking 
for many years (Zahng et al., 2000; Kunzle et al., 2003). 
5-3-1- Smoking and oxidative damage 
5-3-1-1- Smoking and ROS  
Smoking was associated with a 107% increase in reactive oxygen species (ROS) levels and a 10-
point decrease in ROS-Total antioxidant capacity (ROS-TAC) scores (Saleh et al., 2002a). A 
significant reduction of ROS-TAC scores associated with smoking can be attributed to a significant 
increase in seminal ROS levels, which is related to the significant increase in leukocyte 
concentration in the semen of infertile smokers (Close et al., 1990).  
Some studies have reported that the association between man smoking and semen quality was 
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stronger in healthy men than in the infertile population (Vine 1996; Zinaman et al., 2000). It 
should be emphasized that cigarette smoke has been associated with increased frequency of 
aneuploidy in sperm (Twigg et al., 1998a, b), lower seminal plasma antioxidant levels and 
increased oxidative damage to DNA (Fraga et al., 1996; Shen et al., 1997). Agarwal et al., (2006) 
reported that high ROS may serve as a marker of male-factor infertility. Furthermore, it has been 
shown that ROS can damage DNA by causing deletions, mutations, and other lethal genetic effects 
(Tominga et al., 2004). 
The results from this work showed that the ROS concentrations in seminal plasma of all smokers 
(n=72), volunteers smokers (n=19), and patients (n=53) smokers (128.75 ± 39.46, 111.82 ± 28.66, 
138.49 ± 41.85) were significantly higher (p<0.010) than that in non-smokers (52.89 ± 28.48, 40.47 
± 20.45, 65.74 ± 30.16). The concentrations of ROS in all participants samples were negatively 
correlated with other sperm parameters (Table 10c); semen volume (r=-0.176, p=0.062), sperm’s 
concentration (r=-0.133, p=0.160) motility (r= -0.537, p<0.010), vitality (r=-0.298, p<0.010), 
membrane integrity (r=-0.343, p<0.010) and morphologically normal sperm (r=-0.547, p<0.010), 
whereas, positive correlations (p<0.010) were observed with sperm non-condensed chromatin and 
DNA damage (r=0.629, r=0.630 respectively). 
Similarly high levels of seminal oxidative stress have been correlated with sperm impairment of 
sperm metabolism, motility, and fertilizing capacity (Armstrong et al., 1998). 
Several mechanisms had been proposed to explain the effect of smoking on semen quality. 
Oxidative stress induced ROS that has destructive effects on sperm quality and function. Smoking 
may increase oxidative stress by: (i) Smoking itself contains high levels of ROS such as superoxide 
anion (O2-), hydrogen peroxide (H2O2), and hydrogen radicals (OH•) (Saleh et al., 2002a; Kunzle et 
al., (2003). H2O2 directly affects sperm functions critical at fertilization process in a dose- and 
time-dependent fashion. Low concentrations maintain capacitation; whereas, high concentrations 
have deleterious effects, as determined by the end points of the capacitation process. These effects 
are probably dependent on modifications of plasma membrane and intracellular homeostasis by the 
oxidative process (Oehninger et al., 1995), (ii) smoking metabolites may induce an inflammatory 
reaction in the male reproductive tract that cause formation of leukocytes that can generate high 
levels of ROS (Saleh et al., 2002a, b). Oxidative stress induced by leukocytes had a damage effect 
on the polyunsaturated fatty acids of sperm phospholipids which may result, among the other 
effects, in decreased membrane fluidity (Zalata et al., 1998), (iii) smoking metabolites may affect 
spermatogenesis. Excess of free radical generation frequently involves an error in spermiogenesis 
resulting in the release of spermatozoa from the germinal epithelium exhibiting abnormally high 
levels of cytoplasmic retention. Redundant cytoplasm contains enzymes that fuel further generation 
of ROS by the spermatozoa's plasma membrane redox systems (Saleh et al., 2002a; Aitken and 
Sawyer 2003). 
ROS cause oxidative damage to normal sperm DNA, proteins and lipids that may be related to 
sperm abnormalities (Aitken and Baker, 2006). High levels of polyunsaturated fatty acids in the 
plasma membrane of the sperm and the low level of antioxidants in its cytoplasm make it 
susceptible to damage by ROS impaired motility of the sperm  (Agarwal and Prabakaran, 2005; 
Aitken and Baker, 2006). Sperm DNA damage also induced by excessive ROS may enhance sperm 
germ cells apoptosis causing decrease in the concentration of sperms (Agarwal and Allamaneni, 
2004). Studies correlated ROS with impaired motility (Agarwal et al., 1994a, b; Armstrong et al., 
1999; Agarwal and Allamaneni, 2004). Many studies proposed that the effect of smoking on sperm 
parameters may have had a dose-dependent effect, and high levels of cigarette smoking were 
positively related to decreased sperm parameter quality (Wang et al., 2001; Martini et al., 2004; 
Pasqualotto et al., 2004; Colagar et al., 2007). This might be due to the toxic components of smoke.  
Reactive oxygen species status may be used as an important indicator for clinical evaluation and 
treatment of male-factor infertility. Recently, Agarwal et al., (2006) reported that high ROS may 
serve as a marker of male-factor infertility.  
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5-3-1-2- Cotinine and sperm parameters 
Cotinine has been reported to have pharmacological activity. It interferes with the release of brain 
neurotransmitters and affects enzymes involved in the synthesis of estrogen and testosterone, 
decreases vascular resistance and blood pressure in animals, and has been reported to have effects 
on cognitive performance and to modify nicotine withdrawal symptoms in abstinent smokers 
(Zevin et al., 2000). 
Cotinine is the major metabolite of nicotine, which is the major psychoactive substance found in 
cigarette smoke (Zenzes et al., 1996 ). Cotinine had been used as a specific biomarker of cigarette 
smoking (Hulka, 1991). Besides, cotinine with a half-life in sperm of 5–7 days is a better indicator 
of long-term exposure to cigarette smoke than urinary metabolites index (Jarvis et al., 1988). 
Cotinine may decrease male fertility by inhibiting density, reducing total progressively motile 
sperm count, and increasing the percentage of sperm with abnormal morphology (Chen and Kuo 
2007). A previous research found nicotine and cotinine in the seminal plasma of smokers and 
suggested that other harmful components of tobacco smoke would pass through the blood–testis 
barrier (Vine et al., 1993).  
In the current study, seminal plasma cotinine levels were found to be significantly higher (p<0.010) 
in smokers than non-smokers for all participants (88.22 ± 58.05 vs. 2.34 ± 2.20), volunteers (68.55 
± 38.58 vs. 2.02 ± 2.03), and patients (99.55 ± 64.58, 2.68 ± 2.36). 
Furthermore, in all participants samples (Table 10c) an inverse correlations were detected between 
concentrations of cotinine with other sperm parameters; semen volume (r=-0.151, p=0.110), 
sperm’s concentration (r=-0.137, p=0.148), motility (r=-0.489, p<0.010), vitality (r=-0.322, 
p<0.010), membrane integrity (r=-0.555 , p<0.010) and morphologically normal sperm (r=-0.555, 
p<0.010), whereas, a significant positive correlations (p<0.010) were observed with sperm non-
condensed chromatin and DNA damage (r=0.549, r=0.629 respectively). These results demonstrate 
that cigarette smoking is the main contributor to semen cotinine.  
These findings are in according with that of Chen and Kuo (2007). They demonstrated a relation 
between semen cotinine concentrations and sperm quality that was also consistent with other 
reports. Pacifici et al., (1993) found that total motility of spermatozoa was showed significantly 
negative correlation with concentrations of cotinine and hydroxycotinine. Zavos et al., (1998) 
found that smoking affected sperm viability and had a strong detrimental effect on motility of 
spermatozoa. Besides, Wong et al., (2000) found a negative correlation between cotinine 
concentration and morphologically normal sperm. In addition, cotinine concentration impaired 
sperm motility, membrane function, and their ability to undergo capacitation (Sofikitis et al., 1995). 
These results also in agreement with previous work of Hammadeh et al. (2008b). 
Moreover, in this study, negative correlations were recorded between cotinine concentrations and 
fertilization and pregnancy rates (r=-0.164, r=-0.028 respectively, p>0.050). This result 
demonstrated an inverse effect of cotinine on the quality of sperm (concentration, motility, 
morphology, and DNA integrity), discussed above, that will affect the fertilization pregnacy rates. 
These results also consistent with the work of Hammadeh et al. (2008b). 
5-3-1-3- Smoking cigarette and MDA levels 
Peroxidation of polyunsaturated fatty acids has been implicated in a wide variety of pathological 
conditions including infertility, cardiac and cerebral ischaemic-reperfusion injury, and 
inflammatory joint diseases amongst others (Sanocka and Korpisz, 2004). The human sperm cell 
membrane is particularly susceptible to oxidation by ROS and other oxidative agents such as 
smoking metabolities due to the existence of high concentration of polyunsaturated fatty acids 
(PUFA) in these membranes (Tavilani et al., 2005; Cocuzza et al., 2007). Lipid peroxidation 
damage of the plasma membrane of spermatozoa plays an important role in the mechanism of male 
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infertility (Khosrowbeygi and Zarghami, 2007). However, the toxic lipid peroxides are known 
to cause various impairments of the sperm cell, such as membrane damage and decrease in motility 
(Alvarez et al., 1987; Aitken et al., 1993). The most popular (but not the most important) product 
of lipid peroxidation is malondialdehyde (MDA). 
This work reported that seminal plasma concentrations of MDA were significantly lower in all 
participant’s non-smokers compared to that of smokers (6.10 ± 1.18 vs. 8.51 ± 1.43, p<0.010 
respectively). Similar significant lower levels (p<0.010) were found in volunteers (5.71 ± 1.17) and 
patients (6.51 ± 1.06) non-smokers groups in comparison to that of volunteers smokers (7.66 ± 0.9) 
and patients smokers (9.01 ± 1.46).   Moreover, this study showed that MDA was negatively 
correlated with sperm’s concentration (r=-0.069, p>0.050), semen volume (r=-0.205, p<0.050), 
sperm motility (r=-0.513, P<0.010), viability (r=-0.309, p<0.010), membrane integrity (-0.362, 
p<0.010), and morphologically normal sperm (r=-0.514, p<0.010). In addition, MDA showed 
significantly positive correlations (p<0.010) with non-chromatin condensation (r=0.555) and DNA 
fragmentation (r=624). 
These findings are in agreement with that of Elsaeid et al., (2006) who showed a significantly 
negative correlation of MDA with sperm concentration (r=-0.621, p < 0.001), motility (r=-0.572, 
p<0.005), and percentage of normal forms (r=-0.447, p<0.05). Similarly, Saraniya et al., (2008) 
found a significant correlation between MDA concentrations and sperm motility and concentration 
in subfertile patients compared to normal. Besides, Nakamura et al., (2002) found that subfertile 
patients showed significantly higher concentrations of malondialdehyde than fertile controls. There 
was no significant difference between the levels of malondialdehyde in the seminal plasma of 
patients with normozoospermia and asthenozoospermia. 
Moreover, Nabil et al., (2008), reported that lipid peroxidation plays a significant role in disrupting 
sperm functions and semen quality especially sperm motility and morphology and may account for 
some cases of male infertility. Furthermore, Tavilani et al., (2008), observed a higher content of 
lipid peroxidation product malondialdehyde (MDA) in spermatozoa of asthenozoospermic 
compared with normozoospermic samples (p<0.05). Although, they found that the difference in 
MDA of seminal plasma in both groups was not significant. 
5-3-1-4 Smoking cigarette and 8-OHdG levels 
Smoking may increase oxidative stress. ROS including  superoxide radical, hydrogen peroxidase, 
and hydroxyl radical, can cause several types of DNA lesions, such as chemical modifications to 
the bases or to 2-deoyribose moieties, chain breaks, adducts, and crosslinks. Hydroxyl radical can 
add to guanine and adinine at position 4, 5, or 8 in the purine ring, generating a multitude of 
products. One of the most abundant lesions is 8-oxo-7, 8 dihydroguanine (8-oxoG), also called 8-
Hydroxy guanine (8-ODdG), which frequently mispairs with adenine. (8-ODdG) is the most 
commonly used biomarker of DNA oxidation. It has been estimated that several thousand 8-OHdG 
lesions may form daily in a mammalian cell, representing >5% of all oxidative lesions. 
It was reported that sperm DNA damage is closely related to male infertility, and 8-OHdG is a 
sensitive marker of oxidative DNA damage caused by ROS in human sperm (Shen and Ong 2000). 
The levels of 8-OHdG were detected in serum and urine. They were correlated with smoking (Loft 
et al., 1992), cancer (Toyokuni et al., 1995), aging (Halliwell et al., 1998), and diabetes mellitus 
(Leinonen et al., 1997). Elevation levels of 8-OHdG in sperm DNA had been demonstrated by 
Shen et al., (1997), and related to male infertility (Kodama et al., 1997; Shen et al., 1999). Fraga et 
al., (1996) reported that smoking, which depletes antioxidants (a-tocopherol and ascorbate) and 
increases oxidative stress, induced a significant increase in 8-OHdG of sperm DNA. 
In this study we observed that the concentrations of 8-OHdG in seminal plasma of all participants 
non-smokers, volunteers and patients non-smokers (0.71 ± 0.53, 0.61 ± 0.40, 2.99 ± 1.82) were 
significantly lower (p<0.010) than that of the smokers of the three groups (2.63 ± 1.54, 2.02 ± 0.51, 
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2.99 ± 1.82). In addition, the levels of 8-OHdG in all samples showed significant negative 
correlation with sperm concentration (r=-0.169, p=0.073), semen volume (r=-0.193, p<0.050), 
sperm motility (r=-0.532, p<0.010), vitality (r=-0.373, p<0.010), membrane integrity (r=-0.335, 
p<0.010) and morphologically normal sperm (r=-0.513, p<0.010). Whereas, significant positive 
(p<0.010) correlations were found with sperm DNA integrity (r=0.600) and non-condensed 
chromatin (r=0.545).  
These data are consistent with that of Ni et al., (1997) who reported an association between 8-
OHdG with sperm motility, morphology and density. Other studies by Nakamura et al., (2002) 
reported that the levels of 8-OHdG in the seminal plasma of subfertile patients with 
normozoospermia and those with asthenozoospermia were significantly higher than those of fertile 
controls (p<0.050), and Inoue et al., (2003) demonstrated that the serum levels of 8-OHdG of 
smokers was higher than that of non-smokers. Besides, Kao et al., (2008) demonstrated a 
significant negative correlation between 8-OHdG with motility. 
The increased levels of 8-OHdG in seminal plasma of smokers in our data suggest that sperm 
dysfunction caused by smoking induced oxidative stress extends to the DNA levels. 
5-3-2- Smoking and Semen Parameters 
The production and function of healthy normal spermatozoa was affected by the number of 
cigarettes smoked per day, the years of smoking and the level of nicotine by-products present in the 
body fluids, which correlate negatively with semen and sperm quantity and quality (Chia et al., 
1994a; b). While some studies demonstrated a positive correlation between male smoking and 
diminished sperm parameters (concentration, volume, motility and morphology), (Mak et al., 2000; 
Taszarek et al., 2005; Agarwal et al., 2005; Mostafa et al., 2006; Colagar et al., 2007), others 
showed no significant correlation between smoking and semen parameters (Trummer et al., 2002; 
Sobreiro et al., 2005; Sepaniak et al., 2006). Pasqualotto et al., (2005) found the same non-
significant results except for the volume of the semen.  Moreover, there was not a trend to an 
alternation of these conventional parameters (concentration, volume, motility and morphology) in 
smokers, as had been suggested by others (Wong et al., 2000).  
The present study (Table 14) showed that all smokers (n=72) have a significantly lower volume of 
semen (3.1 ± 1.6 vs. 3.6 ± 1.6, p<0.050), and sperm’s concentrations (65.4 ± 31.5 vs. 68.4 ± 31.2, 
p=0.641), motility (23.3 ± 8.0 vs. 35.8 ± 14.6, p<0.010), viability (33.5 ± 17.6 vs. 41.2 ± 17.3, 
p<0.010), membrane integrity (39.2 ± 18.4 vs. 54.1 ± 18.4, p<0.010), morphologically normal 
sperm (26.6 ± 12.0 vs. 41.4 ± 13.7, p<0.010), chromatin condensation (% bad sperm) (34.6 ± 8.1 
vs. 26.4 ± 8.0, p<0.010), and DNA integrity (% bad sperm) (16.8 ± 5.1 vs. 9.6 ± 4.3, p<0.010) than 
non-smokers. On the contrary, the concentrations of oxidative biomarkers MDA, ROS, cotinine and 
8-OHdG were found to be significantly higher (p<0.010) in smokers than non-smokers; (6.10 ± 
1.18 vs. 8.51 ± 1.43), (52.89 ± 28.48 vs. 128.75 ± 39.46), (2.34 ± 2.20 vs. 88.22 ± 58.05), and (0.71 
± 0.53 vs. 2.63 ± 1.54) respectively. 
Besides, non-smokers volunteers (Table 15) showed a significant higher (p<0.010) sperm motility 
(44.7 ± 12.5, vs. 24.7 ± 8.2), and morphologically normal sperm (52.9 ± 10.8 vs. 34.4 ± 10.3) than 
smokers. In contrast, smokers showed  significantly higher (p<0.010) non-condensed chromatin 
(29.4 ± 5.5 vs.19.6 ± 4.8), and DNA fragmentation (15.1 ± 4.5 vs. 6.1 ± 1.8) than non-smokers. The 
concentrations of seminal plasma parameters; ROS, cotinine and 8-OHdG were significantly higher 
(p<0.010) in smokers (7.66 ± 0.9, 111.82 ± 28.66, 68.55 ± 38.58, 2.02 ± 0.51 respectively) in 
comparison to non-smokers (5.71 ± 1.17, 40.47 ± 20.45, 2.02 ± 2.03, 0.61 ± 0.40 respectively).  
In Table 17, non-smokers of patients group showed higher sperm vitality (38.1 ± 17.5 vs. 30.7 ± 
16.4, p<0.050), membrane integrity (52.9 ± 20.1 vs. 36.1 ± 18.1 p<0.010), sperm motility (31.3 ± 
13.6 vs. 23.0 ± 8.0, p<0.010), and morphologically normal sperm (36.1 ± 9.0 vs. 23.4 ± 10.1, 
p<0.010) than that of smokers in the same group; whereas, smokers showed higher percentage of 
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non-chromatin condensation (36.4 ± 8.1vs. 29.8 ± 7.1, p<0.010), and DNA fragmentation (17.4 
± 5.3 vs. 11.3 ± 4.2, p<0.010) in comparison to non-smokers. On the other hand, patients non-
smokers showed significantly lower (p<0.010) seminal plasma concentrations of MDA (6.51 ± 1.06 
vs. 9.01 ± 1.46), ROS (65.74 ± 30.16 vs. 138.49 ± 41.85), cotinine (2.68 ± 2.36 vs. 99.55 ± 64.58), 
and 8-OHdG (0.81 ± 0.63 vs. 2.99 ± 1.82) than smokers.  
Furthermore, the data resulted from comparing volunteers smokers and patients smokers (Table 19) 
demonstrated that volunteers smokers have higher semen volume (3.4 ± 1.0 vs. 3.1 ± 1.8, p=0.128), 
sperm motility (24.7 ± 8.2 vs. 23.0 ± 8.0, p=0.401), sperm concentration (78.9 ± 28.2 vs. 60.6 ± 
31.4, p<0.050), sperm vitality (41.3 ± 19.1 vs. 30.7 ± 16.4, p<0.050), sperm membrane integrity 
(48.2 ± 16.8 vs. 36.1 ± 18.1, p<0.050), and morphologically normal sperm (34.4 ± 10.3 vs. 23.4 ± 
10.1, p<0.010) than patients smokers. On the other hand, sperm non-condensed chromatin (36.4 ± 
8.1 vs. 29.4 ± 5.5, p<0.010), and DNA fragmentation (17.4 ± 5.3 vs. 15.1 ± 4.5, p=0.094) were 
higher in patients smokers than volunteers smokers. In addition, the concentrations of MDA, ROS, 
cotinine and 8-OhdG were significantly higher in patients smokers than volunteers smokers; (7.66 
± 0.90 vs. 9.01 ± 1.46, p<0.010), (111.82 ± 28.66 vs. 138.49 ± 41.85, p<0.050), (99.55 ± 64.58 vs. 
68.55 ± 38.58, p=0.066), and (2.99 ± 1.82 vs. 2.02 ± 0.51, p=0.094) respectively. 
These results reported that smoking has negative effects on sperm and semen parameters 
(concentration, motility, morphology, vitality, membrane integrity, chromatin condensation, DNA 
integrity, MDA, ROS, cotinine, and 8-OHdG). These results were in accordance with other studies 
that showed a deleterious effect of smoking on sperm quality. Omu et al., (1998) found that non-
smokers and light smokers had better sperm parameters than heavy smokers as indicated by the 
sperm count (p<0.030), active motility (p<0.030), asthenozoospermia (p<0.050), and positive 
hypo-osmotic swelling (p<0.050) tests. Also, the number of smokers with higher titers of 
circulating anti-sperm antibodies was larger than that of non-smokers (p< 0.010). Gauer et al., 
(2007) demonstrated a negative correlation of smoking with sperm motility. Colagar et al., (2007) 
showed a reverse effect of smoking on sperm quality. Moreover, many other previous studies found 
an inverse relationship between smoking and sperm parameters (Vine et al., 1996; Saleh et al., 
2002a, Kuntzle et al., 2003). However, these results conflict with others that had found no 
association between smoking and sperm quality and function (Voget et al., 1986; Dikshit et al., 
1987). 
5-3-3- Smoking and Semen volume 
The results of the current study showed significant differences (p<0.050) between the semen 
volume of non-smokers (n=94) (3.6 ± 1.6) and smokers (n=72) (3.1 ± 1.6). This result is in 
accordance with that of Saaranen et al., (1987), who found that there was an effect of smoking on 
semen volume and specifically, semen volume of heavy smokers that was significantly lower than 
that of non-smokers. Other study by Holzki et al., (1991) showed that smokers had significantly 
smaller semen volumes compared to non-smokers. Although, a dose dependent deleterious effect of 
tobacco on semen volume and sperm counts was found (Osser et al., 1992). 
Cigarette smoking effect on semen volume was reported by Chia et al., (1998), who reported 
significantly negative differences in semen volume between smokers and non-smokers. These 
results were supported by Zhang et al., (2000), who performed a study on infertile males in 
Shandong Province, China. Zhang et al. concluded that cigarette smoking had a detrimental effect 
on semen volume of smoking infertile males, compared to non-smoking infertile and control fertile 
ones. While the concentration, motility and morphology of the sperm appeared not affected by 
smoking, semen volume showed a decline in smokers compared to non-smokers (Pasqualotto et al., 
2005). Similar effect of smoking on semen volume was reported by (Ramlau-Hansen et al., 2006). 
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5-3-4- Smoking and Sperm motility 
Many studies had reported that progressive motility of sperms were higher in heavy smoker than 
light smokers (Dikshit et al., 1987; Goverde et al., 1995; Vine et al., 1996; Ozgur et al., 2003). The 
possible explanations for this enhancement of rapidly progressive motility due to heavy smoking in 
comparison to light smoking is a definite number of cigarettes per day that may constitute a 
threshold for the enhancement of rapid progressive motility in smokers. Some researchers have 
found a significant correlation between smoking and decreased sperm motility or morphology and 
lower sperm density (Merino et al., 1998; Zenzes, 2000; Evans et al., 2004).  
The present study showed that sperm motility of all smokers was significantly (p<0.010) lower than 
that of all non-smokers (23.4 ± 8.0 vs. 35.8 ± 14.6 respectively).  Smoker volunteers samples 
analysis showed a significant (p<0.010) decrease in motility comparing with that of non-smokers 
(24.7 ± 8.2 vs. 44.7 ± 12.5 respectively). The same results were detected for patients smokers and 
non-smokers (23.0 ± 8.0 vs. 31.3 ± 13.6 respectively, p<0.010) 
In Table 10a, motility showed significant negative correlations (p<0.010) with non-condensed 
chromatin, DNA fragmentation, (r=-0.458, r=-0.406, respectively), and significant positive 
correlations (p<0.010) demonstrated with sperm vitality (r=0.494), sperm membrane integrity 
(r=0.446), and morphologically normal sperm (%) (r=0.479). On the other hand, motility (Table 
10c) showed significant negative correlations (p<0.010) with seminal plasma concentrations of 
MDA (μM), ROS (μmol/l) (Fig. 14), cotinine (ng/ml), and 8-OH-dG (ng/ml) (r=-0.513, -0.537, -
0.489, and -0.532 respectively) 
These results were in consistent with other studies. Omu et al., (1998) found that motility of sperms 
of smokers was lower than non-smokers, Jedrzejczak et al., (2004) reported that smokers had 
significantly fewer motile spermatozoa, and Gaur et al., (2007) indicated that asthenozoospermia, 
the most common semen variable in their study, can be an early indicator of reduction in quality of 
semen, as seen in light smokers. In addition, heavy smoking produces teratozoospermia, which 
further reduces semen quality. Oligozoospermia may be due to factors other than smoking. Lower 
sperm motility, concentration and morphology had been shown to be lower in smokers than non-
smokers (Colagar et al., 2007).  
Previous studies reported that cigarette smoking effects on sperm motility, concentration and 
morphology were related with poor sperm quality (Close et al., 1990; Sofikitis et al., 1995; Vine et 
al., 1996; Saleh et al., 2002a, Kuntzle et al., 2003), although, Richthoff et al., (2007) found that 
smoking status did not affect sperm density or motility. 
5-3-5- Smoking and Sperm Morphology 
Abnormal sperm morphology is related to sperm head abnormalities, and may involve the 
acrosome, nucleus and post acrosomal region (Zamboni, 1987). Increased quantities of ROS have 
been shown to be detrimental to the DNA of spermatozoa, thus producing a negative effect on the 
viability and morphology of spermatozoa (Koksal et al., 2003).  
The present study indicated that the mean numbers of morphologically normal sperm were 
significant lower (p<0.010) in smokers compared to non-smokers (26.6 ± 12.0% vs. 41.4 ± 13.7% 
respectively). Similarly, like-wise were found within the smokers and non-smokers of volunteers 
group (34.4 ± 10.3 vs. 52.9 ± 10.8) and patients group (23.4 ± 10.1 vs. 36.1 ± 9.0). Moreover, the 
mean percentage of morphologically normal sperm correlated significantly positive (p<0.010) with 
sperm concentration, motility, viability and membrane integrity. Whereas, significant negative 
correlations were demonstrated (p<0.010) with non-condensed chromatin (CMA3 positive), 
membrane integrity, and seminal plasma concentrations of MDA, ROS, cotinine, and 8-OHdG. 
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These data are in agreement with other studies that demonstrated lower percentage of normal 
sperm morphology found in semen samples of smokers compared to non-smokers (Osser et al., 
1992; Chia et al., 1994a: b). Kunzle et al., (2003) and Ozgur et al., (2003) found that cigarette 
smoking significantly reduced the mean percentage of normal sperm morphology, ejaculate volume 
and sperm vitality. In addition, heavy smoking produces teratozoospermia, which further reduces 
semen quality (Gaur et al., 2007). 
5-3-6- Smoking and DNA damage 
The real influence of tobacco on male fertility remains controversial and several mechanisms have 
been proposed such as: impairment of spermatogenesis (Weisberg, 1985), induction of 
ultrastructural abnormalities (Zavos et al., 1998), and apoptosis (Gandini et al., 2000; Sakkas et al., 
2002). 
Several studies attempt to find a correlation between the tobacco consumption and an alteration of 
sperm quality (Oldereid et al., 1989; Vine, 1996). Many other studies showed the effect of smoking 
on conventional sperm parameters such as sperm density (Vine et al., 1994), motility, viability, and  
morphologically normal sperm (Zavos et al., 1998), and nuclear integrity (Potts et al., 1999). 
Indeed, cigarette smoking is linked to significantly increased levels of seminal reactive oxygen 
species (ROS), which are responsible for an oxidative stress (Saleh et al., 2002a). This is why 
smoking may induce alterations of the sperm plasma membrane and a high degree of DNA 
fragmentation (Church and Pryor, 1985). In contrast, others have found no significant correlation 
between smoking and sperm parameters (Vogt et al., 1986; Vine, 1996; Trummer et al., 2002; 
Sepaniak et al., 2006). 
Studies have found that children of fathers who smoked cigarettes pre-conceptually have a higher 
risk of developing childhood cancers (Ji et al., 1997). These studies suggest that there may be a link 
between sperm DNA damage and the subsequent development of childhood diseases. 
The results of this study by using the TUNEL and CMA3 assay for sperm DNA integrity showed a 
statistically significant difference (p< 0.010) between smokers (n=72) and non-smokers (n=94) 
(16.8 ± 5.1 versus 9.6 ± 4.3 by TUNEL), (34.6 ± 8.1 versus 26.4 ± 8.0 by CMA3). A similar effect 
was observed in the healthy volunteers group (Table 15).  In the patients group the results were 
(17.4 ± 5.3 versus 11.3 ± 4.2 by TUNEL) and (36.4 ± 8.1 versus 29.8 ± 7.1 by CMA3). For both 
groups of volunteers smokers and patients smokers, a low difference was found in DNA 
fragmentation (TUNEL) (p>0.050) and a significant difference in chromatin condensation (CMA3) 
(p<0.010).  
These results are in close agreement with other reports (Sofikitis et al., 1995) which showed that 
single-strand-to double-strand breaks DNA spermatozoa were significantly higher in smokers. Potts 
et al., (1999) and Zenses, (2000) showed previously a link between DNA damage and smoking. 
Whereas, Sergerie et al., (2000) showed the opposite, that there is no relationship between smoking 
and DNA fragmentation. Recently, Sepaniak et al., (2006) showed a positive correlation (p<0.010) 
between cigarette smoking and sperm DNA fragmentation among smoker patients seeking for 
infertility counseling. A previous study from our group showed that the sperm of smokers have 
higher DNA fragmentation than the sperm of non-smokers (Hammadeh et al., 2008b).  
In the present study, it was difficult to find a significant correlation between DNA integrity and 
other sperm parameters in the normal and patients smokers group (p>0.050). The same 
observations were made by Sepaniak et al., (2006) and Henkel et al., (2004). Similarly, DNA 
fragmentations evaluated by SCSA were not statistically different whether the conventional sperm 
parameters were normal or abnormal in a population of infertile men (Saleh et al., 2002b). In 
addition, other researchers showed no correlation between sperm DNA damage and pregnancy 
(Gandini et al., 2004; Huang et al., 2005). Borini et al., (2006), which showed inverse and direct 
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correlation between sperm DNA damage and pregnancy and pregnancy loss rates, is also 
explained by paternal genome anomalies blocking the correct embryo development. While Irvine et 
al., (2000) found a significant higher fragmentations in DNA from infertile men in compared to 
fertile men. 
These current findings support previous studies and suggest that DNA fragmentation rate is an 
independent factor as regard to conventional parameters, and cannot be suspected by the means of 
standard sperm evaluation. DNA fragmentation measurement may explain some cases of otherwise 
unexplained infertility. In addition to the above-discussed diagnostic interest of the sperm DNA 
fragmentation rate, most of the authors (Lopes et al., 1998; Zini et al., (2001) agree to consider this 
parameter as a prognostic factor in the probability of a successful pregnancy. 
5-4- Protamines Quantifications 
Protamines are small, highly arginine-rich, nuclear proteins that in the haploid phase of 
spermatogenesis are required for sperm head condensation and associated transcriptional silencing 
(Sassone-Corsi, 2002). Human sperm nuclei contain considerably fewer protamines (approximately 
85%) than those of bull, stallion, hamster and mouse (Gatewood et al., 1987; Bench et al., 1996). In 
contrast to the bull, cat, and ram, whose spermatozoa contain only one type of  protamine (P1) , 
human and mouse spermatozoa contain a second type of protamine (P2), which is deficient in 
cysteine residues (Corzett et al., 2002). Therefore, human sperm chromatin is less regularly 
compacted and frequently contains DNA strand breaks (Sakkas et al., 1999b, Irvine et al., 2000). 
The histone-bound DNA sequences are less tightly compacted, and it is thought that these DNA 
sequences and/or genes may be involved in fertilization and early embryo development (Gatewood 
et al., 1987; Gineitis et al., 2000).  
Similar levels of P1 and P2 were shown in spermatozoa from normozoospermic men (Balhorn et 
al., 1988). Numerous studies, however, demonstrated that male infertility is associated with an 
abnormal histone to protamine ratio (Zhang et al., 2006) and an aberrant P1/P2 ratio at both the 
protein level in ejaculated spermatozoa (Balhorn et al., 1988; Belokopytova et al., 1993) and the 
mRNA level in testicular spermatids (Steger et al., 2003). 
5-4-1- P1 and P2 Concentrations 
Protamines are considered a good marker of sperm nuclear maturity since they are replacing the 
histones in the last stage of spermatogenesis. Many functions of protamines had been proposed by 
Oliva and Dixon, (1991): (i) facilitate the movement of the sperm cell: the spermatozoa with the 
most compact and hydrodynamic nucleus would move faster and may fertilize the oocyte first; (ii) 
protection of the  DNA from chemical and physical damage, such as ROS, nucleases, mutagens or 
other factors potentially present in the internal or in the external media; (iii) confer an epigenetic 
mark on some regions of the sperm genome, influencing its reactivation upon fertilization; (iv) 
removing proteins and transcription factors from the spermatid, allowing a proper post-fertilization 
genetic reprogramming; (v) protamines could be part of a checkpoint during spermiogenesis and 
(vi) they could have a role in the fertilized oocyte, allowing the synchronization of the cell cycle 
between the oocyte in metaphase II phase and spermatozoa in G1 (Braun, 2001). 
Findings from this work showed that protamines in spermatozoa were higher in patients than in 
normal volunteers. P1 concentration in patients was significantly higher (<0.010) in comparison to 
the values observed in semen samples of healthy volunteers (416.30 ± 101.70 vs. 378.20 ± 100.00), 
whereas, the P2 concentration was almost similar in both groups (363.60 ± 114.9 vs. 347.30 ± 
77.30, p>0.050). Besides, the ratios of P1/P2 of patients was significantly higher than that of 
healthy volunteers (1.22 ± 0.36, 1.10 ± 0.20, p<0.050) (Table 20).   
The results of this study showing showed different percentages of P1 and P2 between men who 
underwent ICSI therapy (subfertile) and those healthy fertile volunteers. Higher amounts of 
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protamines in patients samples were observed. One reason for these discrepancies might be the 
technical procedures mainly the measurement of the intensity of the P1 and P2 bands. Moreover, 
patients group members were chosen randomly from men who came to the IVF unit. Many of them 
exhibited a normal sperm parameters including distribution of protamines. On the contrary, many 
of the volunteers showed abnormal P1/P2 ratios.   
In addition, attention has been focused on the possible role of cigarette smoking and protamines 
concentrations and ratios in spermatozoa taking together, the results of present study (Table 21) 
suggest a negative biological effect of smoking on spermatozoa chromatin condensation and 
protamines distribution. Although, the results from this work showed different percentages of 
protamine P1 and P2 and P1/P2 ratios between ICSI patients and volunteers (Table 20; Figures 27-
30). The results in Table 21 showed that concentration of P1 and P1/P2 ratios (Figure 31) were 
higher in smokers in comparison to non-smokers. P2 was significantly lower in smokers (335.60 ± 
110.60 vs. 376.81 ± 97.36, p<0.05). 
Health volunteers smokers and non-smokers revealed similar results (Table 22) P1; (395.60 ± 
125.90 vs. 367.60 ± 80.00, p=0.743), P2: (338.10 ± 90.20 vs. 352.90 ± 69.30, p=0.682) and P1/P2 
ratio: (1.19 ± 0.27 vs. 1.04 ± 0.11, p<0.05). Remarkably, the concentrations in patients of ICSI of 
P1 and P2 levels were higher in non-smokers than levels measured in smokers (Table 23). In 
contrast, P1/P2 ratio was significantly higher in smokers (1.34 ± 0.46 vs. 1.11 ± 0.20, p<0.010) 
(Figure 33). 
These results support the hypothesis that subfertility in general and cigarette smoking in particular, 
increase the sperm susceptibility to chromatin abnormalities and fragmentations. These results are 
in agreement with other reports (Balhorn et al., 1988; Chevaillier et al., 1990; de Yebra et al., 
1993; 1998; Carrell and Liu, 2001; Aoki et al., 2005a) in which they revealed an abnormal 
elevation of P1/P2 ratio of infertile male populations, and proposed that reduction of P2 expression 
is the mean factor responsible for P1/P2 ratios in infertile men. In the since de Yebra et al., (1993) 
and Carrell and Liu, (2001), showing complete absence of P2 in infertile men.  
P2 deregulation is responsible for many cases of abnormal P1/P2 ratios; the reason is that P2 
deregulation occurs more frequently than P1 deregulation. The gene of P2 is more recently derived 
than that of P1and highly variable in mammals (Lewis et al., 2003). Support for this data comes 
from the regulatory mechanisms responsible for P2 expression that are more susceptible to 
variation than those for P1 expression, and about 90% of cases with high P1/P2 ratio exhibited P2 
under-expression. Besides, P1 deregulation proposed as a cause of aberrant P1/P2 ratios with P2 
deregulation in infertile men, no defined mechanism explains the over expression of one 
protamines by under-expression of other (Aoki et al., 2005a). Steger et al., (2008) demonstrated a 
significant difference in the P1/P2 ratios among infertile “1:1.7 in ejaculates” and fertile “1:1 in 
ejaculates” men. Both P1 and P2 change between fertile and infertile men but P2 changes more than 
P1, suggesting different mRNA stabilities for the two molecules. In another study conducted by the 
same group, Steger et al. (2003) did not find differences in P2 transcript levels in spermatozoa 
isolated from men with impaired spermatogenesis compared to men with normal spermatogenesis. 
However, they observed significantly decreased P1 transcript contents in the group of patients with 
impaired smermatogenesis.  
The etiology of protamines deregulation remains unclear; it could be due to mutations in the genes 
of P1, P2, or any of the accessory proteins such as transition proteins 1 and 2, serine/arginine 
protein specific kinase 1, and Ca2+/calmodulin dependent protein kinase IV, these proteins 
demonstrated to play a critical role in protamine expression, processing, and function 
(Papoutsopoulou et al., 1999; Wu et al., 2000; Cho et al., 2001; 2003; Zhao et al., 2004).   
Defects in the regulation process during transcription and translation could be another possible 
cause of irregular P1/P2 ratios. The human sperm P1 and P2 genes exist in single chromatin 
domain and their regulation is regulated by the same upstream regulatory elements. Transcriptional 
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regulation may be a cause of P1/P2 ratio abnormalities (Johnson et al., 1988; De Jonckheere et 
al., 1994; Nelsen and Kraawetz, 1994). Furthermore, defects in translation regulation may be 
another cause of abnormal P1/P2 ratios (Aoki and Carrell, 2003). Defects in post-translational 
process of protamines may end with deregulated P1/P2 ratios (de Yebra et al., 1998; Carrell and 
Liu, 2001).  
Significantly aberrant protamine ratios and a higher Bcl2 content in testes biopsy and ejaculates of 
infertile men were compared to controls, suggesting that these molecules may be useful biomarkers 
for predicting male infertility (Steger et al., 2008). 
Both P1 and P2 are necessary for proper chromatin condensation. Animal models demonstrated by 
Cho et al., (2001) and (2003) showed that insufficiency of P1 or P2 causes infertility in mice and 
P2 deficiency cause damage of the sperm DNA and embryo death. However, no such studies exist 
for humans.   
Smoking may affect protamination inversely by preventing proper binding of P1 and/or P2 with 
DNA. Several chemical agents have been proposed to induce chromatin damage of spermatozoa. 
Smoking increases the levels of oxidative stress by increasing the levels of ROS. Smoking is 
considered as a source of ROS (Knutzle et al., 2003), or enhancing the production of ROS by 
leukocytes that induced by inflammatory reaction in reproductive tract under the effect of smoking 
(Saleh et al., 2002a). One may speculate that under oxidative stress an oxidative damage to sperm 
DNA, proteins and lipids that may be related to sperm abnormalities (Aitken and Baker, 2006). 
This damage of the DNA may prevent binding of protamines to DNA properly. Protamines like 
other proteins in the body may be denatured directly by smoking components, this denaturation 
may cause abnormalities in protamination that make the sperm DNA more susceptible to DNA 
damage (Carrell et al., 2007). Moreover, smoking may affect the levels of protamine through 
affecting the spermatogenesis process. Excess production of free radicals by smoking may be 
involved in errors in spermiogenesis resulting in abnormalities in protamination.  
In the light of the increasing body of evidence, DNA packaging and DNA damage had been 
correlated with abnormal chromatin packaging (Razavi et al., 2003, Aoki et al., 2006b) that might 
be related to poor protamination. Tarozzi et al., (2009) found a highly negative correlation 
(p<0.010) between abnormal protamination (CMA3) and DNA fragmentation (Tunel). 
5-4-2- Protamines and DNA integrity 
Chromatin integrity is crucial for maintaining DNA packaging and reproductive potential of 
spermatozoa. Approximately, 15% of infertile men have been reported to exhibit deficient 
protamine packaging (Carrell and Liu, 2001). Poor or aberrant protamination of sperm DNA during 
spermatogenesis is clearly a major factor defining the susceptibility of sperm chromatin to damage 
(Nasr-Esfahani et al., 2005; Carrell et al., 2007). 
Protamines are critical for proper sperm chromatin packaging (Balhorn et al., 2000). Protamines 
play a crucial role in sperm chromatin condensation and protection of the paternal genome from 
DNA damage (Leberge and Boissonneault, 2005; Aoki et al., 2005b; Kempisty et al., 2006). It was 
proposed that protamine deficiency may lead to DNA damage accumulation in sperm (Evenson et 
al., 2002; Seli and Sakkas, 2005), morphological abnormalities, and initiation of apoptotic pathway, 
inactivating mitochondria and decreasing sperm motility (Miyagawa et al., 2005). Sperm DNA 
damage appeared to be detrimental to fertility in humans and was linked to lower embryo quality 
(Virant-Klun et al., 2002), blastulation rates (Seli and Sakkas, 2005), and in vitro fertilization (IVF) 
pregnancy rates (Bungum et al., 2004; Virro et al., 2004).  
Therefore, it would be helpful to be able to identify with certainty, whether a particular DNA 
damage related to protamination defects. In addition, previous studies attempted to correlate DNA 
damage with abnormal protamination using indirect measurements of protamine levels using the 
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chromomycin A3 (CMA3) fluorochrome. Results of these studies indicated that protamine 
deficiency is related to increasing levels of DNA damage (Bianchi et al., 1993; Manicardi et al., 
1995; Borini et al., 2006; Tarrozi., et al., 2009). 
Evidences from studies using sophisticated atomic force microscopy and proton-induced X-ray 
emission spectroscopy, provided insights into the details of protamine-DNA binding interactions 
(Hud et al., 1994; Bench et al., 1996; Balhorn et al., 2000). Binding of protamines with DNA tends 
to form characteristic clusters within species (Corzett et al., 2002). Disruption of P1/P2 ratio may 
disrupt this characteristic protamine-DNA binding, possibly influencing secondary chromatin 
structure. Additionally, based on amino acid sequencing, P2 requires a longer stretch of DNA 
(approximately 15 bp) than P1 (approximately 11 bp) for proper chromatin incorporation (Bench et 
al., 1996). This may provide evidence for abnormal chromatin packaging when P2 is less abundant 
than P1, as is the case in patients with high P1/P2 ratios (Aoki et al., 2005b). Physical size 
constraints dictate that there would be overall disturbances in the amount of protamine bound to the 
DNA, thereby reducing the overall number of disulphide cross-links. 
In the present study, direct quantitative measurements of sperm protamine concentrations using 
electrophoresis revealed that P1, and P2 inversely correlated with DNA fragmentation. The 
concentrations of P1 and P2 in all participant samples (n=166) (Table 10a), volunteers samples 
(Table 12a) and patients samples (Table 13a) showed a negative correlation (p>0.050) with non-
condensed chromatin (CMA3 positive) and DNA fragmentation (Tunel). The P1/P2 ratios showed 
significant positive (p<0.01) correlations with DNA fragmentation in all participants and healthy 
volunteers samples. The levels of DNA fragmentation assessed by Tunel in patients samples (Table 
11) were significantly higher than healthy volunteers (p<0.010). These data are in agreement with 
those obtained using CMA3 staining which indicated that protamine deficiency is significantly 
related to increases in DNA damage (refer to section 5-1). 
These results support previous study by Aoki et al., 2005b who found that sperm P1 and P2 
concentrations inversely correlate with DNA fragmentation. Moreover, the results of this work 
indicate that protamines play an important and critical role against sperm DNA damage. These 
results are supported by findings of Cho et al., (2001) and (2003) who reported that protamine 
deficiency is a causative agent for DNA damage and infertility in mice. The presence of cysteine in 
protamines structure facilitate the formation of cross-bridges not only within the protamines but 
also between protamines and DNA via disulfide bonds that increase the stability of sperm 
chromatin (Fuentes-Mascorro et al., 2000). Besides, sperm premature chromatin decondensation 
resulted as protamine-deficient human sperm used for ICSI, which indicated a less stable sperm 
chromatin in these patients (Nasr-Esfahani et al., 2004b).  
There is some evidence that links high DNA fragmentation with diminished sperm DNA integrity 
(Aoki et al., 2005b), decreased protamine content (Nasr-Esfahani et al., 2005) and lower IVF and 
ICSI rates (Evenson and Wixon, 2006a). 
Protamines P1/P2 ratio appears to be critical for chromatin stability. Although the P1/P2 ratio 
varies between genera, within a species it is highly conserved (Corzett et al., 2002). The results of 
this study indicated that spermatozoa with high P1/P2 ratios correlated significantly with elevated 
DNA fragmentation (Tables 10a; 12a; 13a) and these findings are in agreement with other previous 
investigators (Chevaillier et al., 1987; Balhorn et al., 1988; Belokopytova et al., 1993; de Yebra et 
al., 1993, 1998; Carrell and Liu, 2001; Aoki and Carrell, 2003; Aoki et al., 2005a, b) who have also 
found a relationship between abnormal protamine expression, DNA fragmentation and male 
infertility. 
Aoki et al., (2005b) demonstrated three reasons for considering evaluation of the P1/P2 ratio as a 
valuable clinical diagnostic test: first, the highly correlation between P1/P2 ratio with sperm 
penetration ability, count, morphology and motility. Second, protamine content appears to be 
critical for chromatin integrity which is important for proper embryogenessis (Manicardi et al., 
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1998; Agarwal and Allamaneni, 2004). Third, human sperm protamines may be of utmost 
clinical significance even though they do not impair IVF/ICSI pregnancy rates. It is now clear that 
in a study by Paldi, (2003), it was found that proper chromatin structure is critical for methylation 
of imprinted genes.  
However, chromatin structure aberrations and abnormalities in the P1/P2 ratio may themselves be 
unrelated and may simply reflect generalized problems during spermiogenesis. Further studies are 
critical for our understanding of these proposed chromatin structure changes in patients with 
aberrant P1/P2 ratios. 
5-4-3- P1/P2 Content and Sperm Quality 
Many studies had detected a relation between abnormal protamine expression and male infertility 
(de Yebra et al., 1993; 1998; Carrell and Liu, 2001; Mengual et al., 2003). Animal studies reported 
that protamine or transition protein haplo-insufficiencies resulted in infertility, abnormal chromatin 
packaging, DNA damage, and altered sperm morphology (Cho et al., 2001; Zhao et al., 2004; 
Suganuma et al., 2005). 
The finding of the current study showed that P1/P2 ratios for all participants (n=166) (Table 10a) 
was correlated negatively with sperm concentration (r=-.055, p>0.050) and sperm viability (r=-
0.139, p>0.050). Significant negative correlations were found with sperm membrane integrity (r=-
0.168, p<0.050), sperm motility (r=-0.235, p<0.010) and morphologically normal sperm (r=-0.253, 
p<0.010). Sperm non-condensed chromatin and DNA fragmentation showed significantly positive 
correlations (p<0.010) with P1/P2 ratios (r=0.264, r=0.337 respectively). In contrast, P1/P2 ratios 
in patients samples were higher than in volunteers samples (1.22 ± 0.36 vs. 1.10 ± 0.20, p<0.05 
respectively). 
In healthy volunteers samples P1/P2 ratios (Table 12a) were correlated (p>0.050) negatively with 
sperm motility, viability, membrane integrity and morphologically normal sperm. A significant 
correlation was found with DNA fragmentation (r=0.296, p<0.050). Likewise, in patients samples 
(Table 13a) negative (p>0.05) correlations were detected with sperm concentrations, viability, 
membrane integrity and morphologically normal sperm, and positive correlations with non-
condensed chromatin and DNA fragmentation. 
Furthermore, in the present investigation the P1/P2 ratios (Table 14) were significantly higher in all 
smokers group (n=72) in comparison to all non-smokers (n=94) (1.30 ± 0.42, vs. 1.09 ± 0.18, 
p<0.010). Nevertheless, in volunteers samples (Table 15) a significant difference (p<0.050) was 
found in the P1/P2 ratios between healthy volunteers smokers (1.19 ± 0.27) and healthy volunteers 
non-smokers (1.04 ± 0.11). Similarly, in subfertile patients samples (Table 17) P1/P2 ratios of 
smokers was significant higher (p<0.010) than non-smokers (1.11 ± 0.20, 1.34 ± 0.46 respectively). 
According to these finding, there seem to be that abnormalities in P1/P2 ratios affect the sperm 
quality and function. These results are in close agreement with other reports (Aoki et al., 2005a,b) 
who showed that in patients with abnormal P1/P2 ratio the mean percentage of sperm count, 
motility, viability, sperm penetration capacity, and abnormal sperm morphology decreased and the 
mean percentage of DNA fragmentation increased (Aoki et al., 2006b). These results are consistent 
with the published literatures (de Yebra et al., 1993; 1998; Carrell and Liu, 2001; Mengual et al., 
2003). Recently, Hammoud et al., (2009) found that patients with abnormal P1/P2 ratios had less 
normal sperm heads and more tapered sperm when compared to patients with a normal protamine 
ratio although these differences were not significantly different among the group with abnormal 
and those with normal P1/P2 ratio groups.  
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5-4-4- P1/P2 Content and Semen Parameters 
When sperm is passing from the testis to the epididymis, a further stabilization of nuclear structure 
is achieved by thiol-oxidation of the cysteine-rich protamines. In mouse and man cauda epididymis, 
95% of SH groups are converted into -S-S- bridges (Seligman et al., 1994). Protamine thiol 
oxidation has been linked to the stability of the DNA (Kosower et al., 1992). 
It was shown that oxidative stress can damage sperm DNA by causing deletions, mutations, and 
other lethal genetic effects (Tominga et al., 2004). Many studies have reported a connection 
between oxidative stress and DNA damage (Irvine et al., 2000; Mustafa et al., 2004). 
Our results showed P1/P2 ratios that were significantly positive (p<0.010) with the concentrations 
of the oxidative biomarkers; MDA, ROS (Fig. 18), cotinine, and 8-OHdG (r=0.384, r=0.410, 
r=0.411, r=0393 respectively) for all participants underwent this study. Moreover, by dividing the 
participants into two groups, a healthy volunteers and subfertile patients who underwent ICSI 
therapy, significant correlations were found between P1/P2 ratios and oxidative stress markers in 
seminal plasma (MDA, ROS, Cotinine, and 8-OHdG) in both groups. 
The current data suggest that the observed alterations in protamines P1/P2 ratios in spermatozoa are 
the negative biological effect of oxidative stress on sperm DNA. 
Oxidative stresses affect DNA, proteins, and lipids in spermatozoa and increase the sperm 
abnormalities (Aitken and Baker, 2006). The damage of the nucleus proteins caused by oxidative 
stress and free radicals may prevent the binding of protamines to sperm DNA. Accordingly, Aoki et 
al., (2006b) pointed out those abnormalities in protamination making the sperm DNA more 
susceptible to DNA damage.  Denaturation of protamines may be resulting from oxidative stress 
compounds directly. Moreover, oxidative stress may affect the levels of protamine through 
affecting the spermatogenesis process. 
As proteins comprise the major non-water component of cells, they are also the major intracellular 
ROS targets (for reviews see Davies, 2005). Under conditions of oxidative stress, the amount of 
ROS generated is expected to be greater than under normal redox regulation conditions and may 
lead to oxidation of specific proteins.  
Proteins are one of the prime targets for oxidative damage (Jung et al., 2007), and cysteine residues 
are particularly sensitive to oxidation because the thiol group (-SH) in cysteine can be oxidized 
(Eaton, 2006). Redox ratios disturbances in plasma, increasing vulnerability of thiol groups to 
oxidative damage (Kemp et al., 2008). Due to the fact that protamines are rich in cysteine, which is 
rich in –SH group, they are susceptible to oxidation, and high levels of these oxidative stress 
components may affect the formation of inter- and intra-disulfide bonds, resulting in less 
compaction of the sperm chromatin and high incidence of DNA damage. Proportion between P1/P2 
ratios indicated that P2 is more vulnerable to oxidative stress. 
5-4-5- P1/P2 Content and Fertilization and Pregnancy Rates 
Normal sperm nuclear composition is essential to maintain sperm DNA integrity (Chao et al., 2001; 
2003), as any disruption will likely have a profound effect on the integrity of sperm DNA and its 
fertilization potential. Abnormalities in sperm protamination are a common defect in male 
infertility, indicating that the proper functioning of protamines is essential for successful egg-sperm 
fertilization process (Nasr-Esfahani et al., 2008). In addition, Sakkas et al., (1999b), reported that a 
high percentage of injected or fail fertilized oocytes contain condense sperm or sperm with 
premature chromosomal condensation. The ratios of sperm P1 to P2 is important since it is directly 
related to fertilization and pregnancy rate. Individual sperm cells that display the lowest protamine 
levels show diminished viability and increased susceptibility to DNA damage (Aoki et al., 2006a; 
b) 
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The result of this study shows that P1, P2 and P1/P2 ratio concentrations (Table 30) correlated 
none significantly with the fertilization rate and pregnancy rate. This non-significant correlation 
may be due to low number of cases involved in this study. These results indicate that protamine 
deficiency or alterations in protamination are associated with male infertility. These results are 
supported by a study conducted by Steger et al., (2008) who reported that protamine ratios 
exhibited a highly significant difference between patients and controls. However, no significant 
correlations could be demonstrated with the fertilization and pregnancy rates. This is in contrast 
with IVF rates that have been reported to be significantly reduced in patients with abnormally low 
and high P1/P2 ratios (Aoki et al., 2006b). Recently, de Mateo et al., (2009) reported that Pre-
P2/P2 and P1/P2 ratios are positively associated with the pregnancy rate and P1/P2 ratio is 
positively associated with the proportion of embryos obtained by IVF, but not by ICSI.  
Carrell et al., (2007) postulated that the selection of morphologically normal sperm for treatment 
decreases the risk of using a sperm with less condensed chromatin. However, these results are 
related to that of previous studies using the same kind of protamine detection (Carrell and Liu, 
2001; Aoki et al., 2005b). 
The influences of the damaged or decondensed sperm chromatin in the fertilization and subsequent 
development of the embryo are not clear. It has been proposed that sperm with normal morphology 
are important up to the fertilization step, while the DNA integrity becomes the most important 
sperm parameter related to the establishment and continuation of a pregnancy (Tomlinson et al., 
2001). It is clear that poor chromatin condensation and possible DNA damage may also contribute 
to failure of sperm decondensation after ICSI and subsequently result in fertilization failure 
(Bianchi et al., 1996). It is possible that protamine 2 acts after the fertilization process as initiating 
factor for pronucleus formation and the correct development of the embryo (Corzett et al., 2002). 
More studies involving a large number of subjects, together with multivariate logistic regression 
analysis including all semen variables and female factors, are needed to determine the impact of 
sperm protamination on the outcome of IVF/ICSI procedures. 
5-4-6- P1/P2 ratio Grouping 
Protamines 1 and 2 are the most abundant of the nuclear proteins in the sperm nucleus that package 
the human male genome (Bianchi et al., 1992; Lewis et al., 2003). The protamine P2 content in the 
nucleus of normal sperm cells is similar to that of protamine P1 (P1/P2 ratio almost equal 1) and  
ratios outside of 0.8 to 1.2 appears to  indicate abnormal expression (Balhorn et al., 1988; Corzett 
et al., 2002). The P1/P2 ratio has been considered by many authors as evidence of nuclear maturity 
(Belokopytova et al., 1993; Colleu et al., 1996). However, it remains unknown whether the 
differences in the P1/P2 ratio among independent samples are due to an overall variation in the 
levels of protamine P2 common to all sperm types present in the ejaculate or whether, instead, the 
differences are due to the mixed sperm populations. A reduction in P2 protamine content has been 
reported in different studies in infertile patients (Torregrosa et al., 2006). 
De Yebra et al., (1993) have demonstrated that infertile men have a higher degree of variability in 
the relative sperm histone to total nuclear protein ratio. 1n addition, de Yebra and Oliva (1993) 
were the first to notice with biochemical methods that over a range of infertile patients higher P1/P2 
ratios correlated with higher histone levels. An excess of nuclear histones may result in poorer 
chromatin compaction due to incomplete protamination and an increased susceptibility to DNA 
damage (Cho et al., 2001; 2003; Aoki et al., 2005b; 2006b). 
It was shown that only 20% of spermatozoa of fertile men possess human testis specific histone 2B, 
suggesting the presence of different sperm population in human ejaculate (Zalensky et al., 2002). 
Moreover, two distinct human testis/sperm –specific H2B variants (hTSH2B/H2BF WT) have been 
cloned and characterized (Zalensky et al., 2002; Churikove et al., 2004a). These isoform variants 
may not be uniformly distributed throughout the sperm population. 
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Many studies reported that high and low P1/P2 ratios were associated with altered seminal 
parameters in infertile patients (Balhorn et al., 1988; de Yebra et al., 1993; Mengual et al., 2003; 
Aoki et al., 2005a).   
In this study 25 samples (15.1%) were identified with abnormally low P1/P2 ratios, 36 samples 
(21.7%) with normal P1/P2 ratios and 105 samples (63.3%) with abnormally high P1/P2 ration. In 
addition, results indicated that 58.0% of the healthy volunteers group revealed protamine 
abnormality (high and low P1/P2 ratios) and the remaining 42.0% were normal. In contrast, the 
patients group underwent ICSI therapy and the corresponding values were 87.1% and 12.9% 
respectively. 
Furthermore, by grouping all participants (Tables 26 and 27) into smokers group (n=72) and non-
smokers group (n=94). 70 samples (97.2%) of smokers showed abnormal P1/P2 ratios comparing 
to 60 samples (63.8%) of non-smokers.  In addition, it was shown that 89.5% of volunteers smokers 
revealed abnormal P1/P2 ratios (low and high), whereas, in non-smokers only 38.8% presented 
abnormal ratios. Besides, patients smokers showed 100% protamine abnormality (no normal P1/P2 
ratio detected), while 76.2% showed such abnormality in the non-smokers group. 
All these findings indicated that most of the participants in this study had high P1/P2 ratio (63.3 %, 
105/166) and 80.5%, (58/72) of the smokers have high P1/P2 ratios. This indicated that under-
expression of P2 is the reason for the majority of the cases.  
In a study by Aoki et al., 37 patients were identified with abnormally low P1/P2 ratios, 99 patients 
with normal P1/P2 ratios and 13 patients with abnormally high P1/P2 ration (Aoki et al., 2005b). 
There was also a significant increase in the incidence of DNA fragmentation in patients with 
diminished levels of either P1 or P2. These data highlight a relationship between human sperm 
protamine content and increased levels of DNA fragmentation. The precise mechanism that is 
responsible for P1/P2 ratios deregulation in infertile males are unknown (Aoki et al., 2006b), 
although studies have shown decreased levels of P1 mRNA in testes from infertile men (Steger et 
al., 2003).  
The present results suggest that those infertile (patients and smokers) with lower or higher P1/ P2 
ratios may also have poor sperm DNA integrity and enhanced susceptibility to DNA damage and 
consequently reduced fertility in vivo and in vitro (Hammadeh. et al., 1996; Spano et al., 2000; Zini 
et al., 2001; Morris et al., 2002; Benchaib et al., 2003, Bungum., et al., 2004; Hammadeh et al., 
2008).  
Sperm protamine deficiency (partial or complete) is observed in a subgroup of infertile men. It is 
noteworthy that altered P1/P2 ratios and the absence of P2 are associated with human male fertility 
problems (Balhorn et al., 1988; de Yebra et al., 1993, 1998a; Bench et al., 1998; Carrell and Liu 
2001; Mengual et al., 2003). Mengual et al., (2003) have reported that the sperm nuclear P1/P2 
ratio in the subgroup of men with asthenospermia was not significantly different from that of the 
fertile men. However, the P1 to P2 ratio was significantly higher in the subgroup of men with 
oligospermia compared to the fertile controls. In addition, when the ratio of P1 to P2 in 
normospermic human samples is around 1 (Balhorn et al., 1988), is evaluated in oligospermic 
subjects, often a shortage of P2 is found in combination with the presence of P2 precursor proteins 
(de Yebra et al., 1998). 
5-4-7- P1/P2 ratios and seminal characteristics 
Numerous reports have indicated abnormalities in the nucleus of ejaculated sperms (Sakkas et al., 
2000; Ollero et al., 2001; Tomlinson et al., 2001). Sperms DNA fragmentation have been 
correlated with non-chromatin condensation (Gorczyca et al., 1993; Borini et al., 2006; Tarrozi., et 
al., 2009). Also, abnormalities in protamination have been correlated with nicking of DNA 
(Bianchi et al., 1993). Marcon and Boissoneault (2004) have suggested that DNA damage may be 
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the result of incorrect repair of transient DNA nicks that are introduced during spermiogenesis. 
These nicks may cause improper replacement of histones by protamines which may have resulted 
in low P1/P2 ratios. Different mechanisms have been proposed to explain the presence of these 
abnormalities in human ejaculate. First Sakkas et al., (2002) had proposed that some sperm could 
have escaped programmed cell death (apoptosis), that could be linked to defects in remodeling of 
the cytoplasm during spermiogenesis. A second proposed mechanism was that damaged DNA 
could be resulting from defective protamine deposition during nuclear remodeling during 
spermiogenesis (Ollero et al., 2001). Ollero et al., (2001) also proposed that the coexistence of both 
mature and immature sperm during transportation from the seminiferous tubules to the epididymis 
could result in oxidative DNA damage of mature sperm. Our findings could be consistent with 
these proposed mechanisms.  
Sperm DNA damage has been associated with protamine deficiency (Cho et al., 2001; Aoki et al., 
2005b; 2006b). Infertile men have an increased sperm histone to protamine ratio when compared 
with fertile controls, and an important subset of infertile men (5%–15%), but not of fertile men, 
possesses a complete protamine deficiency (Zhang et al., 2006). Protamine deficiency (absolute or 
relative) can potentially result in defective chromatin compaction and in an increased susceptibility 
to DNA damage (Aoki et al., 2005b). 
The result of this work showed that within the low, normal and high P1/P2 ratios, the distributions 
of protamines were varied (Table 29; Figures 34-44). Comparing to the levels of P1, P2, and P1/P2/ 
ratio of normal P1/P2 ratios group (373.14 ± 78.12, 370.55 ± 71.07, 1.01 ± 0.05), the low P1/P2 
ratio (0.77 ± 0.07) group showed similar level of P1 (371.31 ± 75.73) and over-expression of P2 
(480.79 ± 91.55) levels, whereas, high P1/P2 ratio (1.35 ± 0.30) group showed over-expression of 
P1 (424.13 ± 110.94) and under-expression of P2 (325.12 ± 95.72). These results indicated that P2 
over-expression was the cause of low P1/P2 ratio, while in high P1/P2 ratio both over-expression of 
P1 and under-expression of P2 were the causes. The levels of oxidative stress markers (MDA, 
ROS, and 8-OHdG) and smoking marker (cotinine) levels were significantly higher (p<0.010) in 
low and high P1/P2 ratios groups compared to normal ratio group. The levels of these markers were 
higher in high P1/P2 ratio than low P1/P2 ratio groups except for 8-OHdG that was almost similar.  
These results demonstrated that oxidative stress and smoking affected the integrity of the sperm 
DNA and the protamines levels could be explained by 1) oxidative stress and smoking may affect 
the protamines proteins by disturbing the formation of inter- and intra- disulphide bonds between 
the protamines and DNA or within the protamines themselves, 2) oxidative stress and smoking may 
affect the sperm DNA directly causing genetic effects (Tominga et al., 2004) that might affect the 
binding of protamines with DNA properly, and 3) oxidative stress and smoking may affect the 
levels of protamine through affecting the spermatogenesis process, where excess production of free 
radicals from cigarette smoke or environmental pollutants, may be involved in errors in 
spermiogenesis resulting in abnormalities in protamination and DNA damage.  
Moreover, these findings could be confirmed on two levels; 1) the results of studying the chromatin 
condensation and DNA integrity within this work showed significantly higher (p<0.010) difference 
in the levels of non-condensed chromatin and DNA fragmentation in low P1/P2 ratio group (30.5 ± 
6.9, 14.7 ± 4.6 respectively) and high P1/P2 ratio group (31.7 ± 9.2, 13.8 ± 6.0 respectively) 
comparing to normal P1/P2 ratio group (24.8 ± 7.9, 8.5 ± 4.1 respectively); and 2) these findings 
are in agreement with numerous previous studies that found a correlation between DNA integrity 
and protamination (Bianchi et al., 1993; Manicardi et al., 1995; Razavi et al., 2003; Naser-Esfahani 
et al., 2005; Aoki et al., 2005 b; 2006; Torregrosa et al., 2006; Borini et al., 2006; Carrell et al., 
2007; Tarrozi., et al., 2009). 
The elevation in high P1/P2 ratios within patients and volunteers indicated  that P2 under-
expression accounts for the majority of cases with high ratios. This is in agreement with the results 
of De Yebra et al., (1998b) who reported that the increased P1/P2 ratio could be due to a decrease 
in the P2 content caused by deficient processing of this protamine. A number of reports have  noted 
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abnormal  P1/P2 ratios in  the sperm of infertile human males, suggesting that the relative 
amounts of each protamine is important for proper spermatid differentiation (Balhorn et al., 1988; 
Belokopytova et al., 1993; Steger et al., 2003; Aoki et al., 2005a , 2006a; Carrell et al., 2007). 
In addition, high P1/P2 ratios were correlated with pre-P2 detected in patients samples. This is 
consistent with the hypothesis that states that incomplete processing of pre-P2 may result in lower 
levels of mature P2 and therefore an increased P1/P2 ratio (Bench et al., 1998; de Yebra et al., 
1998; Torregrosa et al., 2006; de Mateo et al., 2009). Torregrosa et al., (2006) found an inverse 
correlation between Pre P2/P2 ratio with sperm count, normal morphology and motility. They 
suggested that positive correlations between TUNEL –positive sperm and Pre –P2 at low pre2/P2 
ratios link between deficient protamine processing and decreased DNA integrity.  
Inefficient sperm chromatin packaging in sperm of patients with low P1/P2 ratio may be due to P2 
over-expression or/and P1 under-expression (Aoki et al., 2005a). Zhang et al., (2006) found that 
the low P1/P2 ratios patients have high contents of H2B histones. These data suggest that those 
infertile men with high sperm nuclear histone H2B to protamine ratio have a defect in 
spermiogenesis (the later stage of spermatogenesis), as this is the specific step in spermatogenesis 
where the final assembly of sperm proteins (displacement of histones by transition proteins and 
then by protamines) occurs. Recently, Hammoud et al., (2009) had found that a decrease in P1/P2 
ratio corresponded with an increase in the amount of histones retained. Moreover, de Mateo et al., 
(2009) demonstrated that Pre-P2/P2 and P1/P2 ratios are positively associated with the pregnancy 
rate. The potential explanation for this correlation could be that Pre-P2/P2 ratio also correlates with 
P1/P2 ratio and that P1/P2 ratio correlates with pregnancy outcome. Thus, a low pre-P2/P2 ratio 
could be a marker for a low P1/P2 ratio.  
5-4-8- Relationship between Protamines and Smoking 
The real influence of tobacco on male fertility remains controversial. Many studies have been 
conducted to examine the relationship between cigarette smoking and male infertility; however, the 
exact molecular mechanisms are not well understood in most cases (Arabi and Mosthaghi, 2005). 
Cigarette smoking may be associated with subfertility in men and may result in decreased sperm 
concentration, lower sperm motility, and a reduced percentage of morphologically normal sperm 
(Sofikitis et al., 1995). Smoking may damage the chromatin structure and produce endogenous 
DNA strand breaks in human sperm (Zenezes, 2000). In fact, levels of DNA damage tend to be 
higher in smokers (Saleh et al., 2002a). 
The findings of this study showed that total amounts of protamines in all non-smokers were higher 
than smokers (779.44 vs. 743.20 respectively). P1 concentrations in non-smokers and smokers were 
almost equal (402.63 ± 93.96 vs. 407.60 ± 128.80, p>0.05), whereas, P2 concentrations in non-
smokers were significantly higher (p<0.050) than that of smokers (376.81 ± 97.36 vs. 335.60 ± 
110.60 respectively). The data from volunteers group showed that P2 concentrations in smokers 
were lower than in non-smokers (338.10 ± 90.20 vs. 352.9 ± 69.3). The same trend was found 
within the patients group (334.7 ± 117.7 vs. 388.8 ± 107.2). These data also showed that P2 
concentration in smokers of patients was lower than that of volunteers smokers. Besides, the P1/P2 
ratios of smokers in all smokers, volunteers and patients were significantly higher (p<0.010) than 
non-smokers, (1.30 ± 0.42, 1.19 ± 0.27, 1.34 ± 0.46 for smokers respectively) and (1.09 ± 0.18, 
1.04 ± 0.11, 1.11 ± 0.20 for non-smokers respectively).  
These findings indicated that the causative agent for higher P1/P2 ratios in smokers was the under-
expression of P2 and suggest that smoking may affect P2 expression greater than P1. This is the 
first study conducted to evaluate the effect of smoking on protamination process. 
Moreover, smoking may affect protamines themselves directly or their binding with DNA or DNA 
directly through increasing the oxidative stress. Smoking itself may be a source of ROS or inducing 
oxidative stress through its metabolites that may induce an inflammatory reaction, which resulted in 
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leukocytes production considered a source of ROS. Smoking toxic metabolites may also affect 
the spermatogenesis process directly.  
Many studies proposed that P2 under-expression was the reason for elevation of P1/P2 ratio 
(Balhorn et al., 1988; de Yebra et al., 1993; 1998; Mengual et al., 2003; Aoki et al., 2005a), but 
none of them study the effect of smoking on protamines. Studying the evolution of protamines by 
Lewis et al., (2003) revealed that P2 gene is more recently derived than P1 and highly variable 
within the mammalian gen. Also, incomplete post-transitional process of protamines may result in 
under-expression of P2 and an increase in P2-precursors (de Yebra et al., 1998; Carrell and Liu, 
2001).  
Conclusion 
The data from this study indicated that abnormalities in sperm chromatin condensation evaluated 
by CMA3 and DNA integrity evaluated by TUNEL were related to abnormalities in sperm 
parameters, and also affected fertilization and pregnancy rates. This work showed the possibility of 
using CMA3 and TUNEL tests as prognostic tools for IVF/ICSI patients.  
Oxidative stress  induced lipid peroxidation that in turn induces significant sperm membrane 
damage and DNA damage, which remarkably influenced sperm quality (concentration, motility, 
morphology, viability, membrane integrity, chromatin condensation, DNA integrity). It is quite 
probable that such a deleterious effect may account for some cases of male infertility and 
evaluation of oxidative stress biomarkers (ROS, MDA, and 8-OHdG), and may be a part of infertile 
male workup in the near future. Also, oxidative stress inversely affects fertilization and pregnancy 
rates. Reactive oxygen species status may be used as an important indicator for clinical evaluation 
and treatment of malefactor infertility. 
In this study smokers showed high levels of oxidative stress biomarkers and decreased sperm 
quality compared to non-smokers. This study also demonstrated that cigarette smoking impairs 
sperm function by reducing the quality and fertilizing capacity. This is probably because of high 
levels to toxic components of smoking that cause to increase of seminal plasma free radicals and 
oxidative stress.  
The high level of smoking biomarker cotinineas found in this work may decrease male fertility by 
reducing sperm quality and inversely affect the percentage of fertilization and pregnancy rates. 
Quantification of the protamines revealed that most of the cases were of high P1/P2 ratio and the 
majority was due to under-expression of P2. Results also showed that aberrant P1/P2 ratios are 
associated with reduced sperm quality and percentages of fertilization and pregnancy rates. 
Protamine concentrations (P1 and P2), were inversely correlate with the DNA fragmentation and 
non-condensed chromatin. Evaluation of the effects of smoking on protamines demonstrated a 
reduction in protamines concentrations and elevation of P1/P2 ratio in smokers compared to non-
smokers. 
Given the potential adverse effects of smoking on fertility, physicians should advise infertile 
patients who smoke cigarettes to quit smoking. Additional studies with large number of subjects are 
needed to confirm the effect of smoking on protamines and clarifying the potential mechanism 
behind this effect. 
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